var title_f26_20_26944="Faces pain scale children";
var content_f26_20_26944=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 499px\">",
"   <div class=\"ttl\">",
"    Wong-Baker FACES pain rating scale",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 479px; height: 163px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Explain to the child that each face is for a person who feels happy because he has no pain (hurt) or sad because he has some or a lot of pain. Face 0 is very happy because he doesn't hurt at all. Face 1 hurts just a little bit. Face 2 hurts a little more. Face 3 hurts even more. Face 4 hurts a whole lot. Face 5 hurts as much as you can imagine, although you don't have to be crying to feel this bad. Ask the child to choose the face that best describes how he is feeling. Rating scale is recommended for persons age three years and older. Point to each face using the words to describe the pain intensity. Ask the child to choose the face that best describes own pain and record the appropriate number.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wong DL, Hockenberry-Eaton M, Wilson D, et al. Wong's Essentials of Pediatric Nursing, 6th ed. Mosby, St. Louis, 2001. p.301. Copyright &copy; 2001 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26944=[""].join("\n");
var outline_f26_20_26944=null;
var title_f26_20_26945="Patient information: Transient tachypnea of the newborn (The Basics)";
var content_f26_20_26945=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/17/14611\">",
"         Patient information: Pneumonia in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/62/23521\">",
"         Patient information: Sepsis in newborn babies (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/19/27958\">",
"         Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Transient tachypnea of the newborn (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/transient-tachypnea-of-the-newborn-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H23424356\">",
"      <span class=\"h1\">",
"       What is transient tachypnea of the newborn?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Transient tachypnea of the newborn (called &ldquo;TTN&rdquo; here) is a condition that causes breathing problems in newborn babies.",
"     </p>",
"     <p>",
"      Babies have fluid in their lungs before birth. The fluid normally goes away when a baby is born. In some babies, the fluid does not go away as quickly as it should. This causes TTN.",
"     </p>",
"     <p>",
"      A mother who has diabetes, asthma, or a c-section without labor is more likely to have a baby with TTN. A c-section is also called a &ldquo;cesarean delivery.&rdquo; It is a type of surgery used to deliver a baby.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23424371\">",
"      <span class=\"h1\">",
"       What are the symptoms of TTN?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms usually happen within 2 hours after birth. They include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fast breathing &ndash; More than 60 breaths a minute. This is more than 1 breath every second.",
"       </li>",
"       <li>",
"        Skin that looks blue",
"       </li>",
"       <li>",
"        Hard breathing &ndash; This can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Nostrils that open wide when the baby takes a breath",
"       </li>",
"       <li>",
"        Skin and muscles that look like they are caving in - This can happen between the baby&rsquo;s ribs or under the baby&rsquo;s ribcage.",
"       </li>",
"       <li>",
"        Grunting when the baby breathes out",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms of TTN usually last 12 to 72 hours.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23424386\">",
"      <span class=\"h1\">",
"       Is there a test for TTN?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No, there is no single test. The doctor or nurse can often tell if a baby has TTN by doing an exam.",
"     </p>",
"     <p>",
"      Other conditions can cause breathing problems similar to TTN. These include serious conditions such as pneumonia. The doctor can order a chest X-ray that shows changes in the lungs. Looking at the X-ray can help the doctor learn if a baby has TTN or a different condition.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23424400\">",
"      <span class=\"h1\">",
"       How is TTN treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;TTN usually goes away by the time a baby is 3 days old. Until that happens, doctors can help the baby get enough oxygen and nutrition if he or she needs it. Treatments might include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Extra oxygen &ndash; This helps make sure the baby has enough oxygen in his or her blood.",
"       </li>",
"       <li>",
"        Temperature control &ndash; This keeps the baby from getting too hot or too cold.",
"       </li>",
"       <li>",
"        A feeding tube or &ldquo;IV&rdquo; &ndash; If the baby has trouble breathing, he or she might not be able to nurse or drink from a bottle. A feeding tube is a small tube that goes into the baby&rsquo;s mouth or nose, down the throat, and into the stomach. It can be used to put breast milk or formula right into the baby&rsquo;s stomach.",
"        <br/>",
"        <br/>",
"        An IV is a thin tube that goes into a vein. It can carry a sugar mixture into the baby&rsquo;s bloodstream.",
"       </li>",
"       <li>",
"        Antibiotics &ndash; These are medicines to keep infections from happening or stop them if they do happen.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23424415\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/17/14611?source=see_link\">",
"       Patient information: Pneumonia in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=see_link\">",
"       Patient information: Sepsis in newborn babies (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=see_link\">",
"       Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/20/26945?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83311 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-DB21B48F7E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26945=[""].join("\n");
var outline_f26_20_26945=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23424356\">",
"      What is transient tachypnea of the newborn?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23424371\">",
"      What are the symptoms of TTN?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23424386\">",
"      Is there a test for TTN?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23424400\">",
"      How is TTN treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23424415\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/17/14611?source=related_link\">",
"      Patient information: Pneumonia in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=related_link\">",
"      Patient information: Sepsis in newborn babies (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26946="Paraaortic node dissection1";
var content_f26_20_26946=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beginning right paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26946=[""].join("\n");
var outline_f26_20_26946=null;
var title_f26_20_26947="NSAIDs (including aspirin): Treatment of gastroduodenal toxicity";
var content_f26_20_26947=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   NSAIDs (including aspirin): Treatment of gastroduodenal toxicity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26947/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26947/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26947/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26947/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26947/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26947/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/20/26947/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal antiinflammatory drugs (NSAIDs), including low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , cause considerable morbidity and mortality related to gastric and duodenal ulcer disease, particularly gastrointestinal (GI) bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of gastroduodenal toxicity associated with NSAID therapy will be reviewed here. Modalities used for primary and secondary prevention of gastroduodenal toxicity, including the role of cyclooxygenase (COX)-2 selective NSAIDs, are discussed separately as is the pathogenesis of the gastroduodenal toxicity. The prevention of recurrent gastroduodenal toxicity is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=see_link\">",
"     \"NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=see_link\">",
"     \"NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/58/12197?source=see_link\">",
"     \"NSAIDs (including aspirin): Secondary prevention of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a patient develops an ulcer while on a nonsteroidal antiinflammatory drug (NSAID) or low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , the NSAID or low-dose aspirin should be stopped if at all possible and traditional ulcer therapy with a proton pump inhibitor or an H2 antagonist started [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/2\">",
"     2",
"    </a>",
"    ]. Proton pump inhibitors are generally preferred because they are associated with more rapid ulcer healing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=see_link\">",
"     \"Overview of the natural history and treatment of peptic ulcer disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As in all patients with peptic ulcers, the patient's H. pylori status should also be assessed (if not done previously); if positive, appropriate therapy for H. pylori should be instituted [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/3\">",
"     3",
"    </a>",
"    ]. However, the sensitivity of H. pylori testing in the setting of acute GI bleeding is significantly reduced. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37817?source=see_link&amp;anchor=H7949949#H7949949\">",
"     \"Indications and diagnostic tests for Helicobacter pylori infection\", section on 'Peptic ulcers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"     \"Treatment regimens for Helicobacter pylori\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12455?source=see_link\">",
"     \"Management of duodenal ulcers in patients infected with Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who must remain on low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or NSAID therapy, randomized trials have shown that ulcer healing occurs more rapidly with a proton pump inhibitor than an H2 antagonist [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/4,5\">",
"     4,5",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/6\">",
"     6",
"    </a>",
"    ], or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one trial, 541 patients who had ulcers or numerous (&gt;10) erosions in the stomach or duodenum and who required continuous treatment with NSAIDs were randomly assigned to treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      (20 or 40 mg PO daily) or the H2 antagonist",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"       ranitidine",
"      </a>",
"      (150 mg PO twice daily) for four or eight weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/4\">",
"       4",
"      </a>",
"      ]. At eight weeks, the success rate was greater with omeprazole (80 and 79 versus 63 percent with ranitidine).",
"     </li>",
"     <li>",
"      In a second trial, 935 patients who had ulcers or numerous erosions in the stomach or duodenum and who required continuous treatment with NSAIDs were randomly assigned to treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      (20 or 40 mg PO daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      (200 mcg four times per day). Patients were treated for four weeks or, in the absence of healing, eight weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/6\">",
"       6",
"      </a>",
"      ]. The rates of healing of gastric ulcers (87 versus 73 percent) and duodenal ulcers (93 versus 77 percent) were significantly higher with omeprazole (20 mg) than with misoprostol. The outcomes with 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of omeprazole were also superior to misoprostol.",
"     </li>",
"     <li>",
"      The efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      (20 mg daily) was compared to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"       sucralfate",
"      </a>",
"      (2 g twice daily) in a much smaller study of 98 patients with gastric and duodenal ulcers who required continued treatment with NSAIDs [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26947/abstract/7\">",
"       7",
"      </a>",
"      ]. At eight weeks, omeprazole was significantly superior to sucralfate for healing gastric ulcers (87 versus 52 percent), while the differences in the rates of healing of duodenal ulcers (95 versus 73 percent) did not reach statistical significance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no data that suggest that any of the available proton pump inhibitors are more efficacious than another. The table lists the available medications and their usual dose (",
"    <a class=\"graphic graphic_table graphicRef81079 \" href=\"UTD.htm?22/37/23131\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Treatment with a PPI is generally continued for four to eight weeks, depending on the ulcer location (duodenal or gastric (",
"    <a class=\"graphic graphic_table graphicRef81079 \" href=\"UTD.htm?22/37/23131\">",
"     table 1",
"    </a>",
"    )), the original ulcer size and the severity of the initial clinical presentation. Endoscopic follow-up to assess ulcer healing is usually unnecessary for duodenal ulcers, but should be performed to assess healing of gastric ulcers if there had been any concern that malignancy had not been excluded at the initial endoscopy.",
"   </p>",
"   <p>",
"    Maintenance therapy is indicated in patients who remain on or resume NSAID treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/58/12197?source=see_link\">",
"     \"NSAIDs (including aspirin): Secondary prevention of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who develop an ulcer while on a nonsteroidal antiinflammatory drug (NSAID) or low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , we recommend stopping the NSAID if possible. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who can stop",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      or NSAIDs, we recommend treating with a proton pump inhibitor or an H2 receptor antagonist (",
"      <a class=\"graphic graphic_table graphicRef81079 \" href=\"UTD.htm?22/37/23131\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We generally use a proton pump inhibitor as these have been associated with more rapid healing. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who cannot stop low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      or NSAID therapy, we recommend treatment with a proton pump inhibitor (",
"      <a class=\"graphic graphic_table graphicRef81079 \" href=\"UTD.htm?22/37/23131\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Maintenance therapy with a PPI is also warranted in such patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=see_link\">",
"       \"Overview of the natural history and treatment of peptic ulcer disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The patient's H. pylori status should also be assessed; if positive, appropriate therapy should be instituted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37817?source=see_link&amp;anchor=H7949949#H7949949\">",
"       \"Indications and diagnostic tests for Helicobacter pylori infection\", section on 'Peptic ulcers'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"       \"Treatment regimens for Helicobacter pylori\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/1\">",
"      Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112:1000.",
"     </a>",
"    </li>",
"    <li>",
"     Cryer B, Spechler SJ. Peptic Ulcer Disease. In: Gastrointestinal and Liver Disease, 8th ed, Feldman M, Friedman LS, Brandt LJ (Eds), WB Saunders, Philadelphia 2006. p.1089.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/3\">",
"      Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/4\">",
"      Yeomans ND, Tulassay Z, Juh&aacute;sz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/5\">",
"      Agrawal NM, Campbell DR, Safdi MA, et al. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med 2000; 160:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/6\">",
"      Hawkey CJ, Karrasch JA, Szczepa&ntilde;ski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26947/abstract/7\">",
"      Bianchi Porro G, Lazzaroni M, Manzionna G, Petrillo M. Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer. Aliment Pharmacol Ther 1998; 12:355.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-DF7F161079-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26947=[""].join("\n");
var outline_f26_20_26947=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/14\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/14|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/37/23131\" title=\"table 1\">",
"      Active and maintenance therapy of gastroduodenal ulcers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37817?source=related_link\">",
"      Indications and diagnostic tests for Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12455?source=related_link\">",
"      Management of duodenal ulcers in patients infected with Helicobacter pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=related_link\">",
"      NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=related_link\">",
"      NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/58/12197?source=related_link\">",
"      NSAIDs (including aspirin): Secondary prevention of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=related_link\">",
"      Overview of the natural history and treatment of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=related_link\">",
"      Treatment regimens for Helicobacter pylori",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26948="Ureter entering bladder";
var content_f26_20_26948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ureteral insertion into the bladder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 404px; height: 364px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFsAZQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK4/V7nUW1tIrS7ljjbVLaAqMY8tYjLIvT+IYBrpNZimn0e+htZHjuJIJEjdG2srFSAQexz3oAuUVyngjUZrye9juJZXkNvZ3WHYkKJIQCFz0G5GP1JPeuroAKKKKACiiigAooqjrupQ6LomoapdLI1vZW8lzIsYBYqiliACQM4HrQBeorlfB3xA8M+MI1/sPVYJZyMm2kPlzL6/IeT9Rke9dVQAUUVy/ivVts40+3lkQRKtzfPBu8xIs/IiYx88jDaBnON3tQB1FFef6xqt3psNpaXU12upXjnUryOGTebeJSoWBD0G5zHEMddzt612mj201rpsMV1PJPcYLSyO2SXJycegycAdhgUAXKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA4XQbyS68Q5Iyk+p30oP8Aswqtv/Ou6rzz4e28o1OxMhyIdKa5bP8Afu7h5T+kdeh0Aed+DLkr4xhjU4iudFEW3/btbl42P/kUV6JXnHh5Gi8W2eUCiG+1W14GMCR0nUfkM16OeOtABTJ5oreF5Z5EiiQZZ3YKqj1JPSuTbxBqPiGV4fB0cH2NWKSaxdKWgyOCIUBBmIORnKoCOrcip7fwTpskqXGvPPr14p3CTUmEiKfVIQBGn1C59zQAp8b6PMxTSDd6zIDj/iW27zpn3lA8sfiwoXVvE13zZ+GorRT31PUFRgP92FZRn23CumRVRFRFCoowFAwAKWgDmfsni6f/AFur6NaL/dg0+SVv++2lA/8AHayfGHhbX9S8J63ax+JtQubmexnijtY4LWKOZ2jYBGLRkgE4GQwIyeR27yigD5b8I/s2arK8Vx4j1mGw2kMIrIGSUH/fOAp9xur6Q8N6OuhaTFYJfX98sfSa+n86U/VuK1KKAKOt6nDpGmy3c4Z8EJHGoy0sjHCoo7kkgfjXNaBp0l3qEkmoGK4W1uDPPcJws14BjCjP3Ilwgz3HqtVtSvZ9a16L7DIyiKR7ayVh8rOOJ7rHcIpKJngsT6g1peJ/sukeHYtKt4mS0kRklERO5LdRmVh3LEfL6lnHc0AU9BM+teI5b9miksWK3CMoBzENywKPrmSYn/bQV21Y/hXTzY6UrSwLBdXJ8+eNTkRsQAEHsihUHsorYoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKjmmigUNNIkak4BdgKerBlDKQQRkEd6AFooooAKKKKACiiobW6t7tGe1ninRXMbNG4YBgcFTjuO4oAmooooAKo69c/Y9D1G56eTbSSfkpP8ASr1YPjpXl8K38EWd9wFtxj/po6p/7NQBB4QtvKnvmP3o4ra1+myFWx/5ENdLXO+DGaZNauG+7Lqk4X6IRF/7TroqAPPNbuxp3iaAxgAjX7Yv/uz2phH/AI9W/wCM7efVP7N0VBMLK/mZb6SPIxbqhZk3DpvO1D7M2Oa5zxkAvibUYwgLtaWGoKT6292S344YV6PQAyGKOCFIoUWOKNQqIgwqgcAADoKfRRQAUUUUAFFFFABXLeOdXFtbx6ZDOYJ7xHaa4V9ptLVR+9n9RgYVf9p19DW/ql9Bpmn3F7ePst4ELufYdh6k9AO5rhNA0271jxBPdarbmC6Z0uL4oSyqq8wWYY9QoPmSY43nuDQB0XgzS1s7Bbk2/wBn8yNI7e3ZMNbWyj93Ec5OcZZs87mPpXPaXNF4n8Xm8hmd7fCypgfKLaNyIwD/ANNZQ0me6xL2rovHF6YNJFlDOsNxfExbyeY4gpaZx7rGGx/tFfWn+DNPez0rz7i3jt7q7IlaJFA8lAAscX/AECj659aAN+iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzH436Nfa1/wAIhDp+mJqIj1iN5Y5oWkgCbGBMuAcJzySK5DX9B8UeDvC2j6FpEmsSyLHeXDXOkrM0McrMGSERoC2B0UsQvLZB6D32svxRrtl4a0G71fVGdbO1UNIUXc2CwHA+pFAHmmht4xv7m5u9Rm1+IWug2d1HaRIsC3V4YWMkZZ4zht2MgYwSM+lcpYah4/Tw74qa3XxIZW063ns1ntZzLHcGUB0QyLuYhc5wMdwMc16ba/FPQrjVIbB7XWLeeS+XT2NxYvGsUzjMYcnpvzwOvqBUifEnR7uSeCxW68xorlrKeaArBdtAD5gjbvjBz06HGaBnFm08Zad4nbyNS8TXdla+I7SCMTJvSW0lUGd2IQbkU8Z+6nbBqlpMXjrUdavrTWrnW4pLhL6C4gFs5tmUo/kmKXHlJghACDk5II7109h8WLe48IG7u4XsNXGlLqeJ7Z/IkXKqxjwcsAzAYyD3GRzVpPiDcf2ve2ky2kMUOtWWmRP5bsZBPGGPQ8Nk4B6DuDQByngTTvET2vgvSI7vxTpdgllOuoM9v5ZilQR7YwZIyAn3gvc/Ng1d03UfFWj3Oj3lzp+tTacut6kl7b21mWd4WBFuxQAEpuwd3Tvmuzf4kaJBqeoWN9FqVlLY2z3dw1xaMqpEpxuz6EjA9e1U7b4s+HLi0uJVXUFuYpoIFszb5nmebPlhFBIOdrd+MHOKAPP0bx9qXh2z+0T+JrS5TRtSuXEULJI9yk7/AGeNvlJyVC4UYLDpwa7j4Y/8JJF4g1OPXZ9WuLSawsrpXvo9qpcOrGZEwqgAHGVHStz4deJ7jxVYavc3VqLU2mqXFikZUq4SMgDeCTh+eccZrrKBBWVr74GnwnnzryJf++SZP/ZK1a5TxrdNa3enSgfLaxXd630SAr/OQUAXPAcLw+EtN83PmSoZ2z6yMXP/AKFW/VTR4vI0myhPBjgRfyUCrdAHDeP7cpqK3aDl9H1C2P1xHIv6oa7DTLpb7TrW7jIKTxJKpHowB/rWR4qkiiutCMy7klvvsx+kkMq/zxUPwzmeXwHool/1kMAt2+sZMZ/9BoA6aiiigAooooAKKK53xnrbaXa21nZSKmrai7QWhZdyxYUs8zj+4igsc98DuKAMHxLqkmsa2LXThFdWmnXCR+X1Fxf9VXPTbCP3r++B1Uiuy0XTYtJ0+O1iZ5CCzySuctLIxLM7e5JJ/QcVzfgHRYYbeHUNjGFYfJsDI2XMRO5p37eZKxLsQM4255zWx4s1A2OleXDN5N3eOLW3kxnYzA5c+yqGc+y0ActdIvibxgYZbaQ24JjL7uBbRSAsev8Ay1mULjusJ7V6HXM+ArGO30cXURcw3IX7MrZylsq7Yhz3K/Of9p2rpqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArH8X+HrTxV4bvdE1GSeO1u1CyPAwVwAwbgkEdQO1alvPFcwrLbyJLEwyro2QfxqSgDjrz4faVdanPfSXF8JptVttXYK6bRNAoCKPl+4QOR19CKgsfhnotneCaO41FoIVuVtLR5VMNmbjPmmIbc5O4/eLYycVxmrW/jK58Tzyw3/AIkt7VvEiWKxwR4iSxeEl5RlDwGwA5yFPTBrOvZvH3/CLeH4pZNeWBJ72G8nigka6wshFuzhF8wrtycqMHjPFAHYS/C3w7p+hXcOq6zqb2n9nDTEuLy5iX7Jb7gdqHYFBJC5LAnjFaSeA9AvNQuZodQupZk1W11GZI5o28ue3QBEI25AIAJB554Iryfx1D4w1fw3qNlrEXiW9dtLtRYR2djIsVxJv/fNcIqkh/lBCtj6V1Wvz+J4IfEiwWWtBJvECpFPaRSK0dv5I/eARrvkTdx8vfvgYoGdIfAmhafca4mq+IL+eHWklmvbW+uIAJF24LZCBwqDGPmwtLbfDDR30yKOPWNVmVZYLq0ulkhDwNHko6MsYDcMRlg2Qa82aw8V6toVhLrFhq9zfJoWuWrSTWjiRiwxCrDGdzADAPJ962bm48VafrvhDw1Y3dzb22uadZ7wTtksPs4BuNoIyu5MDnvxQB6r4P8ADNr4Wsry3tLm7uvtd3Leyy3TqztJJgtyqgYyPSt6iigQVxvjm2kvRewx9XsltAM/895lQ/otdlXH310ZvEdzCDlReWdtj3VWmP6EUAdgOBgdKKKKAOc8dx7tHtZx1tdQtJ+meBOgb/x0mp/CEaQaddW8ZBEV/dDA/h3Tu+PyYVL4wx/wi2rMRny7aSUD3VSw/UVleDboNr/iy0ByqXsVzHz/AAS28R/9CV6AOsr5p+IeqapbfFDxVKl5qNrp1lf6Sj6hFeyhNNSSIFiYFO11fGDnofXdX0tVPWtSt9H0i81G9bbbWsTTSEdcKM4HqfQUAeVSeOtdPj4WEVzCc6zHYppAt9zSWLRhjeiTrjknP3cDHes2x8deJ9SvprT7dGl3PDqQvLFLTD6P5IbyXLZyd2F+913cdK9g8NNqL6FZya3tGpSJ5kyKABGzHdsHrtBC574zWnQB558GLeLRfhTpt9e3Kbbi3/tC5ncFcZQFmYknJAXk+3Ss/RI7rxhrk97ewzW63cSie0uBk21jnMduVHCyzH95JnkLtU9jVj4jamNV1OPRI4WubG0lie7ijf8A4+rpjm3tCP7hx5smeAirnIY13Hh7TG0rTRDPcPdXcjNNc3D9ZZW5Y47AdAOygDtQBpgAAADAHauC1lZ/EHiYWi+W9huazK/9Mxg3MnrzlIAO25zXU+JNQk03SZJbaMy3crLBbxj+KVyFXPsCck9gCaxPh7p1qlm+pWhlkgmQQWry9WgQn9565kcvIT33LnpQB1wAUAKAAOAB2paKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACkyN2MjPXFLXn3i3W3svHGnC1ihllSEqrrLtLsSS1vIO+5RuT0dVB4egDoL+d/D9/BLHADpF1Lsn8sKotZGJPmkYGVZjhiTwcHoTjoaqRSWWs6Urr5V3YXcXRhuSRGHQg9iDyDXOeHZZfDWow+G9QkeWzk3f2TcsWYtGoyYJGJPzoM7T/Eg9VagDrqKKKACiiigAqs1hZtqCX7Wlub5IzCtyYx5ioTkqGxkDPOOlWaKACiiigArhIFkk8Y2YyCs2pXd4Rn+GK3W3/9Cau7rh/AjSX09lfygZNpcSj6T3LOP0QUAdxRRRQBW1O1F7p13at92eJ4j9GBH9a8/wDhqxOtQXGc/bvDtg0h9ZImlRj/AOPD8q9JrgfDvl6Z4h0SzJALw6lbKB/0zuEZR/3zmgDvq5LxN/xOvEuleH1+a2hK6nf9xsRv3MZ/3pBu+kTDvXU3E0dvBJPO6xwxqXd2OAqgZJNc14BhkuLG6167Rku9al+1BWGGjgA2wRn6IAxH952oA6msDxnrraHpQ+xpHPq95ILXT7ZyQJp26ZxztUZZj2VWNbzMqqWchVAySTgAV5JA03j7xILyOSNtNnhKW3BVoNPJw8o7iS5ZSqnjESZ6mgDa+GOhIkY1RwzIrSCCYjb9skc5nvSvrK33ck4jC4wGxXoVMhijhiSKFFjiRQqogwFA6ADsKo+IdRbS9IuLqKMS3AASCInHmysQqJn3YgUAcd4pnk1vxJFp9jeKnlsbOMDnErLmeT3McJ2jtum55Arv4Y0hiSKJQkaKFVQMAAdBXHfD6xDtPqUkQ/d77OCXn97hy08wHYSTbseqohrtKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAryX4waNG139sujcva3UWx22AxQlMFDkYIYHc4Y9MHkYFetVn6/pcesaVNZykrvwUcdVYHIP+PqMjvQBwfw48SkTfZNRuICbmXYxRNipdcliR/D52GcKejrIuTxXdeIdGtte0qWxvN6qxWSOWM7XhkUhkkQjoysAR9PSvBbtrfwxrD2t5NfW8UyeQVQbiyKRyp7SxlfkYdSicfPXunhS+uL/RIJb0q86jY06LiO4GARKn+ywIb2yR2oAr+FtWuJzLpWttCuvWSjzxGCqzofuzoD/C2DxztYFcnGT0FYHirSLi8FrqOkOI9Z09i9vltqTqRhoJDg/I3H0ZVbtV/QtVh1jTkuoFeNslJYZMb4ZFOGRgOjA8f/WoA0KKKKACiiigAoorOGqRDXm0qUxxztbi4hG/5pVDbXwMfwkpnk/eHSgBfEV01j4f1O7T78FrLKPqqE/0rnPh+jwzz2bD/jw06wtD6bhGzN/6GK1fHUwh8KX4bpMFtvr5rrH/AOz03wom64165IAabUXXIHaNEjA/8cNAHQUUUUAFeY3LhfGdg5yZLDxJJAfaO4sSwPsNzCu71zX9I0GFJNa1K0sVkO2Pz5QpkPooPLH2GTXh3iPxzps/jdJ9HttSvtPutW0uWTUI7OZbeDy2dJSzlQOF2dODn2oA9Y8ck6pLpvhmPJGpuXvMD7tnHgyg/wC+Skf0kPpXWABQABgDoBXn/gLXdN1zUdb8SSXlsq3E/wBist8qg/ZYSQGAzkb3Mjdsjb6Vv6/4u0vStJnu4J4tQuBhILO1lVpbiVjtSNRnqWIHtyTwDQBznxR1lZXi8PRSTrFKqy6g0Cks8RbalqpHSSdsqMchVkPGAa6rwro7aTp7td+S+p3T+deSxJtVnwAFH+yqhUX2Ud81xXw/s4HvJ9a1a9Quk8rM8sylJ7snbJKucfJGB5MXoqsf4s16B/bGmA4Oo2efTz1/xoAv15p8Q746lr9rpNrJLHcxOtvaOgzi8mQ/vAO5gg3y+gLp3xXb67rVrpGhXWpyOskUSZQIc+Y5OFQY6lmIA9zXIfDvSZ5dWvNUv7mO8+ymS0hkAzvuGbddSgkdN4WJQOiw470Ad3p1nDp2n21laqVt7eJYY1JzhVAAGfoKsUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5l8YvCj6rbwajp6THUrd/MgMbfekwAYyDxtlUeXnswjPauU+G/jG90l4NHu7i6u4pVbU9OEqKrXFqR++gGQD5kRzIB1K5XtXuV5bpd2ssEu4JIpUlTgj3B7EeteBfE+11DR2kn06FzdxTNeWs+CPKvEO5+nRHQ78D+84IIyKBH0BBLHPDHNC6yRSKHR1OQwIyCK5zWbeXQ9Sk13T42e2lwNStYo9zSAAATrjkugGCOdyjHVVrA+Eviq11zR7OWztzbaffB5LeFj81tOrHz7YjttbLL6qeg216LQMZBNHcQRzQOskUih0dTkMpGQRT65a3Y+GNYjs22Lod/LttcA/6NcNkmI9gjclemGyvdRXU0AUdR1W005gLxpE3DKkRMwPXgYB54pml63puq8afewTuOWjDYdR7qeR+Iqe6+2+fEbU2xh/5aLJuDdexHH6VT1ezsLyGd9S04yCIYEgj3SEeqFCXH4YNAGhFcJLNLEokWSPG7chAwc4IJGD0PSud8ZWa3dnHLLMtnqVtOZNNu4YzM8LbcElOrAgsrKOqn15FjTzZppktvp2r+aZMlPtspnKD0IYhiPYmqd5p2oIbf7PuYPGDc+TcKYt49IpQwC/RgaAOd17xPFrlt4b0qZDaatdavbedaE7vlifzWIYcFSI8jODg8gdK6L4d6nb3ng9dRa4g8uW5uppHDjamZ5Dhj2IBANcjrVuLXxTYatIVMlhb3l6yCYkAJblQdm9gOZOoArmfB/wj8PapoWmXPiLWdP1mc20JWAAxQR4GeUjkXzGyeWfJOO1AHoGq/Ffw5FcS2Ph6WTxLqyruFppA84DrjfKP3aDIxy2fY1mQX3j7WnebVDB4a0yRP8Aj1tbWW4vI/rNtaMH3Cn8+RqWnw90+ytlhs9L0uOHAx9k3w4HqAxdT+NdNpujwaZJbx20LEIrDzlKxjnsyLgN+VAHBaN4K8N6jrt1qcc6TauzDFxcyRXkmcYKgTR70x6DHU1Y8WeGtStdMax8O20MF5qs4tWuNPR7dIYmU+ZJIgLLwu7BGPmK4ruLW1kfbDfW32hLdh5dxcsju/P3sBeCPwqvqNlMvmbr2K3tMON880pJ38t0dQMdBzwOmKAMK/029tdNs9P0y0e3gtAsSsGkmVIx0UBdjHAwAcngd64PVrxta122K6hNHaZeKxu33OLcglJ7o8B03fNbxgnqZHB4FX/Ht7YWFjFFpWu2n2mfcZpLWWbzooVIEjx7ZTlzuVEUggu6jpmr+gWp8O293dahpdi166KwtrOVXkjRfljiRgwbyk24I2nLbzyScm4eho+H/BdvYxyNp1t4fmhYqSYrWHccDqW2c4HTOT6kmp9c1SXRLZY9Mh0i6njujFIEtstFFjq4Urg5zk9OelY0F/ca5fTC71GOG1vjtME8SmBT2jLgBg4IztfYT2zWzDoUIuLazuJrrSr+MloHRw0cpPBCtjDDgfLhGHUetAHkfiJ9UHi6bU7vRdIs9Psyk4l06OXZEfm/0iQx7ZFbDcO0TxrjOTXpPgTxHPoPh/SdPvbBDp5xDaT280cgkjx8rrIuI5s5zlSrHP3M1vR29tb3VrbeIrUWd1hoory3YrBNn0YYMch644J6Bmqvd+CmsXil0qSUQpkzQQbEW5XOSskJHkyZ9QEb/aoA7DTNXsNT8wWVykjxkrJGcq6EdmU4I/EVerzm3tYZZpJTassqEo0KRGYoD0JjfEsePSNivfmrunaZeTxJLay3QtTnElnqMoPBIx5UwIH50AdzRXJ2dveC5kWbU/EcAjQuTPFbshA9GVDk+3Wr0FvI9x9mXxDftN5Yl2mKEHYTwf8AV0hXN6iseztDcRLLDrl5cpnG9WhIJHX7qVsUxhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXM+PNEh1nQ7qGWUwGRABMP+WTg5jk+isef9kmumpsiLJGySAMjAhge4NAHyB4D8W3Wi+NX0vXi1j9teOxuA6ZXTdUjYrDMR0IYABmUgMCSeBX1foGpf2np4klVIruJjDdQq27ypl+8ue47g9wQe9fOPx/8BKL+61+3uMusK2mrpKm7zYDxDc9vnVRtz0LRr0yc9B8FfHcjaUP7WvPNudM2WepuRuNzBuKQXoJ5OD+7kJzwATjAoEe7alZW+p2c9jfQedazoVkUnAI9Mg5B7gjpisjw/fT2t8+has7Pdwp5lrcO4JvIBgb/APfUkK3uQ38WBvTKzwuschjdlIVwASp9eax9S0q41bSLcXEotNYtyJIbqAZ8qUcbgD1RuQVPVWI96BmpeRzS27JbT/Z5SQRJsD455GD6jiq+pS30at9ltRODjGyYI49fvDH61yj/ABAEMM8E2lXP9rWhWG6gJCospGcKeWZSPmBVT8p7HIFAeJ/GF7IqQabZaf5jhUeWzu7lBk4yzbY8c47UAbF9LeXCH7TpmpnjAWe1trgD/vls15pqWs3GpalJofhnSYZr4s0ZuDp1vBHA+Pu7SXLsOrD5QvGSMgV2t7oXiHxO8cGoeKZbaGNBK8FlpcltFLu5AZncs2B1TOOfmBrLt9H1fRrd9M0u81q2+9G1zBo1uWcHPKuG2rycjjA6YoA831jTrvwnr95BpsFt4n1GbSZNP1+8vrgpEiyspEaojAhUQfMEGSGHQnAz/DU2p6JZvb2nivFqojT+zbq2+2QWrsWGxI2DPsBAwqsSF6kkivQ1+FErMkjXmvKwGC8MNnFK+SD80m8tknOT33NnOa3dL+GFs0Mi351R4giqsE19HGJvXcYYwR0HO459qYjgpvHV/oEnmT6boMEHyqtxBdTWYmJBJVY1b7wABIx3OM456Xwr418c+KbqOLTfBTQaYrkDU7vU5Yoip53AFd8ncfLkcfexzXoOj+CdH0tWW10vTIDEcWsqWweaJeCPncsSc5Pp0rpreMwwrG0skpUcvJjc31wAP0pDR5F4s/4WFZXtstr4b03VLWRsNPDqdy3le7Rsy59eD7ccVyniO61qyka8vJoNLCJI7SWVmqSqgO1nDTFyDGeSAezA8fMPoi5njtoHlmcJGgJJPoOa8m8Z+JI2v7xLG1t5raNTMZGBbcTGGfIzjayADGPX1piPKtG0O+f4v/21eag1zqkNux06PUN9wHmji3Oysx+RfnLIp4DOOu0Z9XTQY5P7P1aG2Wwe+m23BgfEdnehsCdAMYWUjYwB53ocZ3Gud+B1i+o3+o6nqMa/a7fXDpsYBLCOCC2ZlAJ7EyA574X0FerWukW63ur6NcReZpd5DHMkZ6L8vluoPUY2Iw9C2aBmdZaNFqKT288T2erQxmNrqJQcbiSVZTkOjdcEbDzgK2QLOiW4hkm0TWfljljCw2j/ADQyBR8zQuTux0JRiSpHBxg1NawXzxkAKuuaZ+6WVySt3Cfu7j/tAc/3XBxx11iln4h0iN3SQRv8yFgUlgcZGR3V1ORSAiliuLJJIplfUdOlO1kcB5IlIwQR/wAtF/Nv96q+n2r28MU/h28jm04rhbSViyDH9x+WT02nIHQAVZtb24s50s9XZSXYrBdKMJKOyt2WT26HGRjoLLaai3hurR2tpWOZQgBSX/eX1/2hg++OKAKc11Y30cdtrNr9mlY/LHcAfeHdHHGfTBB9q1IIPJLYlldT0V23Y/E8/makliSaMpKiuh6qwyD+FUP7MEUjPY3E9sSMeWG3x/8AfB6f8BxQBo0Ui52jcQT3IGKWgAooooARmCKWchVAySTgAVxtn8R9EvYJbm1i1OSxWKaWO8+wyCCcRKzOEkIAJwrYzjODiuxlDNE6pt3FSBuGRn3rxfSvhXrNpf3k1q2l6NbTWN1by2enXdw8F3LLGVVmjcYiVSd2F3dKAPUNG8UaPq+kRaja39usDW0d06ySqGhR1DL5gz8vB71ct9X025tkuLbULOW3d/LWWOdWVn/ugg4J9q8mb4U6tZ2sP9hyaLY3Y8NRaVM4iyst0ssbtIw2YIYIw3kFgSDjiodO+EmpiNItRGkPaPr9tqktq00k6NCkLo6EtGNzEt0IAI646UAevnWNNE0UR1GzEspVY089dzlhkADPOQQR7VNf31pp0Am1C6gtYSwUPPIEXJ6DJ714pqXgDUta8b+LrKx02x07R5LnTDFfSwsjxRQwxnFqAm04KbT8wA6V3vj/AML3+t614c1PTk025OlSTl7PUSwhlEiBQ3Ct8y4yMjueRQBoeF/Gem+JLezuLCO5S3urR7xJZlVVVFk2EN8xIORnpjHetNdf0ZrJ7xdW082kbbHnFymxW9C2cA+1eT6L8KNYs9Jt7S8l0u4CeHZtHdPOlCtK915oOQoIXbxnrnsRVf8A4VP4hbQhbTT6ZLcR3guLYfaWR7dRHsH74QfvDz0eM4HfkmgD2STWdMiFqZNRskF1/qC06jzv9zn5vwpl/rulafLLFeajaQzRRmZ4mlXzAgGS23OcYGelePar8H9auxatcXWl6mz6dHZXKSM1oqMjM26Py42+XLcjCkkZyM8dBafD3UYNQ1mG4g0C/sNUu57tr67R3u4fMjK7FBUghTwDuHy545oA7bSvFWmau+mnSpGu7e/haaKeMAIAoBwwJDA/MOMfXFX4NY024glmg1GzlhhbZI6Tqyo2cYYg8HPY15Xovww1eGz0a1upNKsVs9KvdNlmsGcu7TRoizAFFy3yknJ7Dk1Rm+EutXegajayPodrPLp9jpscNqXEMwgnWRppcpneQCAAD1xnvQB7PY31pfxvJY3UFyiMUZoZA4Vh1BI6H2qzXH+DfCR8OeKfFV7bx2VvpepyWz2tvbLs8vZFtfKgBRlsnjOe9dhQAUUUUAFed/GG+uNLfwjqC3E9tp1vrUJv5o2ZUSEhgTJj+DOM546V6JRQB4No3ifXzd3Mmi6iPsmt+K5rWzu7uJp4vs/lEho1LLlQy8YIHBq7f+OfFNl8Qxo9xe2EEdvd21v9nuI1iN9EwUPKnVixJOApIXGDnk17ZRQB88WHjPxNovhnVg2tG9vIdfazu5LiHL6dCWl/eHcSFVtoC7htQDvmuh8PeMPFetX/AIa0yHVtJSW9jvGmvYrf7QkgiZNpUBlAJVsHBIz+VezVla/Bq8kcMuhXlvBcRMS0N1FvinGPusR8yH0YZx3DUAatFc5pfiqGW9j03WraTR9XfhLe4YFJz/0xlHyyfThh3UV0dABRRRQBzfjrT4brR5pbiNZLZYniu02bjJbMP3gHuOHH+7jvXxtfSXHwk+IKXdt5V/8AYHw8SufLnsZcjYQezIVIPzYY55r7tIyMHpXzD+0n4QC6Ndz2hxfadEGtkjVt0lhJIFMYA6mOR9uOgSRSelAHt/w78QWeq6XbwWt2buEwLcWc5GDNat90n/aQ/u2HUFeQM10l5GIjJewWxnu0iKKqttLjOdvPHbjP6ZNfNnwzbVPhxf6J4Z1G6+0R3UJvtLCthlnKhprNsjGJUIdR2fb1NfSFrqlpdWNleRS/uLwL5LEEZ3DIB9D2we/HWgDlvFtje3MNv4q8FSQHWIIwHjMYYahbAkm3Y5BVs5KnPytkHhmrQ8OeLYtY06O/FnOtlJnZcRKZFJBwysoG9HVgVZWUYIIzVvUvM0iZ7u1GYLhgkqH7kch4WTHYE4DY9d3Y5801DyfCvxKtdUtbyTSNJ8WB1mkd1WC31CNeRIjYU+Yqkf3t6Hn5jQB61a6tp93HFJb3tvIsrMiYkHzMpwQB6g8EVdrlbL+2ZLqD7fZaNq1oJA8V9bP5bJ/teWwYZ91f8K2bvULmCMumlXk+HZNsbRbiB0YAuOD9c+ooA0aKyNX1ibT5AkWjane5UENbLGV64xy4wRn/ADzWFLr2vXaRTQ6YukWmGMkmoSKrEhiAAM8dO4756AbgDtKwpfFWjrZzXMV5HNHEVVtnPJJwB65wT9K821DxJBMY4Na8SNf3crgNpmhwSXnBJOwNGMbunLYA/AGiWyuWuUfQdLjsihEyz6zMG8oAcbLeNguAMHlhgccdAAbetXl7rOpmYwv9isiXVSdiIduSzucKMAjPcc+9efeKPHOm6DbXi+HtMbxNflMyC2ylpbgRop3y/wAff5U6rnJFaes+Hb3VbyWXWdWvby1kT5bYskVqjs+CTCOMnJ5ZWYZz3FZc/hOx0vSobO1aeBbjNtDM6bm2KpyGVlIjUhmAyf4jwM5LEXf2Z9S1LULK/n1uMwahc67ezTxeX5exvs9vhQvYAE4HoK9r1VZItV0q6RsIJHt5R6q44/8AHlX868j+BA+xWmrLNbC1EPiR4UhSUyLGj2seCrEA7GYgjjgECvYfEEMs+j3Its/aEUSxY/voQyj8wKQyPXLqbThBfIC9pE2LpVUEiM/8tPX5TyQOxPoKL+X+zFa8t7cSW8j+ZdFGO4LgDzFXndgAZA5IHGTwb1vKl3aRShcxzIGAYdiM8/nVDR7W402aSyVVbTFUNatuJaMd42z1A/hPpx2GQC8wt7+z5Ec9tOgP95XUjj8KoAXmlsFUS3tiWAHO6aAfjzIv/jw/2qhaGXQpZJrVJJtLcl5Ldcs0DcfNGP7nUlB0PI9K2YJY54klhdZI3GVZTkEexoAba3EN3Ak1tIskTchlORUtULjTyJGnsJBbXJyThcxyH/bXuffg+/anw3w85be7TyLhhkAnKP8A7rd/pwfagC5RRRQAUUUUAFZfijVhoPhvVNWMDXAsbaS48pTgvsUnGe3Tr2qeXVdOhv1sZb+0S9Yblt2mUSEeu3Oac+oWBhVnu7UxSIXBMq7WQdT15A7mgDxPxZ8RfEk/g7XIbdtOt9QhtrC7W90+VmVIrmQJsyc4kGRz3BJGCBXoXiTXLnwP4O0ea5KXM32m2tLmW4nZgvmMFd97ckDJwT261pxab4Tt7CexistCisp38yW3WKFY5GUg7mXGCQdpyehxV+8k0bVjc6Revp96QuZ7KUpJheDl0OeOnUUAedy/E3UrrXm0vQ7HTLp31eXTIJZblljYJAJN5ZQ3ckcA9KjX4la9P4wn0q10aza3tb9NNuC0jBldgB5u44GzcwwMZIGRzxXeWuneFrIW89rZ6Jb7S1zDJHFEmCF2mRSB/dwCw7cUj2vhXUNRl1Z4NEur+xIMl4UieS3IGQS/VcAeo6UAeW6H8TfEdt4A0S91FbC/1PVNQls4psECMK8n+sRQo3fJhVGMjknOa6Dw54+8R63rul6Qui6db3cti95eefcsBGEufKbZtVskjBCnHJwTxzpWWq+C9Rk1HTbDRbK7t5NRitrryrWFoZppELiQ84cY6nk57V0WjQeGLa9ii0WLRYryOBo40tFiWRYd+WUBeQm7kjpn3oA5T4h3Oty/EbwRo2nXptdNvWuJrgRTNE8nlBCQSB0CtwOhPXjFZem/EnxBeeEtC1eXTdItjrt3FZ2TNcSMkRJk3tN8ox/qwFUMc5PI6V6RDPomq6lFNBLpt7qFnvEboySSwZwrgEZK54B6ds1g3WqeD007WNBitLC6g0dV+06TFbJsXd84CowCHrk46Hrg0Ack/wAUNburDRl0zTdMN9ef2ksrzSv5GbTGWjKjLKwzj+dbPw68d6p4j1yKy1WwsraO70eHWLY20ruVR3KFX3Ac5GeOg9etdSI/DIurCyaHR47uGJktbVliEkUbjDKidQGAwQODijTZPDENwZNLfRY57WJbMtbmINDGG+WLK8qu48L0z2oA3qKqXOpWNrFPLc3ttDHAQJXklVRGT0DEnjr3qeCaK4hSa3kSWFxuV0YMrD1BHWgCSiiigAooooAKKKKACiiigCrqmnWWrWUlnqdrDdWsn3opkDKfwPf3rm/7N13w582hzvrOmDk6fezfv4x6Qzt97/dkz/viuuooAx9B8R6frbSw2zvDfQjM9lcoY54f95Dzj0YZU9ia2Kydf8PadrqRG+hIuITuguoWMc8B9UkHI+nQ9wax/tXiDw3xqMcmv6UvS6towLyIf9NIhxL/ALyYP+wetAHXVxPxKsbTVpNC02fYl3Ncu8EpzmPbGwJGPdl46Zx7V1Oj6rYazZLd6XdxXVuxI3xtnBHUEdQR3B5FYEs9vJ8RIi6iWWO3+yxgn/VMQZZG+uBCPxoA534meHdO1PxR4Qt7hHQ3D3FnHNEcSQEQO8cqHHDoyAg9s96Z4A1S21fT9S0LWdRMuo/bHs7iFImTy7uMF2kRhwqybfPQcYJcDoQOs8TWjz+JPC0qLkRXUu5s/dHkuen4Yr591uGTwv8AFPWtY+2yWVlqOsQ2d/GhX9y7gtb3ajsFkX5s5ysjDo1AH0TqOqW0Gmi3vD9s3H7Nc4XZkcLI2PYNuwO2SM4rhbnRLPW9QsvDuvRfb7FtTN4sc67lm8hJEct6jcISR0Jc54Jq/fyW2omTUL9pbayuIUM8aqSWuY2eKSGPByXddyYU5O1SK6fwtpckLPqF5CtvNInl29qqgfZYM52k5OXY/M5zycDtkgGL/wAKr8HG7muLPw+ml3Kt8kunzyWmeAQwELrxkkYPpVseClERSLxBr8cwToNTmdVbscMxOMjpn8a66UhB5jOVRAS2B1GKQx/vRIm1SeHO3lgM4GfYmgDlZPCFtcRPHNqHiBvl+Uf2pcIcg4zuV8c+h/8A1Mg8A+HoLl7pdLguLvcNs16r3LA54OXYngcZzXThZIcxxMmzYfL8x2Zi/J5J7U7ajsCZSWfDKFYDhSDxjkjPX60AZc0K7o0P72JWXyVaGRfLy3ABHHAU4OMjucHmtfadm4+0m2LXKKTEWLOrNydp64xzhvlHI68itWOH5wZLiYPvBVmUBiCd2wnGCO3Azgde9V/sQe0MKOkM21QZYo2jIOSCfvZwcYHOfqDQBxus6VcD99bQvJbgoUWMI0kjo+5VUnjlQce54KnIFx1je5tryNmUTIGdoSxGFG8KRhgMbR90Hr0Gcnau4j9rLRh5UYlSAv8AqcFgT8vG4blA6HHGetYlw+LS7+0tMxERaYhChATdtDSAZGRGOpLZOARQBk/D3TPt9n4yaGaN/teqBopRgfPHDHscFVAPKqc4HfrXqFtMlxAksTo6MM7kYMv4Eda4L4U2l1F4R+2qgL3moy3i+cfm8pm2ZJ/vbBn/APXXaWNxZJdT6baIsL2yLIYlTau184ZexBIb8QaAI9FMsP2myn5NvIfLP96JuU/Llf8AgNXbq3iureSC4QSQyKVZT3FU9TjeGaLULdC8kIKyoDy8R5OPUjqPxHetBHWRFdGDIwyCDkEetAAu7kMBgHjBzkVFDbRW7yvCmwyne4XoW9cdM/zqaigBFJKgkEHuD2oIDdQDznmql/p0V68ErPLFPA4dJYm2sPVT2KnuDx+IBq5QBUNvcRk/ZrnC/IAky7woBO7ByGJIPcnGBx1q3RQSB1OKACiisafxBZrfwWUHnXFxLN5QWBd2Mcs57BF6Fux+XluKAOAuvhzq8vxGm1u2n0+00+e58+f5zM8o2bQPLeP5H/2lk47LWEvwr8WS6NZabd3eheVYaReaZbvFJKGfzcbGfKcdOcdO2e3utFAHmy/DKyGu+F5m0zRTpemWc0dzbeQMSTuI8SBdm1jlCSxwelZ+i/DPUrPxNa3E9xpwsrS7vbtbuIN9suftAYbJcgABd3Xcc4HAr1migDwpfhX4sl0ay027u9C8qw0i80y3eKSUM/m42M+U46c46ds9tHV/hJdzxapFpR0myhutMsrbykVljlnglDt5iqoyjAAZ5PtXslc94ovJxqnh/TLOVopby882UocEQQqXf8CwjQ+z0AcDZ/DjXDqq3040W0z4htNXa3tJHKJFFC0bIuYx82WBHAB55HSq+k/Ca806z8NMH063vbFdTW/u7QN5souEkWIqdoLld6/eIxjjNez0UAeG/BbRtVt/GNrcXWiDT7HTtA/swzi1lt/tEvmo24rKiMWIUkkAjPc1seJvhtqV/qfjuTT49GWHxFbRrDNKWSaCRUVWU4Q/KxBYkHOccHrXrVFAHj8nwz1r/hNX1W2l0uCzlk8ydWkebz8RbADG0eUbP8aSDA6DPTKsvhF4ht9A1OyjvdKg3LbmytyzTqrxSiQ7pfKR1Q4xt+b1zxXutFAHiuqfDDxLq1zf6le3ekrfzapFqC20UkggcLB5RVmKEqw6hsN9OePRfh3oEnhnwpbaXLHBE0TyMI4JmlRAzlsBmVSevoB7V0tFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHO614Vtry8k1LTJpdJ1ojH221wDJjoJUPyyr/vAkdiOteceFfEM+leI0vvGUAt4bgTTDVoAXtJjM0aRFjyYRthwA/H+1zXqfiqSVNBu47aQR3NwotoXJ+68hCKfwLZ/CpNL0a0022kt4VZ4ZFRCkmGARUCKgH93C9PUn1oAnllVtRtYhI4Yo8u1WGGAwOfX7wxXg3xm0i61/wCIei6PaQW88Oo6ikc8M0hiWRIYUnZS4ViAdvYE8ds19ARwRRlPLijTYmxdqgbV/uj29q8qhS21H41aJNayIsFnpl3qTiRjvLTOkYb027TwR247UAdb4M8KSaPZ2jaxdJf6hbq2xlQrFCzZLlFJJ3MS2XJJOSBgcV1lc7deNfD8M7QRail7crwYLBGu5AfQrEGI/HFVJvEPiC7TOi+ErnB4Eup3Udqv12rvf8CoNAHVqWLMCuADwc9eKSZxGu9iiovLszYCjHWuPj0jxnqWDq/iKz0uI5Bh0a0DOR/11m3c+4QU+D4d6C0iS6ut5rs6HIfV7l7oD6Rsdg/BRQB0djqllqVpLcaTdW9/HGzITbTK43gZ25BwDyOD61LGWhV1W2CwxqCixkZPqMcAdu9JZ2lpplkIbSCC1toxnZEixoo7nAwBUoUmF/KlyXyVc/MBnp9RQBAqyyLBJDI8ZHDJMucrnngEYbjg+/SmzozShFnIwHAicAb2OGDBiD93noD19qtbBvRigaQArvwMgHr+eBVJ1WGSGOZXCCQLDNuLsSQSdxI+UcY688D0oAr3AUwtbXM0ysnzK+5DJ5SqAz+uDkgkDI3cY4Ncj4ynuGFppmnRR3Et4DGWWQ7QDt55zwTtBBPI3HHU11+oS29vGguGS2iHIdZBGYmA3YJHGOCeTg9CDXHeAwniHxJda55YNnbjbaOIvLVtw69BubbkkkdHUDpQB2NpZwQyWtqt4zfYbXypYAcBw2AHcevyNj6ml8OxolkI2YTXFrm1aYqN5VTlQT/ulT+NTYmt7bUbi7MAYl2RolxiML8u49z1/OqPh3zP7W13cjrGZoTlhwX8iPdj9PxzQBvVnQj+zZfJOBZyviLC8RMf4D7E9Prj0rRprosilXUMp6hhkGgB1FZ9lLerqF3b3iB4s+bbzouFKH+Bv9oH8wR3zWhQAUUVneINYttC0qa+uxI6pgJDCu6SZzwsca/xOxwAPU0AQ+JddttEst8rp9plDeRExxvKqWJPoqgZZuwH0Bq+F0nvrCC81Dz2yS8YuECszZP73b/ACCNqHlRjPOa5bwro954k1GfW/EZRoJG/49zh48KcrCjdGiTglv8AlpIM/cVQdfV9Xutbu/7M0Ha0JU77jccHphjgg+Xz2OXIwPl3MABdb8RTXmpwaT4eMc9y/wC8chiBsDlWycEKgIwW6tyqZOSu34d0KDRoWO43F9KFE906gNJtHCgDhUXoqjgD1JJK+G9CtNBsTBagvK53zTuAHlb1OAAB2CgAAcAAVrUAFFFFABRRRQAVy2nY1H4g6rd/ei0q1j0+M+ksmJpf/Hfs9dPLIkUTySMFRAWZj0AHU1zfw5R38MRajOpWfVZZNScHqBKxZFP+7GUX/gNAHTUUUUAFFFFABRRRQAUUUUAFFFFABXB+NNdvdL+JXgKxjvPs+l6gb5bxW2hJCkIMYLHodx4wRmu8qlq2ladrFqLbV7C0v7cMG8q6hWVMjocMCM0AeP8Ag/x/4mu7fRbK1Sy1O+1e81NYZ72UxRrHbldmDGhyMMR05x171q6Z8Sdb1Xxbc2Fjo9r/AGfHfz6bvkdleKRAQruemCwGVAyAeprsdF1Hwlfz40ttL83RZ3sUxEsZtXIUMkeQMA5UZXg9OcVauLLwxHqratcW2jJqUTbDeSRxCZGAzjeeQce/SgDyXQfij4lj8E+FZLpLDUNX1p5xHcEHCrF2kRAo3knAC44GeeldRo/xA1vU9b06x/snT7NTpSapqDXFy2YFE7xShNisGICEgHHXk8V00tj4KGkMstr4cGl3Lm6YNHB5MrdDIf4WPbdV2NPDWjvZzxLo9g8sItraRRFEXizuEaHjK5Odo4yc0AeNal8VNb1Xw74itgkFtINEbVLO+si8ZwJUTgMd2Pm4JCnjpzXvWnsz2FszkszRKST3OBXI6HZ+Dbx/EEOneHNPjNhI9jeqmmx/veFkZQFBLqflOMckDjpVuPxBq12oTRPC14IwMLLqUqWcX/fI3yD8YxQB1VBIUEk4A6k1zH9neKb7/j91y002M/8ALPTbQPIP+2sxZT/37FVb/wCHmh6nAV1x9R1XkMzXt9IynHONgIRR/uqKAMrxt438Ow6rZWr63bCW0El0RApudsoUpEGWPJ+85bH+wParY8a6xfQJ/wAI74R1S9yBie+dLKJ/9oZJbH/ARTPAmn6ENVuLnStHtYfMUTRTCIBo4h+7iwSMgOFd/owPeu+oA4WTTPHmrJi81zTNEibrHp9p58gHoXlJGfcKK5X4deE9C1XxL4je/NzrqaXLHpqNqb+cqMo3MgTGwBSy4GOK9a1W5Nlpl5dDbmCF5fm6fKpPP5VynwgsEtPBNveCPy5dWml1SUHrumcuBnvhSo/CgDsLW2gtIFhtYY4IV+6kahVH0AqWub8YzXoufD1jYahPp/8AaGoNbyzwJG0gQW08uF8xWUZaJf4Txmk/4RzVP+h08Qf9+bD/AORqAOlpiRIjyMow0h3Nz1OAP5AVyt94a157ZhYeONZiuP4WmtbKRfxAgU/rXKeINO+IdlpDta+J7wXqONsotra4gkXvuVbdZI/qBIB3FAHqsLI0Q8pw6jI3Bt3Tg8/WmXBjFvILvZ5TfIQehB4wfrmvNPDV3c3l+ukah4l8SaLrDL5iWs8OnFLkEbi8Eq222UcknGGHJZRW1fWOqWkzx/8ACS+L5guMvDZ2LLz6f6Pk/hQB11wVWOfzE2xBBuaR9qbec/TA68Co5VSG3lMDiJSgxICGCcYDYJxgACuTe3chFbxx4iPmEqUNpZ7l/wB5fsuVHuRirKaHNLbyXEXjbWZYWG13jh09wwHY4tuetAFDxpeyXcg0jSJpJbi5KwSOjlwoZmyrjhRwrdydqtkdM61/CNH0aw8P6RcNDfXmYYpcbnUDmWbHqASfTcyj0FZcmkSJdobTxR4hubt3LZgs7AkEgAszm2AXgAZJyeBzWL4ptvF+lypc2mtagyFNvnT/AGQyDnJBEdi2F4zktigD0fUNLS70pNPSeWC3GxW2H5njUjKEnnDAYJ64JrQry7w/f6hqdszTeKfEQmRtjfZY7CZGYDJCn7KGzjnBUfjW3DaXkn3vF3i2L/rrp1qo/P7JigDtqK5FNLu2Jx4517g45gsR/wC21K+kXqqG/wCE38QMD0229ixP4C2oA62iua/4RzVP+hz8Qf8Afmw/+RqP+Ec1T/odPEH/AH5sP/kagDoLqeK1tpbi5kWKCJDJI7HAVQMkn2xXnDpP4z117q9LW2hWOSEmjCeWNp3EknIkdG5PHlxkjh3O3I1A6trGqXNnb+LtROgwKHurrULGxaLCuCz5MAXbgYTOdxy33VG5biw1vUr3QtK0PXtRTStUhu7m6j1KxslKJFNCC3lC25Lea3ytg5YE4IKkA6q6uZfEZTS9CVIdJRArOFwjRlflPBGEx0QctxnCfe67TrGGwg8uAMSx3O7HLO2AMk/gPYAADAAFc/b+E7228wW/i7XIvMcyPst7BdzHqTi25PvVS4sruGZom8aeJw4bbuFhasufqLXH60AdrRXCjTNVDuq+P9Qmb+GMpYxMPr/o7fyq6mh61szJ4r8RZ/2E09h+tsKAOtorkl0bUNoM3jTxBAT/AAyx6eD/AOk9QXFpJbnbJ4/1rf02rHYM35C2oA7SivOZriddqweL/E1zO5CrDDBp7uW9CFtzt9y2APWpDpHjCZvMi8R63awBQdk8dg8rHBJ4WDA7DqevtQBufEZ3fwxLp0DFZ9Vlj01COoErBXYf7sZdv+A10kUaRRJHGoVEAVVHQAdBXz3rt/4jh8a29trXiu/gg0uMXpkFraTNbSSbok3bYwv3DKSSDgdPWvRNKtNburA3S+MdU1CArvSbTDp8iyDrwDbD+ZoA9Corhkt7rZun8X+K7bAyfPsLRQPx+y4/WrH9n3Pbx1r578W9l/8AItAHY0Vyh0XUPsrXC+M/EbRgFvltrIsfoPsuTVay0/Urx1WPxT4tjBzlprKyjA/76tgaAO0orjZrCaFGZ/HutkK/ltsisGIb0IFseat+CNRnvW123mv5NRjsL9baG5lRFd1NtBId2xVXO6Rhwo4xQB09FFFABRRRQAUUUUAeO3vwx1dY/EKaYNCje51qPWbKdw6sdrI3kSBU+VBtJBUnk9BT4fhprN7qSXevHRZ0k8QDV7iBC7xmLyNmwBk5bd68Y5yOlev0UAeO6P8ACWeDU7NtRi0e40y2fUilsVLqguGBiCqUwNoBz6ds1lXPwc1iTT9Hjmn02+MGkrplzby3EkSLtdmDRuI2JB3Djap4zmvd6KAOP+Hvhm98OTa+9/LBKNQvRcxeU7MQvlInzbgOcqfX612FFFABWL4ondraHTbaVY7vUX8hCeqpjMjAeyA/iRW1VZLVDeG6lVXmGVjYquY0OMqDjOCVBP8A9agCtounGwW5aTyvNnlLnylwqoAFRR9EVR9c1pUUUAZXirT4tY8PX2lXBuBDfxG0kNuQHCSfKxBPTAJJ9s1fs7aGytILW1jWK3gjWKONRgIqjAA9gBUHkzS6qZJ4oPs0Kj7O3Jk3nIc+gGMAd+tXaAOW8aRCfWfBsbM6g6s/KMVI/wBBu+hFakml3Sktaatdxn+7KElX9Rn9ayfG9tFd6t4OgnDGN9WfIVyp/wCPG7PUEGr58NWqbTaXep2hGP8AVXkjD/vlyw/SgCaW41WyZPNto7+DgM9t+7kX32McEfRs+1XLG/tr4SfZpQ7RnbIhBVkPoynkfjSSrdwWDi2Zbq6XlPPbyw3PQlV449qqXsdpd38dtOk0F8Yw8dxGpUjBOVWTGCR3U9QemKAM3x94dOv6O0cCq1zFItxCWJ3xypnZJCxOI5FJyGwQfutkE1B4E8RXOt2F3p9/Isev6cRFcsYCiyAkhJlQngNtbK5+VlZe2TrzX11pbk6komsiwAuol5jHrKvYD++OPUADNcV8SfD2rWV/beNPAqrLrNnk3NjvYR6hbkfOmF/i4BHB5UEc8MAdpJJM7+Xq2nFlQ7o7i2JcD3wMOp+gP1rPkOivfpOtzHbXIJDySo8LvnoC3yk/jmqHhr4iaX4ot0TR5YbbVw5V9L1J/InIXhto53D0ddy9uD0w/iJ8R9U0eWTSdC0uzudY3RrJI9yJIbXeRtWRflJkZcsqZHyguxVVJoA7uyMVvejybmOWBxgvJfvI270CHI/XNXIpU1CK6jltCYFcxgTBSJcdeOeM8c46V5X4f1XW9Mt9B1jxTJb3tnqd4tjJEmlpCUlfPlTQkMWaPcNvzAMQwYAdD6dpusQX9/PbwR3KiONX3S2zxA5JBALAbiMDOBxketAHL674NXUSbeOxtX0y6CPNFOxLwyq2VkUZKllPOOnBHINc34Xm1aPWLiyNpb289tIYnt1uMTybcjzFQlF2sMMNrMOcHBGK6u48PatquoXV7evYWgk+SKE+dOyoOh3CRFUnqQq/iaz30u70tYYNQm06Vp3KxNqkgmieTHCpIxEoYqDgHfgKeaBHV24BVA51SGTHIYM/6/MP1rVgxtJDSHJ/jBB/I1h6PDLp4JXSXj3jB+z3fmx/UByuPwFaaXzu4VbG764JYKAPflv5UDLtee/EDxCZmm0axlEcSoWv7hlzGkYxvUnI+UBgWxychF+Zsrc+I/jGHw9YGCKYR3koALkZ8oE447bz/CPqecYPnvhOwfWYI5VWe0sd37+dInMrsF+7FtLFpAxPzHPlkk8ysxQA2tD0qXxDIthYRm10m1nLXLlUbdOu3DyKRzNhRtjHyxDbnLKqL2CWFtpnjzw9aWMQht49J1EhQSeTPZkkk8kkkkk8kkk1taIY4rO3t7LTZrO0QYUShVwPpknJPrzzzWdf/wDJSdC/7BOof+jrKgDZ1OyF9brGVgJVw486MyLx7ZFZ40RYVVre308SL0MUbW5/76Uk02XUNTh1iWKaOyW13AQqxZWkUgchz8u7Ofkx0wc81soVuYP3kTBWGCki8/QigCtbu0hEN5ZMjLhVckSq3H97r+YFRz2NwpDW2pzwIDkq6o64/EZA/GpVs5IFk+yXMgLHIWYmRF9hnnHtniq63Ae6SK/VrW5KlFXfuhlBPRSeCeOhAYAntzQBU1LR7q9VXNzDLIAOCuEbHqDvA/AVkP4a1KHDWqaf5o+6xjhG38fIzRo/iXR7q+uNO1awXRtUty3mxSYVMA/eWQYyp4IJxnOBkg46sRAW0UdqPOgc/MzTtkKR1B5J7cZHXrQBwa+IbDQdWaa/ubvUdRYpbmOG2fy7WMsofa21VPzYY45O0ACvSAQRkciuauvDVrO63ZgtIZwhBeeMzMgxz824VkaLqUukSxWyXF5q8MkoRnEAjjt06b8glVQADjgc5oAs+C9NuJrjxPq16kkFxql+whZ02sLeICOLg9uHb3DVxniHwlJ4OeW80KZ2syhc6cgjhV5MklkYqFWQ9OSQfTvXWeNPiZovhVkhuS895KqtBaxfNNOpBOUjXc5HB5Kge9cTp/x88P6i0ll4g0680mC5UxKbtWi3ZByCzAKOO5YUAd14B1+HxBoUV9p9/Jd27qGVmQllBHQhWyD9VGe2RzW1c6xPZ6mtn/Z88yOAY5jLGplPUhQxGSPTr7Y5rzvw9FAl3cw6NPcXMGFmgSceTOileEhdQCBgZ2Hpk/IQwau9f7fcCJbW+srhSuTa39viQke6kY/FDQBqx6hkfvbS8iPo0W7/ANBzVK6TSbu/gurqGeW4hI8vfFLhDnghcYz74qsllqu7P2S3gbI5t9RkC4/3THj9KmlsdWmiEZu2jHcibke2VjUn8xQBZu7v7DBK+n6VcXUzMMxwqkRcnuS5UcdzWN4CkupdS8XvqEEdvctqyFoo5PMVf9BtcDdgZOMZ46569av2N5o9pGDHPDc3EYIaSBWmc+vI3N+pqp4KnW41fxjKiyKratGQJEKN/wAeNp1B5FAHVUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBx/xBtTe3/hC3G3L6s33mZRxZXR6qQe3rV5fDsdvZyPDDHLfAHy8XE0KH0BO5iPrzTPFn/Ie8Gf9haT/ANILutttRskOHuoV/wB5wKAMuEagt9FFGl1A3lb3MjCe2J6bAxIcN74A+tW11UQfLqsX2Nt20SFt0Tn1D9vo2DVqLULOZwkN3bux6Ksikn9agutMjlumuYppoJ2Xa5Q5WQAHAZTkHr9fegB88V0Gd4JI5o2H+pmGB+DDt9QayjJDZWUEWZ9FEO4IrKHgGQepGRtBORyv4dKWGwvrKeRoh8jc/wCiOFVvrE+VB91YZqsdS1dZVj82FWdtqpdafKmT6b1ZloAyvEfgXTPFVtP9tj014piZWuIYwRvxjfsbIDY/jUq3A5rzbwp4E0K78bMbKGbUbGbKieZ5mRsf8fcwErs259sMBbI3AuOgNekeNLzVtGsJfIv9I0+S5BjSSC1LzsxP3gpbAVFLMzHcAFJwBWj8NdLitNGF9CLpY7tV+zx3LEukAzsLZ53vuaRieS0h9KBHK/G24e71Lwzoln/ZJkikk1aVdTDm3CRL5cYdU+Y5lmTAHde+MVraNqt3YPbxw2nhoyvsjdIJpLaRicZCCRPm9gWFO8N2t1rvinxJ4ktZ5bJvOGkWxmgVw8NuW3MoPOGleXkHkKprt5IrpkjCTwgqvzF4S25vUfMMUDOX134g6b4Y08Xvi61vdFtTIIfOmQTIXOcAGIuT0PbtUHinxH4V1HT/ALLrUN3PAJoyYpdMueG3DnGwdMk57daxNctLPxH8VtK0efUgLrQbeTVpLP8As4G3laUeWsjMWI3ruJGR3z2Ndu1wjOceIPu8MsKxHH/jpoAyvCSeGtUgaTwrqkphhYxvDBcuPLIOCrI3K/iBVjxl4rsfClpBE0hk1C7YpawndIWbIGSOuAWUYHJJAHJrk/iiypolxd22pWV3f28byp5dytnfxxhSGaCVerDP3GXa3Q9q8Y8A+BZk8R3x8QXWh6XPogjt5UhsZLk3kjxxSN5pLBsKoRWwRkl/7x3AHoPgrwbqHjfxAfEfiNnjtVJaMoSCCchljPdiAu+ZeBgJEdq7q9qlhbTNPt7fR7aKO3gURpBFCMIgGAFG5QAK5pry8bRluL7T7LxFoxRZIJNHi2uoHHETOcgc8q+e22rnh0+FtXLPpJiknVcyQSF0mjGf44nwyc/3gKALA1C9lv7eynlktZZjkbLVSSAMn+Nto4xkjFNv/wDkpOhf9gnUP/R1lXQQW8NupEEUcYPJCKBmufv/APkpOhf9gnUP/R1lQB0DLBd25VhHPA46HDKw/kaomyuLMFtNmLIFwLadyU49G5Zf1HtWiqLGpEaqvfAGBmo7Rp3t0a6iSKc/eRH3gH2OBn8qAMiCdZbwJFI2nam482S1mAYSYGM+jYwPmU+mfSrMUianby2Op2/k3G3MkG/ORnh0YYOMgEEYIOOhqxqtjb6hZtDd5CAh1kVtrRsDkMrdiD3ri9X8b6fpvjDQ/DOuwXw1ecmZby3hIt413bEZ37LIzKmACAzAHHykgHN/Gbw9qGpeHZlsbiZPFekRteaNfwOY57iIY86LI6tt4I6N8px1A8V8E/E7xzY6QLm1j0/VYpXKoiQzxTPlsb9sQCEDkE4zkHOcHPsOmeINQstC13V59SWW10zXJWlN7LnyXCqZYkY/dTcZECnpvGOmK83g8MTabqF/DpenPrOiXGoFrBopX+0pDIrEnyAjOiAMyh/lBDb8EEAiAt3Hxx8VWkzQ3WmEsgTzNtyQqlm2gf6jceo6HPzD3rF8TfFHxlq5tpNHU6bchisczI8wRuhw0vy54YHame445rWk0QWOm3Vn/YWs6WJDtEs9jcShT13b1hGQWK4GVxg5JFZWoaRbS6fcT/aI3FvcAgx3Ee6KSNmdvvvyWUIfL6AdC3SnZCPTv2cdHVUfWdQjF5qer2Ud9LqE+HllZ/vjcfmAByuAMfL271vi14Jt5Y72G7u57iC5JbMzyPtGeBvbcuQRnquOORU37Ml+t7ZSrIpF1ai4tXEke2QAT+cBjGAP9IxwcfKK9P8AGdwUa3t7uCCaxn4wxw2/njlWGOR6fWgD478KeMNb8BXl5ot5INT021KRxIzmOVVbLr5R5GeC2G3KOdpBOT9EaJ8VfDt3qFrFL4ks1ZkV0hv1VGRzgY+cjB91kfOOK4S48Px6r4/utNaN0hksPtUWZo4svHKVdQxDKeJR69O2cC1dfB9Zopmv10uXzNjNH9sGwSH5TjIJUYx059OeaAPcf+EiMyl7J7eWNseWfLlIIxzllUgc+mai1vxzpOjWolvJVBC5bfIkKr6nMhXgfn7V833vwRFndH+zJyZJWIeV5RMsa9Np2qvOcENnPXr1rf0v4cJbGW6zZxzqEIPlpG0hbBKkhSSNwGD19c0gOi8c/Hew03SmTQ5YLvUWG9ILMkqkYG4s08ihF+XptV8nj3roP2cNev8AxP4W13WNXtxbXtzq7l4gWO0C3gVfvEnO0D+gA4Hk1/4dk0bUrnTtL1CyvdVlVYRCrB9ssr4IYDhskoTu5wG5r3/4b6bFo83ifTrc5jttRhiDYALYsLTLHHcnk/WgaOzooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDmvFn/ACHvBf8A2FpP/SC7roJ7iGAfv5Y4wf77AfzrmvGsEd1q/g6GYExvq0gYBiuf9Bu+45rRlGj6bIIWs1Vgu4FLRnGP94Kf50ARzzeGb64S3ml0e4nc7UjZo2cn2HXNVUtxCXt9Kli3jkrBfkMv0RgyisXWviHpcN5/Z3hewk1zWAwUxW0TCK3J7zSbcIB+J9cUvhvTrv8AtRdZ8U655uoAnZZWSGK1gBH3cY3SHvljQBrCXW0tnAFxck8oXEalT6F42wf++KzpH8R3dtcRX2hw3UJOAt5cRhEI/iGFBYfXBrd1DUtJMSwMLiTLbglpBKzAnv8AIOPXmvOdag0XxLrF7oijXRDayW/9oS3JkRESRgViUNl2aTpgAfKxORxkQGb4E8OTeIPEs2oalp9rp8Uofy7ezhAVrMtgO8hG9jcbSApIxGh4y2a9W8d623h/wvd3lu0K3ZAhtvNzs81ztUnAJ2jO44HRTWppVkLK22ssPnPgyGFCikgBRgEnAAAAGe1cw2oQ6h42lkazvpk0fNvblIj5bzSKDI+44X5VKpknq0goAwvC7awtlb2+jG7a0BCNPa31rdQk8bpAZAHBJO4rjAzwBXVQ3jaZc2w1XUru4u54i0djtjZ89T8saDIGMbicUz7bcard/wCivDHDIkiLLZfvpPl6q02NkZyfu/Mc8g8Umm+HbxbVoZJ102B2BdLN2eeQdT5lw/zMST1ABHrQBw+m31z/AML3vLJdJfT7rUNASXzb64E6yRxzFQPLXo3znOXPAFdLq39t2byA3dybeNh++aW3sLRBj7oO15D/AJ5rkPjF4yX4eTaHqOhQRfYoLk22qMluGkaNwflWZgfnDLuKgk5wSMDnxjxr8b2kSe38M+bd6hLKGa+ZWwEXnajN+8YH1AhAx90igD1fWbs63q0cPiVll0DSrU6zfPFeSyW82xv3UTCWJR8zjIKnkIQRg034Z+DtVkvNS1PVRqGleO1nN9qFncXANndrMWKFGi5Rfk25DEqU5DDGfHfgbNrviD4kxaJrN351hqP/ABMLxXVX89lgcRbm64Uvnb0yucZGa+tdMuZp9H0XW2/dzQxeRfo64OAdsnv8jrn6BvWgDG0aKOa+1C20+9lsNcUJPcWqIiXEWTgb1IEc0f3h5mMkDG4mptVtdN1q6tz4ksLWPUIZvJsNVjEkW5t2GVXUiSJsqRtLYPBBbpWt438MQ65Db31uDFrFg3mWtzEdsgGQWTd6Nj3GcZBGQW+G76PWhFDqqpPewRebHMqlI7mF8qG25xnjDoc7W+oNAGFdWvivTZpEsdS1poQ52efbW18m3thg0cg4x97J9zVgR6leeJfDy3N3Jb6k2kakfP8AsyxlSLizxmPcwxjAI3cj07dLc6ZqMCzNo+pmOSSUy7L2MzxjOPlXDKyrxwAcDNZrC5Hj/wAP/bjC1z/ZOo7jCCE/19njAJJ6YoA2re/kgdbbVdqTkZE8aMIZOcdTnaeR8pOfTNJf30EMzW2qpHDaTskMMrv8srsD8n+ycjj1yMHPFTW8VyRcxaiYLi3z+7YL8zL3Dr0yPUdfQVSmnvpp1uNHuLS8tQcTWsp2spx/Cw+6f9lh+IoAlaSTT5xFdv5unzHakshGYmOAEbPUHsTzng5yDXnPxx0uJ/CNzPcNIJ9Hia8tpDyLiAkLNbPjBwylRwQc7GBytdNrniS10WNhrCS2tg+5ZYr6MlWU9o5VymfRGIJzxjpXlOh3niz4tkTafJb6To1iLpNJ1SZN87yoBGsnl5+R8Py3OMHaA2GAB5x4VfXfEmi2mkyXkh0O8vm1LUdQ+zqN180nzRrK58pz8ilXJwDIeGIGPo/RtI/sixSIz+KtPEbGaWdnhuBKeSzOVVsk9ScA+9QaX4XisfCVnaajpNvqthFbKk6RQql2ki8NgoAJPmBzja3+8TioVFz4EiXVdEurjVfBrMWurVy001kOdzxn7xAPVDyOfwAOhvfEMlho8TaPOPEN/fF5LJHljhTy1272eRV2qiZyTjPIGCa8k8WwPrtxqt/od7pH2y3X7TParbCAahCFAeZcuWDx7mxIVBPTODx6No2hy6pF4i1fWLZNLudZtNiHyxGbW3O/YJOfml53uScDKr0XNZnjYXl74sKNpgne2sm0qzlaEoZ7i5VWlkVunlRxKcnpubHWgDg/hXdXFh8StfstNubh42vbJ1i3KkUkbQuryNtLDoi4Gc5xxXuXjWwF9pi8RF0b5fMiDjke6Pj64rxXwakq/EnxTcfZHublNYhtoyspKGSCDbjOOgMhJ44HvXrni2e8W0W1mkgYMfMkZY8YXso+cHOc8989KAPLNWxZ+NfC13532WVVvbKeTJjclo1deNyk/c7len3T1rbvLrUvEum7dL06DU9J8zY99q2otBBMw+Xy4QrsWO7jJ+XPQnFUNT0N/GuuaFYaNIU0PT4bl9Sv4ZflSSQhDGrMgy4jVxgAFC2WORzuS3WtXWrwSaQLSGO2c2unwQ4nh8roD06/KC8gIVFAQb2JoAh0PU7Ge1kiFle2d9auYLi0FvFIbeVQMoSshBwCCD3BB710sl0rwAJFevOVAOdOBJ4x1zgfia5LWtGsPCPiaG3SC4u21CwWSSTcuZJoW2vK25G+ZhIuTx0FWZdVlaW2sLK2mW/vH8q3jHlvhsf6xh5Y/dqOWOcY46kCgDQ8K6PNqnjS5vLi3nt7LTZFcrIUPnXRTgfL0EaN0B+847qa6TwRdQ3mseNJbaQSR/2yE3D+8tlaqw/Agir1pp76NokOk6XJI1yVb/SZhv8AnJy8r+pJJOO544HTN+H9jFpt74rsrbd5MGpxRqWOScWFpyT3J6k+tAHX0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRVHWdXsNEsjd6rdR20AIUM55Zj0VQOWY9gMk1z3neIfEpxapL4e0lus8yA3sw/wBlDlYR7tlv9letAGZ8UfE9hoOr+EvN8y7vY9SaVbC0w9xIrWlzGCqZHG51GenNUJtM8ceNSj60IvD+hMSTpcNyftMy54EsiqQAR1VSODgjvWnrGk6R4Y1Lwi9usVsj6w7XF1PJuklb7DdgNJK5yx5AyT7CulvdZ0p4HWeaRoh1KRyYP4qKAIvD+iHQdOSx0uDTbK0TJEcMTdfUktkn3NXJmvNjAahYxH+8YScfm9c7DrHh55o1tNKkuS52qwgUkk+m8g/pVDxVrdh4fJF1G9rNLxb2sWitcvMxJCIhjJUsxBwpIPc4HNAEGq6/PZ6jHpcE2oatr14uy2hFxDFEoB5lZYm3Ki5yS3J4A5IFXfA/h23jELLNJeWlnM8v2t33HULxvlkuG5JwvKICTgeoVTWP4V0bWdS1BrnxAsNvrFza+RdxW64hsbNmLC3XBwbh/lLtk4AGONpPpU81lo+ltLK0VpYWsXJxtWNFHQAfyoA574jeK7bwtpEAkuo7e91CYWtqzDdsY/ek24JYIuWxjk4HeqOjaRot1Z2mnJa6zqliCXaS/wDNERbJLM6ybQ5ZiT908nsKyY9Uu4Lu+1vVpLPTtQmTb5C5ubq1tAd0aeWOEZslmZjtBIByFBrzn4g/GaGw/tKHwyZJLm4iUz3MU3nBX+4P3itt4/uwZG7PzqcmgD2rxJ4w0HwfbG3laNDbrGDbwKFEKscLnsuecKPmP8IJrz3TvibrfxH8S3+j/Da3S0srIBLrXb6MkRK5O0x2xIy3ynG89jlR0rxp9E1LUZhqnje/u4IbYmcNabNltHGuXCghtr7sjf8AMWKck819JfBHQ30H4e29xexTRX+pO+pXKztvkUv9xWOBysYjUjA5B4oEcJ438APZajbXmoXT67evEI31DVoxPlmJ3KqFTFCvoFXPPJPU+cfE6HQrXX9HSSxthqUenTyXfkoIZHDSCONWOcBgqMB1yGAxjivaJ9Q1LVtcdL25QvPNstYEdoYmt92ACGJBk5AJIOTwFx05y90WbUbzxdrFrBeNBd3v9nxLbbkjjtrRfLXDCRAB5qyHg/1poDi/gxYmw8f3moxo6QQvBteQAZUkI3Tp8rk4/wD1n6T00y2niLU9NucPaXQ+22ufQ4WaP3w2G/7a+1fNPwYhax13xZprCM77iycxooG3zhJFgYZgSPMjJ54KnPIr6S8QQy3GjWerC3lXUtOxepCh+cnb+8i99yllx64PahgjZtHggkFhG5MkMYYIR0Qkhee/TH4c1gXOkCW+nhtQtte2rm8sJxnCmQnzFYAjKlgdy/7QPUAjejuHvLayudPeJrebbIzODkxFSRt9+V6+9Q6qjRzWl7G+3yH2yA9GjbAb8jtb/gNIYui6mmpW75Qw3UDeVcwN96KTAJHuOQQehBBrnfEsljH8QfDzanPFBENNvijyTeWN4nsiozkc57d63NX0c3dzHe2N09lqUSFFmUbldT/DImQHXPI6EdiMnOBdwXl14z8Pxak0EV4dJ1DzGthvTiey+6HHceo4z360AdHY20ywStDqstzHKweFnVHEa4+6CANwPqST71i+J7WG2nGp3MWlRyRr/wAfct3JZuBjoWUEkexNa2oz2Onxt/aN8yxsgKwFgDhepVVAY+45/CvJfG/xAt9D8Iare6JpCCeW3YWTCLJjbadztKMh2AIYhNwQL87DOKAMLVr7UvGniKHT0cvoVpLbXN4Y7uaSGS2aZV2MXIO+QFu3EYJx89eveDYLbTdDt5mEkclxf3LkdcvNO5I6cDOMegArz/4KeHZz8J76R4pUm1ZBfpvJ4JywUewYH8xXoEMqW3hqWSUqI9PvjO5HaLzfM3f9+3z+FAHQ3Fg3k3IspjbSysJVYDIEnqR3BwMj69zmvPJ9TtNU1ny7MXcFu+5tdghi8xC0RUEBgcZ7My5yvB5xjQ1oXXjCZbYajFYaNLLJHBGJwsl+Y85bjloy2OARlQSchgBz93eXOm3XiiBLyWNNK00WrXUMa25e6ZhJbRxKAAThypA4O5QepoA6Hx94y0+38J6r9khbVRPCbS2htlMjXMzqf3aADkKpDMQcAd81yq6neXl0Na1zTdRtL9IBDDG0oAtogc/wyDczEBmOOwXkLk2NP03UWC6jfXUd/rc1usdxDACtrb4JJihCkbV55O47iMk4AFVvFDW1p4dntpYLe3vNQYWVufILOXlOwtuMjYCqS5PYKTQBV+DOmWuo63ZapBdmN9txrFxbL84mku3JR2zkqwjEffPI6g1pfFW5hiZJ7O+VptSuPsrTQ/Lttwhac7xlW2Ro52nBB9cYrrPBtgugeErq6s4reONot9rumBUxqmI9x4UcAd8e9eY+MkuXWK6tZDp2u6fOktjOwJKSSuIlVlcEsp8xlIbPBJXH8QB0fhp0uJ7Kws7JLe4azjh06xAd7WwgK5keSIkAuFZASxyS6D5SWFb/AIl8Q6L4B0sa09lJf3MckFlf3IjCzwQE/wCsYbciNc5CqAuW4x1rD8M+K7vQ2vbvxHoWv3l25WK51W22XMLBcgGGFSsix5ycCLOWJOetY/jT4iT+J9I1yw0Lw5rtvJBbOz3Gq20VpE0I+/saQMzM6ghVCZywJxQBhX/izVdc+Iut2flW1/p2ktKItSublYoIIroQvCmEG6UYiYqAGZiwHGM16Z4K8P39heT3cFojXk8fltq97H5ZWPOVigt8lljB5+dgSeTnjHmPw+8E654U16WJbmzaZUEa21jCsMlysMab0EjciZRIpU9GCvu+9lfdGsLm/s1Wy1uV4lOyQTKGbIPzKxQoQex5zQBvbhDADPKvygbnbCg+/tXNeC547jWfGUsLq8Z1dAGUgg4sbUdR9K1LPSILS5Kw2lmtns4+QmTfnnJPUVmeDVdda8ZCVlZhq6cqu0Y+w2mOMntQB1FFFFABRRRQAU3zE83y96+Zjdtzzj1xTq8a+IfhbxHrHxbTUPDUj2U0GhrCl5IjCAl5pUkTcBguEk3geqrQB7HFIkq7onV1zjKnIptzPDawST3MscMEalnkkYKqgdSSeAK+dNG0rxb4f8C6Tp2mW2tWWnLql6t55EEguQmR5DYRfMKH5iSo547VZ8Wr4v1Dw6LLVv8AhJLyGTQJEgFjYyILi73sD9oQKWXKBMBsA5Pc4oGe/W17a3UssdtcwTSRBTIscgYpuGVyB0yOR6inSXVvFcw28s8SXE+4xRM4DSbeW2jqcZGcdK8Uun8UWNl4mW307WfLLaTFbtaxPG6J9nQTOu1S8gVhhguWHTjFM8DQeJ7vxb4QuNet9WnSwu9YhF1d2siFYCkXlFywyN3zYLHJxjJxQI90orxj4qavrKeOr7StKu9eDHw+tzZ2+lRl83ZnkVGkwDhOAGJIGBTNRm8eL4mVZf7X/tATWAtVtY86c0JVftRlYDaDu3/eOem3igD2qoY7q3luZreKeJ7iDaZYlcFo93K7h1GcHGeuK8N8T6D4o134a+J57668Q3F6upMtvpvlgK0CXasrKmze3yAkcnOBir16/ipW8WSaMmuG1KaT5E8tqUu5IcN9oKZUbpQMZGMgnoDQB7VXJy+ItQ1qR7fwjaK8QJR9VvFZbZCOD5a8NMR7YT/b7VwFgnjC/l0mz+1eJLXR59ZuY0uXjKXS2QhyhlLKSo35ALgN+ld58KX1hvBkCeImvHv4Z54t94hWV41lYIzZAzlcc9+tAF/RvC1rZXo1G/mm1TWMEfbbvBZAeqxqPljX2UD3J610FFFAHK+NYEudY8GRS52nV2PynB4sro9fwqSWxht7q9aTSLNYhGSl5e3AcSNgYBByQPU+1UviNJbRXfhKS+vv7Ptl1Zi9z5oi2f6FdfxHgZPH41wOvfE3wXoV3OmlWV34j1OJjDJdykFFk4wvmSkbjyvEQbqB3AIB2l7418O2Ruo7XX/D9vDbxBpNrZKZ44KnBJPAA5JI4rK8MW+pa1fWmv6tDLHqcyMumWNwsjDTY9zq1y4cj55EK4XapA+XuxFDQdB1/XbHStT+I7Q3GsCVbrTdBtEMVrauANssy/eZl6ncxC9ANxr1TStPWxjkZ3M13MQ885GDI2MdOwHQDsPxNADtL0+DTbUQW4PLF3djlpHPLMx7kmvAvjP8S2uvE48M6NpZ1e1tGxdRNMYo5rkMNqnYDIyxnDYXblh1+TB9Z8barcuTo2ks63Ei77ydEkJggPBCFVOJWGQo7ct2APJaP4X0fTpo20fQ4oZsAK0tuVwcAcBkyTgfzPc0Aect8PPF/iKwlttZ1FbHTPNLiw02yeO2Bx994zGDIQf77MSQOTWpY+D9A8PT2UElnFdXscQUm8hjZrdByPkaVNm4nJCj+NvQV6jKLu2R2tbK2aSNT5hMEaAcjkEjJ9elc9eajqNxJDb6ZdTzaleuVtoVkaKMHHMjhCpEa8ZOCeg6kUxGHF4Wg8YeKLLTYzG2m2jQ3WoyR20IDIh3pAWDMcyP8xwc7VbP3xn07XNaFpG2kpfpLrACsQ+It4YnAB+6p4AwevvmpvD2kSeF7GVTPHJZpE1xPIxZpbi5YlpJGZicDgBV5wOM4AFcRqXiDTtbnW7vvMt4tgYjyf3iLxkqwGJVAIYoQHXBPIOCgM/VtSOk2l7rbQNLc2q7YbVkAf7e5EcURT1ZyrAgYIBPbA6a38JDRPAsGhR4upbS3VVkaNn82XJZpDvcKSzlmP1rBttOhuvFNtodtNcXmi+FXF0ZSPNeTUHBMcanaw2QxuWwc4LoP4a65fPmSVo7XUPNI+VpfNT5scdIhQB4h4NsZLD4ja/aR2zqi6Yt7HKUUNKYLyJt2E+XoxPB6H0xX0Ppscth4q1G2Ds1neRLeRqxz5cgOyQD2PyNjsS3rXh/hm1ubP44azFcrKqf8IrcxIsm/IImRmwH55yDkYBz65r6CMLNqltcBcoLd0LehLIR+eD+VAyh4WEtsl/p0xyLO5ZYT6wth0H4Biv/AAGtmeJJ4JIZV3RyKVYeoIwazklMfieSAqAs1osgPqUcg/8Aoa1qUAR2yGKCOJn3sihSx6ntmvPviR4j0/wx4q0a91O5igEml6hDCJJTF5splsyEVlBOSAegJ4rtL65ltNTscQxG2uS0MspOHRsZT6g4YfUj1NcT8R22+NfDTb5ExY3/ADGu5v8AWWnT5Tj9PrQBxNxrUmtX8Udho081pd8XUslrcLAxzwJZJALidQR/q1REY9WxkVheNLPU5PDutXOqRC7uWspLeXU5oSjeT2jjjdAkSDg4Tk4yWYjNekWn22SRQs2ruB/GY8A/niq/ijTbrVtD1DS2jnKXVs8DbnA4YFSePqeKYjq9L17SvD9l/Z15cLFNHeTW1vbIrSSy/NuUJGoLNhWXoOO+K52/0LxHPZ6i9pf3WjabMsYRYLVLm+lQBso6tlFwG28ZJCDvVT4YtexaJDdao8I8RX8dy2oXccW5hHbN9nWOFfUbVbBzzuJGWGJ/iYbKTRZvF0PiK8gTQkVrPypF8mWcfQHzC+8R7fUY9aQyLwTo+laDBZyjXJ9Zawt1gtHkhC2umxgbUVgBuDndg7iX56ACtG7u7bxLfw3sitLoGnyk6fKJWBu7nBVpwR0SMFlUnhiSRwFJ5iL+1/HOnRP4+8qy0qSVLmLQbdGidyOQLtyDkZG7y1xzjceMV00LcgWsccKgBFWJIE2jtj7uAKAGyafBPaym6ldIs/KVlkYBR9Vx/Os/SrRdd8XK2mwW0tto6iL7TM3zfaJceaF75SA9BjmYelP14X+4WFpcwXF7eKwhjml3RIqj5pXVZOI174HJIX+Kug8B6BbeFPD73rWrhvLyqrl5RETuJbJ5kZiXbHchRnaKAJPiRqb2lpb2sRURtmWUbhkqmPlwSOOc5yMYGSBXm32S21LVdOtLhpDFpTtdzJMilEOWEEYY7eS3mSbeMGIcDO5tjVJ/Ll1K71Brua0jzI7QOWkkjdv3ZjwPmJbAQryHbGAC6jntK0aK7vLifW7mPVNSaX7TPBFvSJWwFVOu3aiqqAYxx05NAHUwJpcNzIX+zSM6lQtxcxDI68bXY1T8UQteaNcyTHT4gzRoF2SdDIo4cjbnB4GRmtKyF9JPt0+3WyY53eTbB2IHTO1QMfjWdrmmrHEzzQzR3oCbXv5FG7MyDaibmIJ7cD60wPRpPD4Op3128cc3+kx39opODHOsXltz23KAP+BGtGCyjFwNQtw1vNLhriNeRKQMYYdNw6bhzxjkVOk7/wBqzW5PyCFJFHoSzA/yFUtRvJ9O1iykllU6bdn7MysvMUx+4wP91sFSD/EVx1NIDY7VzXhP/kPeNP8AsLR/+kFpW7fXcNhavc3T+XAmN7nooJxk+3PJrC8J/wDIe8Z/9haP/wBILSgDpaKKKACiiigAooooAK5/xJ4rstBvrOxkt7291C7V5IrSyh82QomNzkZAAGR1PPbNdBXOeJfCdtrmo2eopfahpup2qPFHd2Miq/lvjchDKykZAPI4PTFAHP6Z8R1az8QX2oWFx9k0/UFtIlgixJsMSuGkDkBSNxByRjgdamk+Kvh4aRpWoQR6ldJqSXDwQ29q0kn7jHmggdMZ65x70lz8LdHntpY2v9W819QTUxcGVHkWZYxHn5kIYEDncCcknNP074Y6NYQ6VHFd6k405b1Yi8iEt9qH7zd8nOO2Me+aAKcXxL8IO9/rTWt1FNa6dFcm6lsCkk1o8mF8skbmQOenTOSM9a0Lj4m6Bawag14t/bXNlcxWrWk1uUmd5QWi2qT0YKxBJGApzisTxV8J7e68K3VjoV3KL86PDosBvJB5XlRzCUM21M7uvI49u9a1z8LtFvLS+XULvU7y+vLmK7fUJpU89ZIlKx7cIEAUMwxtI+Y5zQAh+KWhz6baT6dFf3d5dvPFHZRW+6ZHhGZN4zgBcjJz3GM1ufD7XZ/E3gvSNZu4o4p7yASukedqnJ6Z5rFf4aaeY7Fk1bWIry0aYpdxPCkjLKoV0IEezaQo6KCDyDmum8LaHbeGvD1jo9i80lrZx+VG0xBcj3IAGfwFAGrRRRQAUUUUAePftO20N54O0O3uZbmKN9ZiCm1TdM7+TMUSMdnZtqhv4SwODjFN8DeBk0OSy1fWbT7RrrBn0vSTKWWyySWJYk7n+bLyNuIJOCxxXb+OHaPVvBrRQGeT+12CoMck2V0AST0A6k+g71v6fZmAyT3D+beTY8xxnaMfwqD0Uen4nmgCLSdMNo0lzdSi51GYYlnKheASQijsoycD8TkkmqHi7xEuixR29onn6rcg+RDtZlUAgGR9o+VRnvjJwAeeJvE/iCDQraPKNPdzHbDAgJPu7Y5CL1Zu3uSAfPrO9t/7Qmmadr3ULlg8s0YwHOMYXfHlEH8K7vXkkk0AR6TpT2cJlv5RfTSuZ57q82xM7EDLMoJUYA9BwAOgra8KXlnf2NvqcEcUdjOMrtjXeV5wQEi3cjnk9CPpWD421a7PhO9itorWC4v1TTYg06szNOwiyAG6gMTnHY0PHZPbNp+nF5oLCMW63k8swtrd1GFjUlsyMAPuR5OcAkUxGpe7ZLpYrMQefOGMdpb2kTZI5AJeMEA92PA/KtbwtY3F0/mRXQcDC3F/EvyPhj/o9t0xGCDufHJ6c/dqeEfBxVWlnhktLGciWWOcn7XdNnOJCDiOLjIhGevzHlgd7xTqs1q1tY6TPDDcOxQnAOw7couO2Tj8AfakMx/id4rn0eBbWxhSUOQJ5M58jkFd6kD922drOrbkyDg8kcVdXUOm6ZLqttaSXV+ZUgtdKQr5kt8GLJARgHC5LFhj5Ax4yQJtTvdJXWLi38T3P9mWU1q1213P8sU0YKloSSfmkCuowOTuY9Tg2/D9iNc1BPEGrWDQwxwm30XTriMPJaQMFDSSKVYieTaM9cJhepamI6PwfpT+H9FSzl8x5izT3lyFnRrq5kO6WUg7R8zk4GTgYHanSCCPzDJaw73Oczui57c7pyTUsy8ELFKpHGz7KQo9wRb/ANagFxj91Ol20IwOrxgjPdmZOaQzzbwFYyn43eLLhxaJb22gyLGlsAwVZZt4BI6H5WOMn73BxivoK28wxwnK+X5YyMc54/8Ar15D8Obkaj/wsfW40khVrv8AslEkO7Z9nQqdr7mLLukJznqTgCvZQAAABgCgDM1IJHqulXDEBi724Ps6Fsfmi1p1leIY3kisfKVi63sLcDOBu+Y/985rVoAy/EsDzaNOYs+bCVnTHXcjBx/6DiuN+I9zPaeMPD8ltP5D/wBnagN/mbOPMtO/9K9CuI/Ot5Ys43qVz6ZFec/ESCaXxb4ahjldX/s6+DFAx3fvLTIIXnFAFWwudTvpEkOqxiIYJBuyc/pUmoX8LMsWpa1awiMHO65HB9eagtdDJQblkWR2Hl+Wlz075w3Fa0WgTJGjTh5oz/BmUEc4+bLdPrQBxen3cXhWe6bw/rWi6naC5a9S0vzJ5lrLKMSGKWMNlXJLFNgxuODUkl2niW7jufFdtPfQRsGtLIaeY7K2kXrIpdgZJOSAzAY5woySe+j09LKczJBbxRkbhKwLgnpgde3tXPa3d6lPcr/Z66daxrKweSWzSYyJtwMEEFTn69KAGwNbqGnt9OSMj7vnIsZP0Oar6r4lmsYSWjCSBgkSRS/NK7cJGBu5ZjwBUWoXtvZ2Yl1a83MAEGyKVUDE4AwhJOTwAOSSAAa0fB+lXetal9rv5ZbWWybK2yJlLXeASoc5BuCBh2yditsXBJYgjU8FeG7u3nkuNdimk1O7jinu5vtDbYSpzHbR44ZV5LMMbieQQcDnPiRqUHibU7XT7CQyi2mV7V4XMZa4yyEB8jHXb0IyR25HVfETxcujQCysmSW9kI81FZldYyQpKEfxjcpx1AOcGuClKWuo3OlPfNFcXcQOpTwxv+5iZeYwQpC3Eg25yBtXLfeZaBkEFy+qND9pW+uLe1ZhE4TYl1dZIeXaSCFj+YDnaZHkYdFNdBa28j5e7hbykYP5dsxY7fdcHjp0PermkpZQWEEWj2RhgRdsMaxqNqgYAA2g4wB3q3EHht5X1GynEgfIZwX2/QZkH5CgCO+kllZJsPZRglY4mbDsMc/K/wAo+maypT9qn06ws7RQtxqEAcmJchVkEjN8px92M81YGp3b3YRZ/KdhwkMRUen3i8P8jWv4RtHufEsty/lGOxi2vJuDuZXH3S29+FXJIJ/jFAHWCTb4laPHL2gYH6Of/ihVHUopZRqunyh5RNCbm1d+QrDHy+21grD/AHvarelxRnUr6WOd5jGRF86n5CSZDhujD94vTpgCrd1GhvLORg5dWZVw4AGVJOR36dqAEspo9T0qCZ0VorqFXZDyCGXJB/Oub8A27WmoeL7d3DiLVkRCP7gsbXaPqFwK6HQ4GttJtYHUq0aBMHtjpWR4T/5D3jT/ALC0f/pBaUAdLRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHNeLP+Q94L/7C0n/AKQXdT+K/EcWg2yKkEt5qM+fs9pEpLPgjLMQDtRcgliOPckA4Hxa1aTQ08L38EcLyx6qwQTyCOMFrO5UM7Hoo3ZOOSAQATgV5xNr2l2P2jVNSN5rdxOS9ze21i9wF4GQuYz5cK9lzxzyTk0AdI+lm/llvvEVxFc30pyxMbKka9kQvECEB6Lnryck1NZ6ppdlf21gheW9kGIkt53eaRR1bYkgJHqcY+lYllH/AGnpsEos5dP0645t4FtCmo3A6ZiiGAinI/ePwMZxgg13vhvwRBa2wjubeO1tcqxtYpWeSbA63Mx+aU5/hzt/3qAOT1TTr7xP400PR9VtYba3tkk1d7NXcTMqERReZLuZV3NI52rkgIeckV6rFpOm24shFZW0YsgVtQIwBDkYOz0yOOK860/xHZweM/E01jGtzqRki0mws0AG2OBSzsf7qb5Jfr5Rx0q4l7qPiLW9Ihi3T2tnKxe7RD5RlVH/AHjrxx5i4VQTkNkn0ANHxbrt5/a8mk6fIUZUWQiBS00g2uZAF64G6DJHI8ys+eSz8PaLHq/jK8SGO6kjYxSIzTyS9I40VfmL9OACevQZNZl/40s9Aabw74HhXX/EKrLPdXbMXhhlY/MZnTJaQtjESc4AHyAA1jaHoHifUNafWtS0y+vNUlwov7/bbiCPvHDAJSYk4GRjcx5JNAFHxFZar4wjS/1UvpJssNoukvNCqWkiOGSeZzJl5GCgYHCKxxlvmrpdB8ZXWvaak8duiXQJjuIDP5hhlX5WUjzCcZ6HHIINa7eCtWuwsUl1ZWVuG3Ex+ZO59sMVA/HdWD4q8EaX4e8Q2mu6jJc3GhXbLa6qhnMKRMcLFORHtBUHCNuzgMD2NAibVrx7a3NzqNzplhDnB81hlyfQNEcn2B7VmrdaldRT3eiafeRWUUZnk1XUoRaWkSAEs4QYlkIAJACqPVhXrek+HtG0iNE0vS7K1CcKYoVU/njNU/Fix6gbHQ5IWmjv5N0452rBHhn3exO1Md99AzE+GmkyaP8ADnTI762e8u9Qk+23gCjPmXEvmMxDHou/nknC9zXd1Xu7d55LYrK0aRS+Y4XI3jaQF+mSD+FWKAM/WYbqdbNbQldt1G8rB9uI1OT9c4Ax71oUUUAFea/Ey4htvGnhgzhiHsr9FVerEyWvH3h2Br0qvP8Ax5pl/q3jbw/BpV5b2dwum37+ZPAZQQJbQYADLg8jnnoeOaAM7TrzSsjdBNB5bc+YpG0+p+c1dH2G5OIljkBcRpGspZmJ5zhHOOnciooPCnieOTdLcadPzk4vLmIH/gK8D9afqWn67ptpLd3d9pNjYxDLy3F/duFHA7Mg68AfSgCG51HTHuwl5E7yoDEEMQKx47DL8H61j3+r6ZDdPpunW819q4jaVLK1WHeowMNId2IlOR874H16VUhsNd15WuNRvPsPh1w8cezTniv749mgikkcoPRnG7HJVRhq9B8M+DbDS7K3gFoltaQnfHZo5Ybsffmc8yv15YkDPGcA0Acv4W8J6hqt4NT1S9wu1Wt5LXiO2BX5ltieWLAkNOwBIOECgk1u+KtWj8P6TJpuhW624hALmMhdivkl19W3cknu3q2a0vE+uWsSzaclyYZtq75EzmHdkIwGMMNygEe/vXmGkprGueJtR0/RI4pxDFEjalcKWtrZlkDbTj/XSgBfkBA+UbiOhAGTTXsl0jnym8QystxG12Fxaw/Mq3Mqkjk4BWPqzAdADW7pCWWnW4itgzvkvI6yo7yyHlpHYMGZmPJJNW9L+HOv2MZU+KbWaR5GmnnbTnV7iRjlnk2zDJ7DsAAAABiujsvB80FuYn1q5QsMM1vBGpP4uHP60xGO82pX0CLZ29y8Tfe+XGB9WLAVl79Ne8/s+WT7TdIpJtrc/aZPclY4sL1xliBXYaf4E0W2kWS6F3qUoO4Nf3LzLn/cJ2D8Frpba3htYxHbQxwxjosahR+QpDPLL3/hJ7axe40nQ7PTYIxsjOpTO007k4RVhhfA3MQMlwRnpXbaZo66d4Zj0m+vXmu7tWW4ucfNNKyku3OcDAOM9AAPSpY1Gq+InmdH+zaW2yIn7rzsvzN77VIUH1ZvSs2V/wC2NbujC+5gzWEQYnCRKR9okA9ScRg+qj3oA6XSrhLrT4Z4o/LicZjXGPkz8p/EYP41FqWTfaWq9rhmP0ETj+ZFXkVURUQBVUYAAwAKyhun8Usc/u7W0AH+9I3P6Rj86AJdFlkcXySOzmK7kUFjk4OGA/Ddj8Ky/Cf/ACHvGn/YWj/9ILStPR1K3GqZxg3ZIx/1zSszwn/yHvGn/YWj/wDSC0oA6WiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOP+IsFvLL4Ym1DT5dQsLXVfPnjjsnu9gFrcBHMaKxOJGjwccHB461zkutRavNPeavp2rlIAy6dpUmh35gVgfklmxCQznCkDBCDpk816nRQBwmg65pGlxNJNH4jvNRm5uLyXw/fb5DnOBiH5UGThRwPrkmbXviBZWGkXd1aafrc00UTuqy6LexRghScs5h+VeOT2612tcv8AEb/SPD6aUud2r3UWnkDvG7Zl/wDISyn8KAPJ/DBOj/Dq1gt9L1iXxNfxtNf350a8Z9zM0m0v5PzZ3lSQcck8g1tCbzbfTNEil8UafoMcKS6hJBot+txdyYC+QjLF+6T5dzsvLbsAjLGvZhwOKKAOO0jxB4c0bT4rDSNI1iysohhILfw5eoi/gIauf8Jppf8Az6+IP/BBf/8AxmulooA5r/hNNL/59fEH/ggv/wD4zUF94q0S/sp7S8sNdmtp42iljfw/fEOrDBB/c9CDXWUUAeYeBvGVvpMMvh3VY9dllsSRYzNo14ZLm042OyiLcCudjEgAlQQTmtHR/EtkNW1HVL+18Qie4IhhiOhXxEMCE7QMQ9WJLn6gfw1ueMtLubq3t9S0gD+2tMYzWwJAEykYeBj/AHXXj2YK38Namh6pba1pNtqNkzGCdNwDDDKehVh2YEEEdiDQBkf8Jppf/Pr4g/8ABBf/APxmj/hNNL/59fEH/ggv/wD4zXS0UAc1/wAJppf/AD6+IP8AwQX/AP8AGaP+E00v/n18Qf8Aggv/AP4zXS0UAc1/wmml/wDPr4g/8EF//wDGaw7vxNaSeN9J1BLHxAbSDTryCST+wr35XkktWQY8nJyI356cc9Rn0GigDite8fRWelzTaRoniDUr4YEVsdHvYQxJxlnaHgDqcAnA4BPFYWm3Vjd6nHq/i4a7qOoRssltaJoF/wDY7FlHDRIYfmk5P7xvm9Ao4r1KigDkIfE2hxXb3X2LxA9y2R5r6DfsyqTnapMPC+w4p9743sktZGtLHXpJ8fIraDfAE57/ALnpXWUUAfP1/bT6/wCJ7qK5XxLpHh2MnfJFot69zekuGOxhEfKX5EJY/NndjHWvUNG8QeHdF02DT9J0rWrSyhBEcMXh6+VRk5J/1PUkkk9SSSa7GigDmv8AhNNL/wCfXxB/4IL/AP8AjNH/AAmml/8APr4g/wDBBf8A/wAZrpaKAOa/4TTS/wDn18Qf+CC//wDjNVtS8b2iafcNYWOuyXYQ+Sr6DfBS+OMnyemetddRQBxmj+JtM0zSoLXyvEU8sakvK+gX4Mrkksx/c8ZYk/jVHwtr2naZbyC4sdc8/wCWPzF0G+O9QMk/6nu7SH8a9BooA5r/AITTS/8An18Qf+CC/wD/AIzVKw8X2KXOoST2OvL5k4MZGg3x3IEUDP7n1DV2VFAHMr4y0lSxWz18Fjk40C+5P/fmk8FM1xfeJ70QXUNveakk0H2m3kgZ0FnbITscBgNyMOR2rp6KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiqGv6nFoug6lqtwjyQ2NtJcuiY3MqKWIGe+BXncXxksJ/DWtarDo98G021gvDFJJHtkjmICYdGYK2DkqcEenXAB6nXL6h/p/xD0q2BzHplnLfOPSSU+VEf++RcVZuvGGg2uvrotzqKRak0iwrE6MAZGUMqb8bdxBBAznkVy1p4x0O3+JBsLG7GoXWsTPDNKp2x2S20BbZuxh/m8wnB4LHPSgD0iiuG0/4m6BqPiSbT7O5iewg02TUZdRZykShJFQj5gMj5s7gcVoR/ELwo9g162uWkVss627PMTHtkZSyghgCMqpIJ4IBoA6mioLG7gv7G3vLOVZrW4jWWKRejowyCPYgg1PQAUUUUAFce3/FK+K9/3dE1ybDelvengH2WUDH++B3etvxNr+n+GtJfUtXlaK0R0jLKhc5Zgq8DnqRWfqmpaFrsuveGr6f5rS3R70NmMRI43K4c8AjGQQeCAaAOlorD8OagieH7E6jq9heTbTH9rhlXZPtz83puKgFgOAc9qvtq2nJeLaPf2gumTzFhMy7yuM7guc4x3oAu0ViaT4r0LVtE/tex1S2bTQxUzyN5SqQxUht+COQevXtwa0F1KxYRlb22IlUOmJV+dScAjnkEkDNAFuiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAM3xPpf9ueG9W0nzvI+32ktr5u3ds3oV3YyM4znGRXlsHwS26LqVlLrsKy3WmQ6Wr2unCGMJHIr+ZIgkPmSHbjcSOpr2SigDzPW/hhPqvjSLXJdeLRRalb6jHBNamR4/KIPlJJ5gCocdl6nnNQ2PwneC702KbXfN0bT3vjb2gs9soS6R1cNLv5I8wkHb2xXqVFAHk0XwgkntntdZ8Qfa7UaJ/YcKwWQgaOMSI6OTvbcQUGeBn2qzp/wqe3uLKe41a1ee31K01Bnh08xmbyFlUKxMrcnzevQY4XmvUKKACiiigAooooA5b4m+GJvF/g280m0uI7e5do5YpJQSm9HDgNjnBxjI6Z79K4jWfhpr3iFfE9/qd5p1pqeqvZmK3tmklgC2/O12ZVY7j6Lxgda9gooA8d0z4VXPn6T/AGnaaQ1nDqkt/eWjTvcpKHgCcB41BJYAkbQMDqTTpPhXeL44k1IDTrrTJNTi1BPMmeKWAKFBjCKhV1CgqAWUYOCDXsFFAHiUfwm1iLwjp2lRvo6T6ZqUl3E0bOq3qMXx5p2ZR1D4UgOBitXwd8LjpniLS73VrPSZbGx06WCK23tceTO115yuhdB0Bb5uCCeBivWKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As the ureter is traced down through the parametrium, the parametrium is divided superior and lateral to the ureter and mobilized medially, until the actual insertion of the ureter into the bladder can be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26948=[""].join("\n");
var outline_f26_20_26948=null;
var title_f26_20_26949="RUL atelectasis II";
var content_f26_20_26949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right upper lobe atelectasis with juxtaphrenic peak",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 356px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right upper lobe atelectasis leading to hazy opacification of the right upper lung field. A juxtaphrenic peak is present (arrow); this finding indicates loss of volume in the upper lobe and can be a helpful sign of upper lobe atelectasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26949=[""].join("\n");
var outline_f26_20_26949=null;
var title_f26_20_26950="Clinical manifestations and diagnosis of ampullary adenomas";
var content_f26_20_26950=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of ampullary adenomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26950/contributors\">",
"     John A Martin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Gregory B Haber, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26950/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/20/26950/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H40125471\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign neoplasms of the ampulla of Vater are rare, representing less than 10 percent of periampullary neoplasms, the majority of which are malignant tumors arising from the duodenum, ampulla, or pancreas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The most common benign lesions are villous and tubulovillous adenomas; others include hemangiomas, leiomyomas, leiomyofibromas, lipomas, lymphangiomas, and mixed endocrine neurogenic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/3-7\">",
"     3-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although classified as benign, ampullary adenomas have the potential to undergo malignant transformation to ampullary carcinomas, similar to the adenoma-to-carcinoma sequence that occurs elsewhere in the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/1,8-18\">",
"     1,8-18",
"    </a>",
"    ]. As a result, their clinical significance extends beyond the need to treat any associated symptoms.",
"   </p>",
"   <p>",
"    Ampullary adenomas can occur sporadically, or in the setting of familial polyposis syndromes such as familial adenomatous polyposis (FAP) and its related conditions. Approximately 40 to 100 percent of patients with ampullary adenomas in the setting of FAP have coexisting duodenal adenomatous polyps, which are frequently numerous and also have malignant potential [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=see_link\">",
"     \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of ampullary adenomas has been estimated to be 0.04 to 0.12 percent in autopsy series [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/8,24,25\">",
"     8,24,25",
"    </a>",
"    ]. However, they are being increasingly recognized with the extensive availability of flexible endoscopy and the widespread application of screening and surveillance programs for high-risk patients such as those with FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/10,19,21,23,26\">",
"     10,19,21,23,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the clinical manifestations and diagnosis of ampullary adenomas. The treatment of ampullary adenomas is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13897?source=see_link\">",
"     \"Treatment of ampullary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125479\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sporadic ampullary adenomas are usually diagnosed in patients who are older than 40 years of age, most commonly in patients who are in their seventies. By contrast, patients with ampullary adenomas developing in the setting of familial polyposis syndromes are frequently diagnosed decades earlier in the setting of a surveillance program rather than because of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=see_link\">",
"     \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Presenting symptoms (if any) are usually non-specific, reflecting ampullary (biliary or pancreatic) obstruction resulting from the mass-effect of the adenoma compressing and impeding biliary or pancreatic outflow. The most common presentation is with jaundice, which is present in 50 to 75 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/3,28-31\">",
"     3,28-31",
"    </a>",
"    ]. It is usually painless or accompanied only by a vague or dull ache in the epigastrium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/3\">",
"     3",
"    </a>",
"    ]. Such patients rarely have pruritus and infrequently develop cholangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/32\">",
"     32",
"    </a>",
"    ]. Up to 25 percent of patients have associated common bile duct stones secondary to cholestasis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/33\">",
"     33",
"    </a>",
"    ]. Other symptoms may include biliary colic, nausea, vomiting, and weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/3,30,34\">",
"     3,30,34",
"    </a>",
"    ]. Less commonly, patients may present with acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/34-38\">",
"     34-38",
"    </a>",
"    ], iron deficiency anemia, and overt upper gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125487\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of an ampullary adenoma is based upon its endoscopic, radiologic, and histologic appearance. The primary concern in the evaluation of an ampullary adenoma is ruling out a focus of cancer. However, it may be difficult to distinguish an adenoma from a carcinoma without complete resection since a focus of carcinoma may be found within an adenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/1,13,39\">",
"     1,13,39",
"    </a>",
"    ]. Thus, the methods used to diagnose an ampullary adenoma are the same ones used for the evaluation of ampullary cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43848?source=see_link&amp;anchor=H5#H5\">",
"     \"Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging\", section on 'Diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies commonly obtained as part of the evaluation of ampullary adenomas include transabdominal ultrasound (US), abdominal computed tomographic (CT) scan, endoscopic retrograde cholangiopancreatography (ERCP), magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasound (EUS). Findings on these studies may help to distinguish benign from malignant lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125495\">",
"    <span class=\"h2\">",
"     Transabdominal ultrasound and CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transabdominal US or CT scan may show bile duct dilation or incidental common bile duct stones, but infrequently reveals the adenoma itself. CT scanning has a more important role in the staging of ampullary carcinoma and in excluding other causes of biliary tract obstruction such as a pancreatic mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125503\">",
"    <span class=\"h2\">",
"     Cholangiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visualization of the biliary tree can be achieved with ERCP, MRCP, or via percutaneous transhepatic cholangiography (PTC). All three approaches can suggest obstruction at the level of the ampulla.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRCP may be undertaken to confirm CT scan findings suggesting biliary obstruction at the ampullary level prior to subjecting the patient to an invasive endoscopic procedure, or may be performed for more detailed evaluation of bile duct dilation identified on US. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link\">",
"       \"Magnetic resonance cholangiopancreatography\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43848?source=see_link&amp;anchor=H11#H11\">",
"       \"Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging\", section on 'MRCP and percutaneous transhepatic cholangiography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      PTC is typically performed on patients with a dilated biliary tree in whom ERCP is unsuccessful or who have contraindications to ERCP.",
"      <strong>",
"      </strong>",
"      Because it only permits opacification of the biliary tree, it does not provide assessment of tumor ingrowth into the pancreatic duct, compression of the pancreatic duct by tumor, or visualization of the duodenal mass. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=see_link\">",
"       \"Percutaneous transhepatic cholangiography\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ERCP can identify the presence of an ampullary lesion in virtually 100 percent of patients. Compared to the other methods, it has the advantage of permitting direct visualization of the ampulla and the ability to perform biliary decompression via an internal stent. It is also a better means of determining the degree of intraductal extension of the tumor, although it does not provide accurate information with respect to the presence, absence, or extent of tumor invasion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ERCP is essential so that biopsies can be obtained of the papilla and sometimes the ampullary segment of the common bile duct or pancreatic duct. However, biopsies obtained during ERCP cannot reliably exclude the presence of a malignant focus within an ampullary adenoma. This is a significant shortcoming, since foci of adenocarcinoma are reported in 15 to 60 percent of ampullary adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/13,39-42\">",
"     13,39-42",
"    </a>",
"    ]. False-negative results from endoscopic biopsies have been described in 16 to 60 percent of patients with carcinoma, with diagnostic accuracy rates of 45 to 80 percent in several reports [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/14,40,41,43-45\">",
"     14,40,41,43-45",
"    </a>",
"    ]. Thus, as a general rule, the absence of carcinoma on endoscopic biopsy specimens in the setting of an ampullary adenoma does not exclude the presence of a focus of adenocarcinoma.",
"   </p>",
"   <p>",
"    Endoscopic signs that suggest malignant transformation include induration and rigidity of the papilla on probing, ulceration of the lesion, and a submucosal mass effect that leaves the overlying mucosa intact (due to tumor extension into the duodenal wall). One report found that failure to achieve a cleavage plane with submucosal injection was the strongest independent predictor of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/46\">",
"     46",
"    </a>",
"    ]. Resection of all ampullary adenomas may be the only way to truly exclude foci of malignancy.",
"   </p>",
"   <p>",
"    The accuracy of endoscopic biopsies can be enhanced when additional techniques are employed. As an example, one report described false negative results in 62 percent of 21 patients with ampullary neoplasms who underwent biopsy during ERCP [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/47\">",
"     47",
"    </a>",
"    ]. The false negative rate was reduced to zero when biopsies were taken more than 10 days following sphincterotomy. An earlier study also confirmed a higher yield for detecting foci of carcinoma when biopsies were taken 48 hours after sphincterotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/48\">",
"     48",
"    </a>",
"    ]. A third series (involving only six patients) suggested that at least six biopsies were required to minimize the chance of false negative results [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunohistochemical staining for the p53 tumor suppressor gene [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/1,8,42,49\">",
"     1,8,42,49",
"    </a>",
"    ], polymerase chain reaction analysis of tumor DNA for K-ras gene mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/50,51\">",
"     50,51",
"    </a>",
"    ], and the addition of flow cytometry to assess aneuploidy have also been suggested. However, all of these modalities remain investigative.",
"   </p>",
"   <p>",
"    Despite its shortcomings, endoscopic forceps biopsy is the mainstay of pre-excisional histologic evaluation of patients with an ampullary neoplasm. At least six biopsies (including intraductal biopsies if possible) should be obtained, preferably after sphincterotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125511\">",
"    <span class=\"h2\">",
"     Endoscopic ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary role for endoscopic ultrasound (EUS) in the evaluation of ampullary neoplasms is in preoperative staging of ampullary carcinomas rather than in the detection of benign ampullary neoplasms (",
"    <a class=\"graphic graphic_table graphicRef77606 \" href=\"UTD.htm?39/13/40156\">",
"     table 1",
"    </a>",
"    ). However, EUS may detect an invasive carcinoma that was not evident on other imaging tests or endoscopic biopsies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43848?source=see_link&amp;anchor=H12#H12\">",
"     \"Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging\", section on 'Endoscopic ultrasonography (EUS)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125519\">",
"    <span class=\"h2\">",
"     Other endoscopic imaging modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraductal ultrasound, magnification endoscopy, narrow-band imaging endoscopy, and capsule endoscopy are all under investigation with respect to their potential utility in the evaluation of ampullary adenomas. However, their role presently remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26950/abstract/52-55\">",
"     52-55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40125527\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial evaluation of patients with clinical features suggesting an ampullary neoplasm (most commonly painless jaundice) should include radiologic imaging, typically beginning with a transabdominal ultrasound. A computed tomographic scan is frequently obtained to exclude a pancreatic mass in patients with evidence of bile duct obstruction on ultrasound. (See",
"      <a class=\"local\" href=\"#H40125479\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H40125495\">",
"       'Transabdominal ultrasound and CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with biliary obstruction should undergo cholangiography, which is typically accomplished via endoscopic retrograde cholangiopancreatography (ERCP). Pancreatic and biliary ductal anatomy can be visualized noninvasively with magnetic resonance cholangiopancreatography in the high-risk or risk-averse patient, but concurrent side-viewing duodenoscopy (ie, the endoscopic portion of an ERCP) will still be necessary to directly visualize and biopsy the papilla of Vater. (See",
"      <a class=\"local\" href=\"#H40125503\">",
"       'Cholangiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biopsies and biliary or pancreatic drainage can be performed during ERCP. Where local expertise is available, endoscopic ultrasound and intraductal ultrasound can provide valuable tumor staging information (",
"      <a class=\"graphic graphic_table graphicRef77606 \" href=\"UTD.htm?39/13/40156\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H40125511\">",
"       'Endoscopic ultrasonography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H40125519\">",
"       'Other endoscopic imaging modalities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/1\">",
"      Park SH, Kim YI, Park YH, et al. Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/2\">",
"      Park SW, Song SY, Chung JB, et al. Endoscopic snare resection for tumors of the ampulla of Vater. Yonsei Med J 2000; 41:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/3\">",
"      Treitschke F, Beger HG. Local resection of benign periampullary tumors. Ann Oncol 1999; 10 Suppl 4:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/4\">",
"      Allgaier HP, Schwacha H, Kleinschmidt M, et al. Ampullary hamartoma: A rare cause of biliary obstruction. Digestion 1999; 60:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/5\">",
"      Deschamps L, Dokmak S, Guedj N, et al. Mixed endocrine somatostatinoma of the ampulla of vater associated with a neurofibromatosis type 1: a case report and review of the literature. JOP 2010; 11:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/6\">",
"      Sun JH, Chao M, Zhang SZ, et al. Coexistence of small cell neuroendocrine carcinoma and villous adenoma in the ampulla of Vater. World J Gastroenterol 2008; 14:4709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/7\">",
"      Kwon TH, Park do H, Shim KY, et al. Ampullary adenomyoma presenting as acute recurrent pancreatitis. World J Gastroenterol 2007; 13:2892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/8\">",
"      Sato T, Konishi K, Kimura H, et al. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA. Hepatogastroenterology 1999; 46:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/9\">",
"      Sellner FJ, Riegler FM, Machacek E. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma. Eur J Surg 1999; 165:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/10\">",
"      Stolte M, Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 1996; 31:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/11\">",
"      Asbun HJ, Rossi RL, Munson JL. Local resection for ampullary tumors. Is there a place for it? Arch Surg 1993; 128:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/12\">",
"      Seifert E, Schulte F, Stolte M. Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study. Am J Gastroenterol 1992; 87:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/13\">",
"      Yamaguchi K, Enjoji M. Adenoma of the ampulla of Vater: putative precancerous lesion. Gut 1991; 32:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/14\">",
"      Ryan DP, Schapiro RH, Warshaw AL. Villous tumors of the duodenum. Ann Surg 1986; 203:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/15\">",
"      Kozuka S, Tsubone M, Yamaguchi A, Hachisuka K. Adenomatous residue in cancerous papilla of Vater. Gut 1981; 22:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/16\">",
"      Perzin KH, Bridge MF. Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer 1981; 48:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/17\">",
"      Ruemmele P, Dietmaier W, Terracciano L, et al. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol 2009; 33:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/18\">",
"      Wagner PL, Chen YT, Yantiss RK. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa. Am J Surg Pathol 2008; 32:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/19\">",
"      Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998; 90:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/20\">",
"      Heiskanen I, Kellokumpu I, J&auml;rvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999; 31:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/21\">",
"      Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992; 102:1980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/22\">",
"      Vasen HF, B&uuml;low S, Myrh&oslash;j T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997; 40:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/23\">",
"      Galandiuk S, Hermann RE, Jagelman DG, et al. Villous tumors of the duodenum. Ann Surg 1988; 207:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/24\">",
"      Shapiro PF, Lifvendahl RA. Tumors of the Extrahepatic Bile-ducts. Ann Surg 1931; 94:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/25\">",
"      BAKER HL, CALDWELL DW. Lesions of the ampulla of Vater. Surgery 1947; 21:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/26\">",
"      van Stolk R, Sivak MV Jr, Petrini JL, et al. Endoscopic management of upper gastrointestinal polyps and periampullary lesions in familial adenomatous polyposis and Gardner's syndrome. Endoscopy 1987; 19 Suppl 1:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/27\">",
"      Bleau BL, Gostout CJ. Endoscopic treatment of ampullary adenomas in familial adenomatous polyposis. J Clin Gastroenterol 1996; 22:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/28\">",
"      Ashkar K, Deeb LS, Bikhazi K, Arnaout MS. Unusual manifestation of an ampullary tumor presenting with severe upper gastrointestinal bleeding. Digestion 1999; 60:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/29\">",
"      Sharp KW, Brandes JL. Local resection of tumors of the ampulla of Vater. Am Surg 1990; 56:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/30\">",
"      Taxier M, Sivak MV Jr, Cooperman A. Villous adenoma of the ampulla of Vater. Gastrointest Endosc 1979; 25:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/31\">",
"      Greco S, Cassinotti A, Massari A, et al. Isolated ampullary adenoma causing biliary obstruction. J Gastrointestin Liver Dis 2008; 17:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/32\">",
"      Sand JA, Nordback IH. Transduodenal excision of benign adenoma of the papilla of Vater. Eur J Surg 1995; 161:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/33\">",
"      Binmoeller KF, Boaventura S, Ramsperger K, Soehendra N. Endoscopic snare excision of benign adenomas of the papilla of Vater. Gastrointest Endosc 1993; 39:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/34\">",
"      Shemesh E, Nass S, Czerniak A. Endoscopic sphincterotomy and endoscopic fulguration in the management of adenoma of the papilla of Vater. Surg Gynecol Obstet 1989; 169:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/35\">",
"      Sato T, Konishi K, Kimura H, et al. Necrotizing acute pancreatitis caused by tiny carcinoma in adenoma in Vater's papilla. Gastrointest Endosc 1999; 50:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/36\">",
"      Ohmori K, Kinoshita H, Shiraha Y, Satake K. Pancreatic duct obstruction by a benign polypoid adenoma of the ampulla of Vater. Am J Surg 1976; 132:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/37\">",
"      Akatsu T, Aiura K, Takahashi S, et al. Recurrent pancreatitis caused by ampullary carcinoma and minor papilla adenoma in familial polyposis: report of a case. Surg Today 2008; 38:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/38\">",
"      Murakami Y, Uemura K, Hayashidani Y, et al. Relapsing acute pancreatitis due to ampullary adenoma in a patient with familial adenomatous polyposis. J Gastroenterol 2006; 41:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/39\">",
"      Yamaguchi K, Enjoji M. Carcinoma of the ampulla of vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/40\">",
"      Posner S, Colletti L, Knol J, et al. Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of Vater. Surgery 2000; 128:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/41\">",
"      Clary BM, Tyler DS, Dematos P, et al. Local ampullary resection with careful intraoperative frozen section evaluation for presumed benign ampullary neoplasms. Surgery 2000; 127:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/42\">",
"      Takashima M, Ueki T, Nagai E, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 2000; 13:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/43\">",
"      Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/44\">",
"      Yamaguchi K, Enjoji M, Kitamura K. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 1990; 36:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/45\">",
"      Lee SY, Jang KT, Lee KT, et al. Can endoscopic resection be applied for early stage ampulla of Vater cancer? Gastrointest Endosc 2006; 63:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/46\">",
"      Kahaleh M, Shami VM, Brock A, et al. Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia. Am J Gastroenterol 2004; 99:2335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/47\">",
"      Ponchon T, Berger F, Chavaillon A, et al. Contribution of endoscopy to diagnosis and treatment of tumors of the ampulla of Vater. Cancer 1989; 64:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/48\">",
"      Bourgeois N, Dunham F, Verhest A, Cremer M. Endoscopic biopsies of the papilla of Vater at the time of endoscopic sphincterotomy: difficulties in interpretation. Gastrointest Endosc 1984; 30:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/49\">",
"      Younes M, Riley S, Genta RM, et al. p53 protein accumulation in tumors of the ampulla of Vater. Cancer 1995; 76:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/50\">",
"      Howe JR, Klimstra DS, Cordon-Cardo C, et al. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res 1997; 3:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/51\">",
"      Chung CH, Wilentz RE, Polak MM, et al. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996; 49:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/52\">",
"      Ito K, Fujita N, Noda Y, et al. Preoperative evaluation of ampullary neoplasm with EUS and transpapillary intraductal US: a prospective and histopathologically controlled study. Gastrointest Endosc 2007; 66:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/53\">",
"      Uchiyama Y, Imazu H, Kakutani H, et al. New approach to diagnosing ampullary tumors by magnifying endoscopy combined with a narrow-band imaging system. J Gastroenterol 2006; 41:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/54\">",
"      Yamao T, Isomoto H, Yamaguchi N, et al. Magnified endoscopic observation using narrow-band imaging of periampullary adenoma in a patient with familial adenomatous polyposis. Med Sci Monit 2009; 15:CS169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26950/abstract/55\">",
"      Iaquinto G, Fornasarig M, Quaia M, et al. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc 2008; 67:61.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 644 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-794AB5B1AF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26950=[""].join("\n");
var outline_f26_20_26950=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40125527\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40125471\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40125479\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40125487\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40125495\">",
"      Transabdominal ultrasound and CT scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40125503\">",
"      Cholangiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40125511\">",
"      Endoscopic ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40125519\">",
"      Other endoscopic imaging modalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40125527\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/644\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/644|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/13/40156\" title=\"table 1\">",
"      TNM staging ampullary CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43848?source=related_link\">",
"      Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=related_link\">",
"      Clinical manifestations and diagnosis of familial adenomatous polyposis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=related_link\">",
"      Percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13897?source=related_link\">",
"      Treatment of ampullary adenomas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26951="Steroid responsive autoimmune chronic hepatitis - low power";
var content_f26_20_26951=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Steroid responsive autoimmune chronic hepatitis (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Portal triads are greatly expanded and show bridging inflammation and fibrosis and marked interface hepatitis. There is scattered liver cell necrosis throughout the parenchyma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26951=[""].join("\n");
var outline_f26_20_26951=null;
var title_f26_20_26952="Cardiac complications of stroke";
var content_f26_20_26952=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cardiac complications of stroke",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Julio A Chalela, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Teresa L Jacobs, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26952/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26952/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/20/26952/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac disturbances are common following stroke. To provide optimal care, it is essential to distinguish whether cardiopulmonary abnormalities are caused by the stroke, unrelated to it, or in the case of cardiac arrhythmias, the cause of the stroke. The distinction is often difficult because preexisting cardiac abnormalities are highly prevalent among stroke patients.",
"   </p>",
"   <p>",
"    In this topic, we will review some of the major cardiac complications associated with stroke. Other medical complications of acute stroke are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=see_link\">",
"     \"Medical complications of stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/54/10087?source=see_link\">",
"     \"Stroke-related pulmonary complications and abnormal respiratory patterns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CARDIAC MORBIDITY AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serious cardiac events and cardiac death after acute stroke may be caused by acute myocardial infarction, heart failure, ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation, and cardiac arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study involving 846 patients with acute ischemic stroke, cardiac death and serious cardiac adverse events in the first three months after stroke occurred in 35 and 161 patients (4 and 19 percent) respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/2\">",
"       2",
"      </a>",
"      ]. Independent risk factors for serious cardiac adverse events were a history of heart failure, baseline creatinine &gt;1.3",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (&gt;115",
"      <span class=\"nowrap\">",
"       micromol/L),",
"      </span>",
"      severe stroke, and long QTc or ventricular extrasystoles on ECG.",
"     </li>",
"     <li>",
"      In a meta-analysis that included approximately 67,000 patients followed for a mean of 3.5 years after acute stroke, the annual risk of MI was about 2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/3\">",
"       3",
"      </a>",
"      ]. The accumulation of risk was linear, suggesting that at 10 years after acute stroke, the risk of MI was approximately 20 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These and similar data from other studies suggest that stroke is a coronary heart disease risk equivalent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/4\">",
"     4",
"    </a>",
"    ], meaning that patients with stroke but without known coronary heart disease have a risk of subsequent cardiovascular events that is comparable to that seen in patients with established coronary disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link&amp;anchor=H2#H2\">",
"     \"Secondary prevention of cardiovascular disease\", section on 'Patients with coronary heart disease risk equivalents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H138412094\">",
"    <span class=\"h1\">",
"     MYOCARDIAL INFARCTION AND REGIONAL WALL MOTION ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concurrent stroke and myocardial infarction (MI) are not uncommon. Literature from the pre-CT era when cardiac markers were less sensitive support a concurrence rate of 12.7 percent in patients older than 60 presenting within 72 hours of stroke symptom onset [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/5\">",
"     5",
"    </a>",
"    ]. The majority of the MIs were asymptomatic, underscoring the need for screening tests in this population.",
"   </p>",
"   <p>",
"    Data from the RANTTAS trial placebo cohort suggest that angina, MI, and cardiac ischemia complicate 6 percent of acute strokes and constitute serious or life-threatening medical events in 1 percent (",
"    <a class=\"graphic graphic_table graphicRef68148 \" href=\"UTD.htm?10/49/11036\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A wide spectrum of regional left ventricular wall motion abnormalities, typically but not always reversible, can occur with subarachnoid hemorrhage and possibly with other types of stroke. Some patients develop a pattern of transient apical left ventricular dysfunction that mimics myocardial infarction, but in the absence of significant coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/7\">",
"     7",
"    </a>",
"    ]. This condition is known as takotsubo cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=see_link\">",
"     \"Stress-induced (takotsubo) cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment options for acute MI are more limited in the setting of acute ischemic stroke. Not only is MI a contraindication to thrombolysis in acute stroke, but the converse is also true [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140694714\">",
"    <span class=\"h1\">",
"     ELEVATED CARDIAC ENZYMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated troponin T may be a poor prognostic sign after acute ischemic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/9\">",
"     9",
"    </a>",
"    ]. In 181 patients admitted with acute ischemic stroke who had a history, but not active symptoms, of ischemic heart disease, an elevated troponin T occurred in 30 patients (17 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/10\">",
"     10",
"    </a>",
"    ]. In-hospital death among patients with an elevated troponin T was significantly higher than among patients with a normal troponin T (40 and 13 percent respectively); the relative risk of mortality associated with an elevated troponin T was 3.2 (95% CI 1.7-5. 8).",
"   </p>",
"   <p>",
"    Troponin levels may also be useful in attempting to differentiate neurogenic left ventricular dysfunction associated with subarachnoid hemorrhage from dysfunction associated with myocardial infarction; there may be a lower level of troponin elevation accompanying the reversible myocardial dysfunction associated with a stroke than with a myocardial infarction. Elevation of troponin and other cardiac enzymes after acute stroke may also be related to stroke-related autonomic dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=see_link\">",
"     \"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain elevations in cardiac enzymes after acute ischemic stroke may not be indicative of myocardial injury. In a study of patients with first ever acute large hemispheric ischemic infarctions, CK-MB, myoglobin, and total CK rose over three days (above the normal threshold values), and then decreased on day four, while troponin T, a more sensitive and specific marker of myocytolysis, remained within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, a retrospective case series of 160 patients with an acute stroke found elevated troponin levels in 10 (6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/12\">",
"     12",
"    </a>",
"    ]. Troponin elevations were associated with stroke severity but not underlying heart disease; changes on ECG suggestive of cardiac ischemia occurred in only 2 of the 10 patients with high troponin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac troponin elevation may also occur with intracranial hemorrhage (ICH), but data are limited and the association with outcome is unclear. A retrospective study of 235 patients with ICH found an elevated cardiac troponin level (&gt;0.4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [&gt;0.4",
"    <span class=\"nowrap\">",
"     g/L])",
"    </span>",
"    in approximately 16 percent of patients within 24 hours of hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, elevated troponin was an independent predictor of in-hospital mortality. In another series of patients admitted with supratentorial ICH that excluded those who died within 12 hours of admission or were moribund, an elevated cardiac troponin level was seen in 10 of 49 patients (20 percent), but elevated troponin was not associated with outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140695105\">",
"    <span class=\"h1\">",
"     NEUROGENIC CARDIAC DAMAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence of subendocardial infarction or anterolateral ischemia (eg, ST segment changes or enzyme elevation) is common after stroke, particularly after subarachnoid hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, an elevated CK-MB is found in approximately 10 percent of stroke patients and tends to occur in a slow and delayed fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/18\">",
"     18",
"    </a>",
"    ]. The development of actual myocardial injury (in as many as 20 percent of patients) can also be established by elevations of serum troponin I (&gt;0.1",
"    <span class=\"nowrap\">",
"     mcg/L),",
"    </span>",
"    which is a specific marker of myocardial necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/19\">",
"     19",
"    </a>",
"    ]. Patients with elevated troponin I concentrations are more likely to have ECG abnormalities and clinical evidence of left ventricular dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=see_link&amp;anchor=H12#H12\">",
"     \"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome\", section on 'Acute stroke'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link&amp;anchor=H24#H24\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Cardiac abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unlikely that the only mechanism explaining cardiac damage after acute stroke is the presence of underlying coronary disease, particularly since signs of cardiac damage are found in patients with subarachnoid hemorrhage who are often young and without underlying heart disease. In addition, the rapid appearance and disappearance of the ST changes argue against macrovascular factors and in favor of neural factors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/16,18\">",
"     16,18",
"    </a>",
"    ]. Myocardial injury is most likely the result of a centrally mediated release of catecholamines due to hypoperfusion of the posterior hypothalamus. Subendocardial ischemia is an independent predictor of poor outcome in patients with subarachnoid hemorrhage and must be managed aggressively (although without the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac myofibrillar degeneration is often seen in patients dying from acute stroke, and is histologically identical to the cardiac lesions of catecholamine infusion, \"voodoo death,\" hypothalamic stimulation, or reperfusion of transiently ischemic cardiac muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/17\">",
"     17",
"    </a>",
"    ]. The myofibrillar degeneration occurs in the vicinity of the cardiac nerves, and not in the macrovascular distribution seen in patients with coronary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/17,20\">",
"     17,20",
"    </a>",
"    ]. The lesion also differs from the necrosis seen in coronary disease because it is visible within minutes of onset, and the cells die in a hypercontracted state with contraction bands, associated mononuclear infiltration, and early calcification. Supportive care for patients with myocardial injury following stroke should include beta-blockers, since these agents may reduce sympathetic tone and may prevent arrhythmias and cardiac damage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac stunning, defined as a transient decrease in cardiac function associated with ST and Q wave abnormalities and segmental hypokinesis, has been described with right hemispheric infarction and is believed to reflect transient coronary vasospasm secondary to increased sympathetic tone [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/21\">",
"     21",
"    </a>",
"    ]. Post-stroke cardiac stunning resolves a few days after the onset of the symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=see_link\">",
"     \"Clinical syndromes of stunned or hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=see_link\">",
"     \"Pathophysiology of stunned or hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140695142\">",
"    <span class=\"h2\">",
"     Insular stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accumulating experimental and clinical evidence suggests that stroke involving the insular cortex may be associated with adverse cardiac outcomes including repolarization abnormalities, arrhythmias, neurogenic cardiac damage, heart failure, and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/22-27\">",
"     22-27",
"    </a>",
"    ]. The presumed biologic basis for this association is the role of the insular cortex in the autonomic control of cardiovascular function [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/25,28-34\">",
"     25,28-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While most agree that insular stroke can perturb the autonomic regulation of the heart, the differential impact of stroke involving the right and left insular cortex is not yet clear. Human data are sparse and derived mainly from observational studies. Furthermore, the reports are conflicting, perhaps due in part to differences in studies examining acute and chronic stroke. The following observations illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study independently compared each voxel of infarction on diffusion-weighted magnetic resonance imaging (MRI) for patients with and without cardiac troponin elevation within three days of acute ischemic stroke to produce a map of brain regions associated with troponin elevation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/35\">",
"       35",
"      </a>",
"      ]. Patients were excluded if they had a condition expected to cause acute cardiac troponin elevation (eg, myocardial infarction, angina, coronary revascularization, etc). Brain regions associated with troponin elevation included the right insula (posterior, superior, and medial regions) and the right inferior parietal lobe (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50996 \" href=\"UTD.htm?22/58/23462\">",
"       image 1",
"      </a>",
"      ). The right parietal lobe may have been included as a bystander, as it is within the territory of the inferior division of the middle cerebral artery that often supplies the posterior insula.",
"     </li>",
"     <li>",
"      A prospective study compared 32 patients who had left insular stroke with 84 patients who had non-insular stroke or TIA [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/26\">",
"       26",
"      </a>",
"      ]. Over a one-year follow-up period, left insular stroke was significantly associated with adverse cardiac outcome compared with non-insular stroke (relative risk [RR] 1.75; 95% CI 1.02-3.0), and remained an independent risk factor of cardiac outcome in multivariate analysis. Left insular stroke was also associated with cardiac wall motion impairment independent of heart disease.",
"      <br/>",
"      <br/>",
"      In the subgroup of patients without symptomatic heart disease, the association of left insular stroke with adverse cardiac outcome was even higher (RR 4.06; 95% CI 1.83-9.01), while in patients with symptomatic heart disease (acute myocardial infarction or angina) there was no association (RR 0.36; 95% CI 0.06-2.13) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/26\">",
"       26",
"      </a>",
"      ]. The latter finding was attributed to the protective effect of beta-blockers, as these medications were more likely to be used in patients with symptomatic heart disease.",
"     </li>",
"     <li>",
"      In a study that analyzed data from 2885 patients with symptomatic carotid disease enrolled in the North American Symptomatic Carotid Endarterectomy Trial (NASCET), insular infarction occurred in 41 patients and none died suddenly over five years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/36\">",
"       36",
"      </a>",
"      ]. The long-term risk of sudden death was significantly increased for patients with left brain infarction compared with no infarction (adjusted hazard ratio [HR] 1.45; 95% CI 1.00-2.10), nonsignificantly increased in patients with bilateral infarction compared with no infarction (HR 1.40; 95% CI 0.98-2.00), and not increased for patients with right brain infarction compared with no infarction (HR 0.96; 95% CI 0.62-1.47).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     REPOLARIZATION AND ECG ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac arrhythmias or repolarization abnormalities occur after stroke in approximately 60 to 70 percent of patients and may have important prognostic implications [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,37,38\">",
"     15,37,38",
"    </a>",
"    ]. Repolarization abnormalities are particularly important, as they increase the vulnerable period during which an extrasystole is more likely to result in ventricular tachycardia or fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/37-41\">",
"     37-41",
"    </a>",
"    ]. Repolarization abnormalities thus may account for the excess number of arrhythmias and sudden death following acute neurologic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Electrocardiogram (ECG) abnormalities are present in 92 percent of patients with acute stroke (",
"    <a class=\"graphic graphic_table graphicRef51965 \" href=\"UTD.htm?34/34/35372\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15\">",
"     15",
"    </a>",
"    ]. The classic large and upright T waves (\"cerebral T waves\") and prolonged QT intervals were first described in patients with subarachnoid hemorrhage. Subsequent studies revealed that such findings also occur in ischemic stroke, transient ischemic attacks, and nonvascular cerebral lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,39,40\">",
"     15,39,40",
"    </a>",
"    ]. Although it was previously thought that such findings could be related to preexisting underlying heart disease, case-control studies comparing acute ECG tracings with prior recordings suggest that most repolarization abnormalities do not antedate the stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,42\">",
"     15,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ECG changes are predominately reflective of ischemic changes in the subendocardium of the left ventricle. Myocardial injury is most likely the result of a centrally mediated release of catecholamines due to hypoperfusion of the posterior hypothalamus (see",
"    <a class=\"local\" href=\"#H140695105\">",
"     'Neurogenic cardiac damage'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    ECG abnormalities are also common in intracerebral hemorrhage (ICH) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/14\">",
"     14",
"    </a>",
"    ]. However, most of these appear to be minor and do not require medical intervention or impact prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     QT prolongation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common stroke-related ECG abnormality is QT prolongation, found in up to 71 percent of patients with subarachnoid hemorrhage, 64 percent of patients with intraparenchymal hemorrhage, and 38 percent of patients with ischemic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. QT prolongation often correlates with elevated systolic blood pressure on admission [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,18,44\">",
"     15,18,44",
"    </a>",
"    ]. QT abnormalities accompanied by U waves and T wave changes are most likely due to stroke if hypokalemia is absent.",
"   </p>",
"   <p>",
"    QT prolongation may occur more commonly with right than with left hemispheric strokes because of some degree of lateralization of autonomic function [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/47\">",
"     47",
"    </a>",
"    ]. Among patients with subarachnoid hemorrhage, serious ventricular arrhythmias including sudden death and torsades de pointes are often preceded by QT prolongation (",
"    <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"     waveform 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/18,44,47\">",
"     18,44,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    QT dispersion, a marker of abnormal cardiac repolarization, is associated with increased mortality in patients with acute intracranial hemorrhage. In a series of patients with spontaneous ICH, QTc (difference between maximal and minimal QT) was significantly increased in patients who died as a result of an intracranial hemorrhage, compared to survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     T wave abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;New T wave abnormalities appear in approximately 15 percent of patients with acute stroke, even in the absence of electrolyte disturbances or primary ischemic heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/49\">",
"     49",
"    </a>",
"    ]. Experimentally, T wave abnormalities have been provoked by manipulation of the circle of Willis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/39\">",
"     39",
"    </a>",
"    ]. Upright prominent T waves as well as inverted T waves have been described.",
"   </p>",
"   <p>",
"    T wave inversion is four more times more prevalent among stroke patients than among age-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/40\">",
"     40",
"    </a>",
"    ]. The characteristic large T waves previously known as \"cerebral T waves\" have been noted in 50 percent of patients with intracranial hemorrhage, and appear particularly common following left frontal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/39\">",
"     39",
"    </a>",
"    ]. The suggestion that these abnormalities are neurally induced is supported by the observation that inverted T waves may normalize if brain death occurs. Furthermore, inverted or flat T waves have been reported in 55 percent of patients with subarachnoid hemorrhage, but autopsy studies of these patients have failed to reveal any underlying cardiac abnormality (",
"    <a class=\"graphic graphic_waveform graphicRef56660 \" href=\"UTD.htm?29/34/30255\">",
"     waveform 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     ST segment alterations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific ST changes occur in 22 percent of patients with stroke. Patients with stroke have a 7 to 10-fold higher incidence of ST segment depression when compared with controls, particularly if the left middle cerebral artery territory has been affected [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/40,47,49,50\">",
"     40,47,49,50",
"    </a>",
"    ]. In one series, ST changes appeared to be more common among patients with ischemic stroke than among patients with intracerebral hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ST changes are generally most apparent in the precordial and lateral leads, and are usually transient [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/18\">",
"     18",
"    </a>",
"    ]. Although coexisting myocardial infarction occurs in 5 to 11 percent of patients with acute stroke, nearly 35 percent of patients develop new ischemic-appearing ST changes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/49,51\">",
"     49,51",
"    </a>",
"    ]. In patients over 65 years of age or with diabetes mellitus, ST segment changes are more likely to represent true myocardial ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/49,52\">",
"     49,52",
"    </a>",
"    ]. ST segment alterations secondary to neurogenic heart disease also improve dramatically with brain death [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Q waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aberrant Q waves identical to those observed in acute myocardial infarction are well recognized after acute stroke. The Q waves may be transient or proceed through the evolutionary changes seen in myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,49\">",
"     15,49",
"    </a>",
"    ]. New Q waves have been identified in about 10 percent of patients with acute ischemic or hemorrhagic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/40,42\">",
"     40,42",
"    </a>",
"    ]. It seems unlikely that the ischemic changes seen on ECG tracings in patients with acute stroke result entirely from the coincidence of acute cerebrovascular and cardiac events, as the prevalence of acute myocardial infarction among stroke patients is lower than the incidence of pathologic Q waves. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=see_link\">",
"     \"Pathogenesis and diagnosis of Q waves on the electrocardiogram\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     U waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;U waves unrelated to any electrolyte abnormality are common after stroke (",
"    <a class=\"graphic graphic_figure graphicRef57086 \" href=\"UTD.htm?15/19/15671\">",
"     figure 1",
"    </a>",
"    ). They may occur in isolation or with prominent T waves and QT prolongation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/53\">",
"     53",
"    </a>",
"    ]. One case-control study found new U waves in 13 percent of patients with acute stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15\">",
"     15",
"    </a>",
"    ]. U waves where equally distributed between ischemic and hemorrhagic strokes, and there was no relation between the presence of U waves and stroke mortality. The combination of U waves and QT prolongation was more common among patients with intraparenchymal and subarachnoid hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ARRHYTHMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a prospective study of 501 patients, serious arrhythmia in the first 72 hours after admission with acute stroke was detected in 126 patients (25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/54\">",
"     54",
"    </a>",
"    ]. The incidence of arrhythmia was highest in the first 24 hours after admission. Obvious clinical symptoms accompanied arrhythmia in approximately 24 percent of events, and antiarrhythmia treatment was initiated in 78 percent of cases where arrhythmia was detected.",
"   </p>",
"   <p>",
"    In older case series, cardiac arrhythmias not identified by clinical history or admission ECG were detected by continuous telemetry in 6 to 25 percent of patients after stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/15,52\">",
"     15,52",
"    </a>",
"    ]. Some rhythm disturbances likely were present prior to the stroke and were not directly related to the stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation was the most common serious cardiac arrhythmia in a prospective study of 501 patients with acute stroke, accounting for approximately 60 percent of all events of arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of patients with different causes of tachycardia was as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/54\">",
"     54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atrial fibrillation, 57 patients (11 percent)",
"     </li>",
"     <li>",
"      Focal atrial tachycardia, 15 patients (3 percent)",
"     </li>",
"     <li>",
"      Undetermined supraventricular tachycardia, 10 patients (2 percent)",
"     </li>",
"     <li>",
"      Ventricular ectopy, 7 patients (1 percent)",
"     </li>",
"     <li>",
"      Nonsustained ventricular tachycardia, 6 patients (1 percent)",
"     </li>",
"     <li>",
"      Atrial flutter, 1 patient (&lt;1 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The number of patients with different causes of bradycardia was as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/54\">",
"     54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atrial fibrillation, 24 patients (5 percent)",
"     </li>",
"     <li>",
"      Mobitz type II atrioventricular block, 10 patients (2 percent)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Asystole/sinoatrial",
"      </span>",
"      block, 8 patients (2 percent)",
"     </li>",
"     <li>",
"      Complete atrioventricular block, 1 patient (&lt;1 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Transient atrial fibrillation is more common among patients with ischemic stroke than with intracranial hemorrhage; it occurs in the latter setting more frequently among patients who have developed brainstem or peri-insular hematomas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/42,50\">",
"     42,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circadian heart rate variability is altered in the setting of acute ischemic stroke. In normal subjects, arterial blood pressure and heart rate decrease at night while heart rate variability increases, but this pattern is reversed in patients with coronary disease or stroke. The normal relative vagal dominance is replaced by increased sympathetic tone, and may account for the excess number of sudden deaths after stroke. This pattern returns to normal six months after a stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A significant proportion of cardiac arrhythmias occur in patients with normal cardiac function, suggesting neurogenic mechanisms. Furthermore, the type and location of the stroke may correlate with the type of arrhythmia, with each cerebral hemisphere having a different influence on cardiac functions. Animal studies demonstrate that the sinoatrial node is under right-sided autonomic control, and that stimulation or inhibition of the right medulla, hypothalamus, and cerebral hemisphere exerts a greater influence upon heart rate than do comparable manipulations on the left.",
"   </p>",
"   <p>",
"    Bradycardia and vasodepressor effects may be more common with injury of the right insula, while tachycardia and hypertension may be more common with injury of the left insular region. Evidence from experimental and observational studies suggests that supraventricular arrhythmias are more common after right than left hemisphere stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/22,47\">",
"     22,47",
"    </a>",
"    ]. Since supraventricular tachycardia can be activated by an increase in sympathetic tone, it is hypothesized that the impaired parasympathetic tone caused by right hemispheric injury is responsible for the excess in arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26952/abstract/22,23,38,44\">",
"     22,23,38,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54662694\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serious cardiac events and cardiac death after acute stroke may be caused by acute myocardial infarction, heart failure, ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation, and cardiac arrest. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Cardiac morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Concurrent stroke and myocardial infarction (MI) are not uncommon. Angina, MI, and cardiac ischemia complicate 6 percent of acute strokes and constitute serious or life-threatening medical events in 1 percent (",
"      <a class=\"graphic graphic_table graphicRef68148 \" href=\"UTD.htm?10/49/11036\">",
"       table 1",
"      </a>",
"      ). In addition, a wide spectrum of regional left ventricular wall motion abnormalities, typically but not always reversible, can occur with subarachnoid hemorrhage and possibly with other types of stroke. (See",
"      <a class=\"local\" href=\"#H138412094\">",
"       'Myocardial infarction and regional wall motion abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elevations in cardiac enzymes after acute ischemic stroke may not be indicative of myocardial injury. However, elevated troponin T after stroke may be a poor prognostic sign, and troponin levels may be useful in attempting to differentiate neurogenic left ventricular dysfunction associated with subarachnoid hemorrhage from dysfunction associated with myocardial infarction. (See",
"      <a class=\"local\" href=\"#H140694714\">",
"       'Elevated cardiac enzymes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evidence of subendocardial infarction or anterolateral ischemia (eg, ST segment changes or enzyme elevation) is common after stroke, particularly after subarachnoid hemorrhage. (See",
"      <a class=\"local\" href=\"#H140695105\">",
"       'Neurogenic cardiac damage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repolarization abnormalities are particularly important, as they increase the vulnerable period during which an extrasystole is more likely to result in ventricular tachycardia or fibrillation. Repolarization abnormalities thus may account for the excess number of arrhythmias and sudden death following acute neurologic disorders. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Repolarization and ECG abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac arrhythmia in the first 72 hours after admission for acute stroke is detected in approximately 25 percent of patients. Atrial fibrillation is the most common serious arrhythmia in this setting. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Arrhythmias'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/1\">",
"      Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol 2010; 9:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/2\">",
"      Prosser J, MacGregor L, Lees KR, et al. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007; 38:2295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/3\">",
"      Touz&eacute; E, Varenne O, Chatellier G, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005; 36:2748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/4\">",
"      Amarenco P, Steg PG. Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention. Eur Heart J 2008; 29:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/5\">",
"      Chin PL, Kaminski J, Rout M. Myocardial infarction coincident with cerebrovascular accidents in the elderly. Age Ageing 1977; 6:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/6\">",
"      Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998; 29:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/7\">",
"      Yoshimura S, Toyoda K, Ohara T, et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 2008; 64:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/8\">",
"      Wong CK, White HD. Medical treatment for acute coronary syndromes. Curr Opin Cardiol 2000; 15:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/9\">",
"      Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol 2007; 99:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/10\">",
"      James P, Ellis CJ, Whitlock RM, et al. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 2000; 320:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/11\">",
"      Ay H, Arsava EM, Sariba O. Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 2002; 33:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/12\">",
"      Chalela JA, Ezzeddine MA, Davis L, Warach S. Myocardial injury in acute stroke: a troponin I study. Neurocrit Care 2004; 1:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/13\">",
"      Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006; 66:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/14\">",
"      Maramattom BV, Manno EM, Fulgham JR, et al. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc 2006; 81:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/15\">",
"      Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979; 10:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/16\">",
"      Chua HC, Sen S, Cosgriff RF, et al. Neurogenic ST depression in stroke. Clin Neurol Neurosurg 1999; 101:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/17\">",
"      Samuels MA. The brain-heart connection. Circulation 2007; 116:77.",
"     </a>",
"    </li>",
"    <li>",
"     Oppenheimer, S, Norris, JW. Cardiac manifestations of acute neurological lesions. In: Aminoff, MJ (Ed), Neurology and General Medicine, Churchill-Livingstone, 1995, p 183.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/19\">",
"      Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000; 36:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/20\">",
"      Jacob WA, Van Bogaert A, De Groodt-Lasseel MH. Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage. J Mol Cell Cardiol 1972; 4:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/21\">",
"      Wang TD, Wu CC, Lee YT. Myocardial stunning after cerebral infarction. Int J Cardiol 1997; 58:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/22\">",
"      Lane RD, Wallace JD, Petrosky PP, et al. Supraventricular tachycardia in patients with right hemisphere strokes. Stroke 1992; 23:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/23\">",
"      Tokg&ouml;zoglu SL, Batur MK, Top uoglu MA, et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999; 30:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/24\">",
"      Oppenheimer SM, Wilson JX, Guiraudon C, Cechetto DF. Insular cortex stimulation produces lethal cardiac arrhythmias: a mechanism of sudden death? Brain Res 1991; 550:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/25\">",
"      Sander D, Klingelh&ouml;fer J. Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 1994; 25:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/26\">",
"      Laowattana S, Zeger SL, Lima JA, et al. Left insular stroke is associated with adverse cardiac outcome. Neurology 2006; 66:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/27\">",
"      Abboud H, Berroir S, Labreuche J, et al. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol 2006; 59:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/28\">",
"      Meyer S, Strittmatter M, Fischer C, et al. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport 2004; 15:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/29\">",
"      Smith KE, Hachinski VC, Gibson CJ, Ciriello J. Changes in plasma catecholamine levels after insula damage in experimental stroke. Brain Res 1986; 375:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/30\">",
"      Ruggiero DA, Mraovitch S, Granata AR, et al. A role of insular cortex in cardiovascular function. J Comp Neurol 1987; 257:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/31\">",
"      Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology 1992; 42:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/32\">",
"      Oppenheimer SM, Kedem G, Martin WM. Left-insular cortex lesions perturb cardiac autonomic tone in humans. Clin Auton Res 1996; 6:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/33\">",
"      Zhang ZH, Rashba S, Oppenheimer SM. Insular cortex lesions alter baroreceptor sensitivity in the urethane-anesthetized rat. Brain Res 1998; 813:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/34\">",
"      S&ouml;r&ouml;s P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol 2012; 11:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/35\">",
"      Ay H, Koroshetz WJ, Benner T, et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology 2006; 66:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/36\">",
"      Algra A, Gates PC, Fox AJ, et al. Side of brain infarction and long-term risk of sudden death in patients with symptomatic carotid disease. Stroke 2003; 34:2871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/37\">",
"      Hachinski VC. The clinical problem of brain and heart. Stroke 1993; 24:I1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/38\">",
"      Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllyl&auml; VV. Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke. Stroke 1997; 28:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/39\">",
"      BYER E, ASHMAN R, TOTH LA. Electrocardiograms with large, upright T waves and long Q-T intervals. Am Heart J 1947; 33:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/40\">",
"      Dimant J, Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 1977; 8:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/41\">",
"      Ramani A, Shetty U, Kundaje GN. Electrocardiographic abnormalities in cerebrovascular accidents. Angiology 1990; 41:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/42\">",
"      Yamour BJ, Sridharan MR, Rice JF, Flowers NC. Electrocardiographic changes in cerebrovascular hemorrhage. Am Heart J 1980; 99:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/43\">",
"      Di Pasquale G, Pinelli G, Andreoli A, et al. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 1987; 59:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/44\">",
"      Oppenheimer SM, Cechetto DF, Hachinski VC. Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death. Arch Neurol 1990; 47:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/45\">",
"      Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2012; 43:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/46\">",
"      Khechinashvili G, Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002; 14:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/47\">",
"      Hachinski VC, Oppenheimer SM, Wilson JX, et al. Asymmetry of sympathetic consequences of experimental stroke. Arch Neurol 1992; 49:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/48\">",
"      Huang CH, Chen WJ, Chang WT, et al. QTc dispersion as a prognostic factor in intracerebral hemorrhage. Am J Emerg Med 2004; 22:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/49\">",
"      Lavy S, Yaar I, Melamed E, Stern S. The effect of acute stroke on cardiac functions as observed in an intensive stroke care unit. Stroke 1974; 5:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/50\">",
"      Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke 1993; 24:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/51\">",
"      Valeriano J, Elson J. Electrocardiographic changes in central nervous system disease. Neurol Clin 1993; 11:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/52\">",
"      Rem JA, Hachinski VC, Boughner DR, Barnett HJ. Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 1985; 16:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/53\">",
"      Samuels MA. Electrocardiographic manifestations of neurologic disease. Semin Neurol 1984; 4:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26952/abstract/54\">",
"      Kallm&uuml;nzer B, Breuer L, Kahl N, et al. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis. Stroke 2012; 43:2892.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1095 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-4F267068D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26952=[""].join("\n");
var outline_f26_20_26952=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H54662694\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CARDIAC MORBIDITY AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H138412094\">",
"      MYOCARDIAL INFARCTION AND REGIONAL WALL MOTION ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H140694714\">",
"      ELEVATED CARDIAC ENZYMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H140695105\">",
"      NEUROGENIC CARDIAC DAMAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H140695142\">",
"      Insular stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      REPOLARIZATION AND ECG ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      QT prolongation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      T wave abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ST segment alterations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Q waves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      U waves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mechanism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H54662694\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1095\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1095|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/58/23462\" title=\"diagnostic image 1\">",
"      Brain sites associated with cardiac troponin T elevation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1095|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/19/15671\" title=\"figure 1\">",
"      Prominent U waves tutorial",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1095|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/49/11036\" title=\"table 1\">",
"      Serious medical complications of stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/34/35372\" title=\"table 2\">",
"      ECG disturbances stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1095|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/23/43380\" title=\"waveform 1A\">",
"      ECG Torsades de pointes tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/7/43134\" title=\"waveform 1B\">",
"      ECG torsades de pointes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?29/34/30255\" title=\"waveform 2\">",
"      ECG subarachnoid hemorrhage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=related_link\">",
"      Clinical syndromes of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=related_link\">",
"      Elevated cardiac troponin concentration in the absence of an acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=related_link\">",
"      Medical complications of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=related_link\">",
"      Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=related_link\">",
"      Pathogenesis and diagnosis of Q waves on the electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=related_link\">",
"      Pathophysiology and etiology of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=related_link\">",
"      Pathophysiology of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=related_link\">",
"      Stress-induced (takotsubo) cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/54/10087?source=related_link\">",
"      Stroke-related pulmonary complications and abnormal respiratory patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26953="Lung transplantation: General guidelines for recipient selection";
var content_f26_20_26953=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lung transplantation: General guidelines for recipient selection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Ramsey R Hachem, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Elbert P Trulock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26953/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/20/26953/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common indications for lung transplantation are advanced chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), emphysema due to alpha-1 antitrypsin deficiency, and idiopathic pulmonary arterial hypertension (IPAH) (",
"    <a class=\"graphic graphic_figure graphicRef61485 \" href=\"UTD.htm?30/25/31135\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"     1",
"    </a>",
"    ]. These account for approximately 85 percent of all procedures performed worldwide. The remaining 15 percent consist of a variety of diagnoses that span the spectrum of end-stage lung disease from sarcoidosis to lymphangioleiomyomatosis (LAM) to pulmonary Langerhans' cell histiocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/2-7\">",
"     2-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The indications and general guidelines for recipient selection will be presented here. An overview of lung transplantation, the international guidelines for recipient selection, disease-specific indications, and choice of procedure are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"     \"Lung transplantation: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31192?source=see_link\">",
"     \"Lung transplantation: Disease-based choice of procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung transplantation should be considered for patients with advanced lung disease whose clinical status has progressively declined despite maximal medical or surgical therapy. Candidates are usually symptomatic during activities of daily living and have a limited expected survival over the next two years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. In addition, the ideal candidate should be free of significant other organ dysfunction and extrapulmonary manifestations of a systemic disease. Guidelines for recipient selection have been developed by the American Thoracic Society and the International Society of Heart and Lung Transplantation and include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Appropriate age (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Recipient age'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Clinically and physiologically severe disease",
"     </li>",
"     <li>",
"      Ineffective or unavailable medical therapy",
"     </li>",
"     <li>",
"      Limited life expectancy due to lung disease",
"     </li>",
"     <li>",
"      Acceptable nutritional status, usually 80 to 120 percent of ideal body weight or body mass index (BMI) less than 30 kg per m",
"      <sup>",
"       2",
"      </sup>",
"     </li>",
"     <li>",
"      Satisfactory psychosocial profile and support system",
"     </li>",
"     <li>",
"      Adequate financial coverage for the procedure and postoperative care",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Recipient age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because older recipients have a significantly shorter survival than younger ones [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"     1",
"    </a>",
"    ], age older than 65 is considered a relative contraindication for lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    Nevertheless, approximately 13 percent of all lung transplants performed worldwide in 2011 were for recipients older than 65 years of age and almost 40 percent of all transplants were for recipients older than 60 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. As might be expected, recipients older than 60 have a shorter survival than younger recipients. The median survivals after transplantation for those older than 60 and younger than 50 years are approximately 4.5 and 6.5 years, respectively (",
"    <a class=\"graphic graphic_figure graphicRef80159 \" href=\"UTD.htm?40/5/41055\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"     1",
"    </a>",
"    ]. However, among patients undergoing primary lung transplantation since 2005, the risk of mortality for those age 70 or older was not greater than those age 60 to 69 (HR 1.02, 95% CI 0.71 to 1.46) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/14\">",
"     14",
"    </a>",
"    ]. While older age is not an absolute contraindication, multiple co-morbidities resulting in multiple relative contraindications can combine to increase the risks beyond an acceptable threshold.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to lung transplantation have traditionally included the following [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/8,11,12\">",
"     8,11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Uncontrolled or untreatable pulmonary or extrapulmonary infection",
"     </li>",
"     <li>",
"      Malignancy in the last two years",
"     </li>",
"     <li>",
"      Significant dysfunction of other vital organs",
"     </li>",
"     <li>",
"      Significant coronary artery disease or heart failure",
"     </li>",
"     <li>",
"      Significant chest",
"      <span class=\"nowrap\">",
"       wall/spinal",
"      </span>",
"      deformity",
"     </li>",
"     <li>",
"      Active tobacco smoking",
"     </li>",
"     <li>",
"      Drug or alcohol dependency",
"     </li>",
"     <li>",
"      Unresolved psychosocial problems or noncompliance with medical therapy",
"     </li>",
"     <li>",
"      HIV infection",
"     </li>",
"     <li>",
"      Ongoing hepatitis B or C viral infection",
"     </li>",
"     <li>",
"      Absence of a consistent or reliable social support system",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other factors must be taken into account on an individual basis. These include ventilator dependence, nutritional status, previous cardiothoracic surgery, and preexisting medical conditions such as coronary artery disease, hypertension, diabetes mellitus, and osteoporosis, which will be aggravated by the medical regimen after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/8,11,12\">",
"     8,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ventilator dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, invasive mechanical ventilation was considered a strong relative contraindication to transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/12,15\">",
"     12,15",
"    </a>",
"    ]. Invasive mechanical ventilation before transplantation has consistently been a significant risk factor for mortality after transplantation in the International Society for Heart and Lung Transplantation (ISHLT) Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, respiratory failure is not an unusual complication of end-stage lung disease because of disease progression, acute exacerbation, or a superimposed process. Thus, some patients awaiting transplantation may develop respiratory failure requiring invasive mechanical ventilation.",
"   </p>",
"   <p>",
"    Multiple reports have demonstrated that carefully selected candidates requiring invasive mechanical ventilation can have satisfactory short and long-term outcomes after lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. In one study, clinically stable patients requiring mechanical ventilation before transplantation had a similar survival to recipients who did not require mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/16\">",
"     16",
"    </a>",
"    ]. In contrast, unstable patients requiring mechanical ventilation before transplantation had a significantly worse survival. Since implementation of the new Lung Allocation System in the US in 2005, a growing proportion of patients undergoing transplantation are ventilator dependent pretransplant [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When feasible, noninvasive positive pressure ventilation is preferred over invasive ventilation because it obviates the need for sedation, and the patient can remain ambulatory and participate in pulmonary rehabilitation. Multiple studies have confirmed satisfactory outcomes after the use of noninvasive ventilation as a bridge to transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/22-24\">",
"     22-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emerging data suggest that extracorporeal membrane oxygenation (ECMO) can be used successfully as a bridge to lung transplantation in patients with pulmonary or cardio-pulmonary failure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. In addition, carefully selected patients can be supported with veno-venous ECMO while awake and off invasive mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/27\">",
"     27",
"    </a>",
"    ]. This approach allows patients to undergo physical therapy and maintain an adequate nutritional status. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Nutritional status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have identified pretransplant obesity as a significant risk for mortality after transplantation independent of other risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1,28-33\">",
"     1,28-33",
"    </a>",
"    ]. As an example, an analysis of the United Network for Organ Sharing (UNOS) database demonstrated a 15 percent higher mortality for overweight recipients (BMI = 25 &ndash; 29.9 kg per m",
"    <sup>",
"     2",
"    </sup>",
"    ) and a 22 percent higher mortality for obese recipients (BMI &gt;30 kg per m",
"    <sup>",
"     2",
"    </sup>",
"    ) than normal weight recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/31\">",
"     31",
"    </a>",
"    ]. Among 512 adult lung transplant recipients, obesity was also an independent risk factor for development of grade 3 primary graft dysfunction within 72 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/34\">",
"     34",
"    </a>",
"    ]. However, one single-center study did not find an association between the percent predicted ideal body weight (IBW) or body mass index (BMI) and overall survival, even though recipients with a BMI greater than 30 kg per m",
"    <sup>",
"     2",
"    </sup>",
"    were at increased risk for 90-day mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Low BMI has not been a risk factor for mortality after transplantation in the ISHLT Registry, although one study found a trend to a higher 90-day mortality among recipients with a BMI less than 17 kg per m",
"    <sup>",
"     2",
"    </sup>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1,28,33\">",
"     1,28,33",
"    </a>",
"    ]. Nonetheless, multiple series have shown that malnutrition is ominous, especially among patients with CF and COPD [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/31,36-39\">",
"     31,36-39",
"    </a>",
"    ]. Aggressive attempts to improve the nutritional status are warranted, but low BMI alone generally should not preclude listing or transplantation.",
"   </p>",
"   <p>",
"    Guidelines for recipient selection state that severe obesity defined as a body mass index (BMI) exceeding 30",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    is a relative contraindication for lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/12\">",
"     12",
"    </a>",
"    ]. Because waiting time is irrelevant under the current United Network for Organ Sharing (UNOS) lung organ allocation system, there is no advantage to listing obese patients before they reach 130 percent of IBW or BMI less than 30 kg per m",
"    <sup>",
"     2",
"    </sup>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H127609039\">",
"    <span class=\"h2\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of diabetes mellitus is common among patients with end-stage lung disease and is not considered a contraindication to lung transplantation. However, most programs require that blood sugars be under good control (eg, a hemoglobin A1C level of 7 percent or less) and consider significant end-organ disease a strong relative or absolute contraindication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11993?source=see_link&amp;anchor=H12#H12\">",
"     \"Estimation of blood glucose control in diabetes mellitus\", section on 'Recommendations in type 2 diabetes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies have examined mortality outcomes in patients with co-morbid diabetes mellitus. In data from the largest lung transplantation registry, recipient diabetes is associated with a small increase in five year mortality (RR 1.21, 95% CI 1.07&ndash;1.37), but no increase in one year mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/40\">",
"     40",
"    </a>",
"    ]. Similarly, in a review of 5873 lung transplant recipients with COPD, diabetes mellitus was associated with an increased risk of death (HR 1.41, 95% CI 1.08&ndash;1.83) during the followup period of up to 14.9 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/41\">",
"     41",
"    </a>",
"    ]. A single center reported a somewhat higher risk of death in a retrospective series of 258 lung transplant recipients (HR 2.3, 95% CI 1.2-4.4), particularly death due to cardiovascular causes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Previous cardiothoracic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Previous cardiothoracic surgery, pleurodesis, or pleurectomy increase the technical difficulty of extracting the native lung and the operative risk of lung transplantation. Simple pneumothorax that was treated by closed tube thoracostomy (with or without pleurodesis), open lung biopsy, or uncomplicated lobectomy are not usually an impediment to transplantation, but more complex cases must be individually assessed.",
"   </p>",
"   <p>",
"    A previous thoracic procedure alone rarely precludes lung transplantation; however, if cardiopulmonary bypass is required for the transplant procedure, the morbidity and mortality may be increased [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Chronic obstructive pulmonary disease (COPD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with emphysema may be considered for lung volume reduction surgery (LVRS), lung transplantation, or both. A discussion of the general indications for lung transplantation in COPD is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link&amp;anchor=H33#H33\">",
"     \"Management of stable chronic obstructive pulmonary disease\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited experience with patients who initially undergo LVRS indicates that subsequent successful transplantation is possible [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. However, one study suggested that patients who do not attain a significant benefit from LVRS have a higher perioperative risk after lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link\">",
"     \"Lung volume reduction surgery in COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many lung transplant candidates are at risk for coronary artery disease because of their age, smoking history, or other risk factors. One series demonstrated an incidence of clinically important coronary artery disease of 17 percent among lung transplant candidates over the age of 50, and 8 percent of those listed required revascularization either before or at the time of transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/50\">",
"     50",
"    </a>",
"    ]. Candidates should therefore be screened for occult disease during their pretransplant evaluation.",
"   </p>",
"   <p>",
"    Noninvasive screening tests have a high false positive rate in patients with end-stage lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/51\">",
"     51",
"    </a>",
"    ]. In addition, some have advocated reserving angiography for patients with multiple risk factors since the majority without risk factors will have normal coronary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. However, the value of a negative angiogram should not be underestimated, especially in the perioperative period, when hemodynamics are unstable and nonspecific chest pain and electrocardiographic abnormalities are common.",
"   </p>",
"   <p>",
"    At our center, essentially all patients over the age of 45 undergo angiography. This practice is not uniform among transplant programs. Some employ a noninvasive, provocative test for cardiac ischemia as a screen; if this is negative, coronary angiography is not done. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Coronary artery disease is a relative contraindication to lung transplantation. Carefully selected patients with advanced coronary disease and left ventricular dysfunction may be candidates for heart-lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/12\">",
"     12",
"    </a>",
"    ]. Alternatively, percutaneous or surgical revascularization may be an option in selected patients with preserved left ventricular function. Several small series have documented satisfactory results with percutaneous revascularization before transplantation or concomitant bypass surgery at the time of transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/50,54-56\">",
"     50,54-56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glucocorticoid use",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of glucocorticoids to manage the underlying lung disease is not a contraindication to transplantation. Perioperative glucocorticoid treatment was prohibited in the first few years of lung transplantation because of concerns about airway anastomosis healing. However, with current surgical techniques, pretransplantation glucocorticoid therapy has not been associated with airway complications, and the use of glucocorticoids before transplantation has not been a risk factor for early mortality after transplantation in the ISHLT Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The glucocorticoid dose may be an important determinant of outcomes post-transplant. Studies have generally found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    doses of 0.2 to 0.3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day are safe [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. A retrospective study of patients undergoing lung transplantation compared the outcomes of 64 who had taken low dose (&lt;0.42",
"    <span class=\"nowrap\">",
"     mg/kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per day) versus 62 who had taken high dose (&ge;0.42",
"    <span class=\"nowrap\">",
"     mg/kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per day) prednisone [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/59\">",
"     59",
"    </a>",
"    ]. Survival after transplantation was significantly better in the low dose group. Nonetheless, high dose prednisone for relatively short periods of time is typically not considered a contraindication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Chronic infection or colonization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic infection or colonization is a special issue in patients with bronchiectasis, especially those with cystic fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/60\">",
"     60",
"    </a>",
"    ]. Aspergillus species, nontuberculous mycobacteria, and multi-drug resistant bacteria are frequently cultured from the sputum of patients with end-stage CF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. In addition, multiple studies have reported infection early after transplantation with the same organisms that were cultured from the recipients' airways before transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/61,64-66\">",
"     61,64-66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=see_link\">",
"     \"Cystic fibrosis: Overview of the treatment of lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aspergillus species are isolated in sputum cultures from 20 to 50 percent of patients with CF awaiting transplantation and from over 50 percent after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/63,65,66\">",
"     63,65,66",
"    </a>",
"    ]. In addition, those colonized with Aspergillus before transplantation have a higher risk of Aspergillus tracheobronchitis and anastomotic infections after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Therefore, most centers initiate antifungal suppressive therapy when Aspergillus is isolated before or after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12778?source=see_link\">",
"     \"Bacterial infections following lung transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nontuberculous mycobacterial infections occur in about 8 percent of lung transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/68\">",
"     68",
"    </a>",
"    ]. One study showed that CF patients with nontuberculous mycobacteria cultured from sputum before transplantation were at increased risk for infection after transplantation, and the risk was highest among those infected with Mycobacterium abscessus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/61\">",
"     61",
"    </a>",
"    ]. Thus, attempts to eradicate these pathogens before transplantation are prudent, and persistently positive cultures on antimycobacterial treatment are a relative contraindication to transplantation.",
"   </p>",
"   <p>",
"    The prevalence of infection or colonization with multidrug resistant bacteria among patients with CF coming to lung transplantation may be increasing; one series found that over 50 percent harbored at least one pan-resistant organism [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In addition, those with multidrug resistant Pseudomonas aeruginosa isolated from the sputum have a more rapid decline in lung function and are more likely to need transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/71\">",
"     71",
"    </a>",
"    ]. Although several series found no statistically significant difference in survival after transplantation between those with resistant organisms and those with sensitive ones, one multicenter study reported that recipients infected with pan-resistant organisms before transplantation had a significantly worse survival after transplantation than those infected with sensitive organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/69,72-74\">",
"     69,72-74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infection with Burkholderia cepacia complex (Bcc) is also a problem for CF patients, affecting 3 to 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. Bcc infection is associated with accelerated decline in lung function, making it even more prevalent among transplant candidates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/77-80\">",
"     77-80",
"    </a>",
"    ]. However, certain genomovars, or subspecies, may have greater virulence than others [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/66,73,81\">",
"     66,73,81",
"    </a>",
"    ]. Patients infected with Bcc, subspecies Burkholderia cenocepacia in particular, have significantly worse survival after transplantation compared to uninfected patients with CF, and the increased mortality is directly attributable to Bcc infection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/75,77,82-84\">",
"     75,77,82-84",
"    </a>",
"    ]. Many transplant centers still consider infection with any Burkholderia cepacia complex an absolute contraindication to transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=see_link&amp;anchor=H902257#H902257\">",
"     \"Cystic fibrosis: Antibiotic therapy for lung disease\", section on 'Burkholderia cepacia complex'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prior malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient with a previous malignancy, the risk of cancer recurrence affects the appropriateness and timing of lung transplantation. Based on experience with kidney transplantation, a two-year period between treatment and transplantation is advised in most cases, but longer than two years is recommended for malignant melanomas, breast cancers, and colorectal (other than in situ Duke's A or B1) carcinomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26490?source=see_link&amp;anchor=H17838597#H17838597\">",
"     \"Evaluation of the potential renal transplant recipient\", section on 'Patients with a history of cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of prior malignancy on lung transplant outcomes has been examined in observational series, such as the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 13,613 lung transplant recipients in the ISHLT registry, proportionate hazard modeling found that pre-transplant malignancy was not associated with an increased hazard of mortality at five years; no specific malignancy was associated with a change in the hazard of mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/85\">",
"       85",
"      </a>",
"      ]. These observations suggest that current selection techniques for choosing which patients with pretransplant malignancy are transplanted are successful.",
"     </li>",
"     <li>",
"      Among 111 heart and lung transplant recipients with a prior malignancy, almost 50 percent were due to hematopoietic malignancies. Recurrences were noted in 23 recipients with the majority occurring in those with less than five years since treatment of the tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/86\">",
"       86",
"      </a>",
"      ]. Among eight lung recipients with tumors found incidentally in the explanted lung, six were fatal. This high recurrence rate contrasts with other cases in which unsuspected T1N0M0 non-small cell cancers discovered in the excised native lungs of transplant recipients did not recur [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/87,88\">",
"       87,88",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an analysis of the UNOS registry of lung transplantation as a treatment for bronchioloalveolar cell carcinoma (BAC), the five-year survival of 29 patients transplanted for BAC over a 23-year period was similar to the general lung transplant cohort, suggesting that lung transplantation may be a treatment option for carefully selected patients with BAC [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/89\">",
"       89",
"      </a>",
"      ]. Nonetheless, because experience is limited and predictors of a good outcome are unclear, many transplant centers consider BAC a contraindication to lung transplantation.",
"     </li>",
"     <li>",
"      Children can develop bronchiectasis or bronchiolitis obliterans following treatment of acute leukemia with chemotherapy and radiation, and these pulmonary complications can eventually progress to end-stage lung disease. The experience with lung transplantation in these patients is limited, but one small series noted similar outcomes when patients transplanted following treatment of malignancy were compared to those without a history of malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Allosensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The highly allosensitized recipient presents a special problem. Antibodies to human leukocyte antigens (HLA) can be induced by blood transfusions, pregnancy, and previous transplantation. These anti-HLA antibodies are identified in vitro by routinely screening the potential recipient's serum against an HLA-typed lymphocyte panel (panel reactive antibodies, PRA). A more specific multiplexed flow cytometry assay is now in use, and this can help identify the specificity of the recipient's anti-HLA antibodies. If antibodies are present, there is a risk of hyperacute rejection if the donor's phenotype includes the reactive HLA.",
"   </p>",
"   <p>",
"    Retrospective studies suggest that recipients who have a PRA greater than 25 percent before transplantation have an increased risk of death, especially in the early post-operative period [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. However, improved management techniques appear to have reduced the mortality risk of higher PRA levels, perhaps because more specific and sensitive assays have been used in recent years to avoid the reactive HLA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two strategies have been used to reduce the HLA alloreactivity and make transplantation feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/93,94\">",
"     93,94",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Plasmapheresis combined with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      treatment",
"     </li>",
"     <li>",
"      Intravenous immunoglobulin infusions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Results with either approach have not been reported in lung transplantation, but both have been successful in other solid organ transplants. The alternative and most frequently used strategy in lung transplantation is avoiding potential donors with the reactive HLA for the corresponding recipient. However, if the recipient's anti-HLA antibody specificity cannot be determined, a prospective cross-match between the donor and the recipient would be necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Systemic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carefully selected patients with underlying systemic diseases such as sarcoidosis, lymphangioleiomyomatosis (LAM), and pulmonary Langerhans' cell histiocytosis have had satisfactory results after lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Recurrent disease in the allograft has been reported, but in general, this has not been clinically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/6,7,95\">",
"     6,7,95",
"    </a>",
"    ]. Furthermore, carefully selected patients with scleroderma have also had satisfactory results after lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/96-98\">",
"     96-98",
"    </a>",
"    ]. However, in one report of three patients with systemic lupus erythematosus, two patients had anticardiolipin antibodies and died early after transplantation because of recurrent vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OTHER FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Matching donor and recipient lungs for race may have a modest effect to improve lung transplantation outcomes. This possibility was examined in a retrospective study of 11,323 adult lung transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26953/abstract/100\">",
"     100",
"    </a>",
"    ]. Race matching decreased the risk adjusted cumulative mortality (HR 0.88, 95% CI 0.80 to 0.96). Further studies are needed to determine underlying mechanisms for this observation. Race matching is not clinically feasible and, in view of the small effect size, should not be used to guide lung allocation at present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), emphysema due to alpha-1 antitrypsin deficiency, and idiopathic pulmonary arterial hypertension (IPAH) are the most common diseases that lead to lung transplantation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific guidelines for lung transplantation have been developed by the American Thoracic Society and the International Society of Heart and Lung Transplantation. These guidelines include consideration of the severity of the underlying lung disease, presence of systemic disease, age of the candidate, ability to be ambulatory, nutritional status, psychosocial support, and financial coverage. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following are generally considered to be contraindications to lung transplantation, although occasional exceptions occur: uncontrolled acute infection, uncured malignancy, infection with HIV, hepatitis B or C, active tobacco smoking, drug or alcohol dependency, significant chest",
"      <span class=\"nowrap\">",
"       wall/spinal",
"      </span>",
"      deformity, unresolved psychosocial problems or noncompliance with medical therapy, and absence of an adequate psychosocial support system. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive mechanical ventilation has been a risk factor for mortality post transplant and is generally considered a relative contraindication for lung transplant, however some carefully selected patients have done well post transplant. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ventilator dependence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As obesity has been a risk factor for mortality post lung transplant, it is recommended that candidates reach a BMI less than 30 kg per m",
"      <sup>",
"       2",
"      </sup>",
"      or a weight less than 130 percent of IBW. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Nutritional status'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many lung transplant candidates have risk factors for coronary artery disease. The value of noninvasive testing may be limited because of the underlying lung disease. We suggest coronary angiography in all candidates age 45 or older. Good outcomes have been achieved in selected patients who can be revascularized prior to or at the time of lung transplant. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Coronary heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Significant dysfunction of other vital organs, as might occur with systemic diseases like systemic sclerosis or sarcoidosis, is a contraindication. Certain other special considerations, like prior cardiac surgery, glucocorticoid use, chronic infection and allosensitization also influence decisions on appropriateness for lung transplantation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Special considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/1\">",
"      Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/2\">",
"      Shorr AF, Davies DB, Nathan SD. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002; 122:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/3\">",
"      Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003; 124:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/4\">",
"      Milman N, Burton C, Andersen CB, et al. Lung transplantation for end-stage pulmonary sarcoidosis: outcome in a series of seven consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/5\">",
"      Kpodonu J, Massad MG, Chaer RA, et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant 2005; 24:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/6\">",
"      Pechet TT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/7\">",
"      Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006; 81:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/8\">",
"      Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J 2003; 22:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/9\">",
"      Nathan SD. Lung transplantation: disease-specific considerations for referral. Chest 2005; 127:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/10\">",
"      Tuppin MP, Paratz JD, Chang AT, et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation. J Heart Lung Transplant 2008; 27:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/11\">",
"      Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/12\">",
"      Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/13\">",
"      Mahidhara R, Bastani S, Ross DJ, et al. Lung transplantation in older patients? J Thorac Cardiovasc Surg 2008; 135:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/14\">",
"      Kilic A, Merlo CA, Conte JV, Shah AS. Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? J Thorac Cardiovasc Surg 2012; 144:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/15\">",
"      O'Brien G, Criner GJ. Mechanical ventilation as a bridge to lung transplantation. J Heart Lung Transplant 1999; 18:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/16\">",
"      Meyers BF, Lynch JP, Battafarano RJ, et al. Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 2000; 70:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/17\">",
"      Baz MA, Palmer SM, Staples ED, et al. Lung transplantation after long-term mechanical ventilation : results and 1-year follow-up. Chest 2001; 119:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/18\">",
"      Meertens JH, Van der Bij W, Erasmus ME, et al. Lung transplantation for acute respiratory failure in rapidly progressive idiopathic pulmonary fibrosis. Transpl Int 2005; 18:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/19\">",
"      Bartz RR, Love RB, Leverson GE, et al. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 2003; 22:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/20\">",
"      Vermeijden JW, Zijlstra JG, Erasmus ME, et al. Lung transplantation for ventilator-dependent respiratory failure. J Heart Lung Transplant 2009; 28:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/21\">",
"      Yusen RD, Shearon TH, Qian Y, et al. Lung transplantation in the United States, 1999-2008. Am J Transplant 2010; 10:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/22\">",
"      Efrati O, Modan-Moses D, Barak A, et al. Long-term non-invasive positive pressure ventilation among cystic fibrosis patients awaiting lung transplantation. Isr Med Assoc J 2004; 6:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/23\">",
"      Hodson ME, Madden BP, Steven MH, et al. Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J 1991; 4:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/24\">",
"      Vedam H, Moriarty C, Torzillo PJ, et al. Improved outcomes of patients with cystic fibrosis admitted to the intensive care unit. J Cyst Fibros 2004; 3:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/25\">",
"      Bermudez CA, Rocha RV, Zaldonis D, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg 2011; 92:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/26\">",
"      Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation 2012; 93:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/27\">",
"      Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/28\">",
"      Madill J, Gutierrez C, Grossman J, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant 2001; 20:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/29\">",
"      Kanasky WF Jr, Anton SD, Rodrigue JR, et al. Impact of body weight on long-term survival after lung transplantation. Chest 2002; 121:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/30\">",
"      Sekine Y, Waddell TK, Matte-Martyn A, et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 2004; 23:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/31\">",
"      Lederer DJ, Wilt JS, D'Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/32\">",
"      Allen JG, Arnaoutakis GJ, Weiss ES, et al. The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant 2010; 29:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/33\">",
"      Benden C, Ridout DA, Edwards LB, et al. Body mass index and its effect on outcome in children after lung transplantation. J Heart Lung Transplant 2013; 32:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/34\">",
"      Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 2011; 184:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/35\">",
"      Culver DA, Mazzone PJ, Khandwala F, et al. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant 2005; 24:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/36\">",
"      Snell GI, Bennetts K, Bartolo J, et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant 1998; 17:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/37\">",
"      Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001; 286:2683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/38\">",
"      Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/39\">",
"      Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/40\">",
"      Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant 2010; 29:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/41\">",
"      Thabut G, Ravaud P, Christie JD, et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/42\">",
"      Plantier L, Skhiri N, Biondi G, et al. Impact of previous cardiovascular disease on the outcome of lung transplantation. J Heart Lung Transplant 2010; 29:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/43\">",
"      Detterbeck FC, Egan TM, Mill MR. Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg 1995; 60:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/44\">",
"      Dusmet M, Winton TL, Kesten S, Maurer J. Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 1996; 15:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/45\">",
"      Calhoon JH, Grover FL, Gibbons WJ, et al. Single lung transplantation. Alternative indications and technique. J Thorac Cardiovasc Surg 1991; 101:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/46\">",
"      Burns KE, Keenan RJ, Grgurich WF, et al. Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study. Ann Thorac Surg 2002; 73:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/47\">",
"      Shitrit D, Fink G, Sahar G, et al. Successful lung transplantation following lung volume reduction surgery. Thorac Cardiovasc Surg 2003; 51:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/48\">",
"      Nathan SD, Edwards LB, Barnett SD, et al. Outcomes of COPD lung transplant recipients after lung volume reduction surgery. Chest 2004; 126:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/49\">",
"      Wisser W, Deviatko E, Simon-Kupilik N, et al. Lung transplantation following lung volume reduction surgery. J Heart Lung Transplant 2000; 19:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/50\">",
"      Snell GI, Richardson M, Griffiths AP, et al. Coronary artery disease in potential lung transplant recipients &gt; 50 years old: the role of coronary intervention. Chest 1999; 116:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/51\">",
"      Henzlova MJ, Padilla ML, Freilich A, et al. Dobutamine thallium 201 perfusion imaging in candidates for lung transplantation. J Heart Lung Transplant 1995; 14:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/52\">",
"      Leibowitz DW, Caputo AL, Shapiro GC, et al. Coronary angiography in smokers undergoing evaluation for lung transplantation: is routine use justified? J Heart Lung Transplant 1994; 13:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/53\">",
"      Ben-Dor I, Shitrit D, Kramer MR, et al. Is routine coronary angiography and revascularization indicated among patients undergoing evaluation for lung transplantation? Chest 2005; 128:2557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/54\">",
"      Patel VS, Palmer SM, Messier RH, Davis RD. Clinical outcome after coronary artery revascularization and lung transplantation. Ann Thorac Surg 2003; 75:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/55\">",
"      Seoane L, Arcement LM, Valentine VG, McFadden PM. Long-term survival in lung transplant recipients after successful preoperative coronary revascularization. J Thorac Cardiovasc Surg 2005; 130:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/56\">",
"      Lee R, Meyers BF, Sundt TM, et al. Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 2002; 124:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/57\">",
"      Sch&auml;fers HJ, Wagner TO, Demertzis S, et al. Preoperative corticosteroids. A contraindication to lung transplantation? Chest 1992; 102:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/58\">",
"      Park SJ, Nguyen DQ, Savik K, et al. Pre-transplant corticosteroid use and outcome in lung transplantation. J Heart Lung Transplant 2001; 20:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/59\">",
"      McAnally KJ, Valentine VG, LaPlace SG, et al. Effect of pre-transplantation prednisone on survival after lung transplantation. J Heart Lung Transplant 2006; 25:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/60\">",
"      Kotloff RM, Zuckerman JB. Lung transplantation for cystic fibrosis: special considerations. Chest 1996; 109:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/61\">",
"      Chalermskulrat W, Sood N, Neuringer IP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006; 61:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/62\">",
"      Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005; 43:3467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/63\">",
"      Bakare N, Rickerts V, Bargon J, Just-N&uuml;bling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003; 46:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/64\">",
"      Quattrucci S, Rolla M, Cimino G, et al. Lung transplantation for cystic fibrosis: 6-year follow-up. J Cyst Fibros 2005; 4:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/65\">",
"      Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998; 114:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/66\">",
"      Helmi M, Love RB, Welter D, et al. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 2003; 123:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/67\">",
"      Dummer JS, Lazariashvilli N, Barnes J, et al. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004; 23:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/68\">",
"      Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999; 160:1611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/69\">",
"      Dobbin C, Maley M, Harkness J, et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 2004; 56:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/70\">",
"      Saiman L, Mehar F, Niu WW, et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996; 23:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/71\">",
"      Lechtzin N, John M, Irizarry R, et al. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa. Respiration 2006; 73:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/72\">",
"      Aris RM, Gilligan PH, Neuringer IP, et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997; 155:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/73\">",
"      De Soyza A, Archer L, Wardle J, et al. Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis. J Heart Lung Transplant 2003; 22:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/74\">",
"      Hadjiliadis D, Steele MP, Chaparro C, et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007; 26:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/75\">",
"      Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001; 164:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/76\">",
"      Speert DP, Henry D, Vandamme P, et al. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/77\">",
"      Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001; 163:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/78\">",
"      Courtney JM, Dunbar KE, McDowell A, et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004; 3:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/79\">",
"      Ledson MJ, Gallagher MJ, Jackson M, et al. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002; 57:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/80\">",
"      Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/81\">",
"      Mahenthiralingam E, Vandamme P, Campbell ME, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001; 33:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/82\">",
"      Snell GI, de Hoyos A, Krajden M, et al. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993; 103:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/83\">",
"      De Soyza A, McDowell A, Archer L, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001; 358:1780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/84\">",
"      De Soyza A, Morris K, McDowell A, et al. Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 2004; 59:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/85\">",
"      Beaty CA, George TJ, Kilic A, et al. Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation. J Heart Lung Transplant 2013; 32:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/86\">",
"      Sigurdardottir V, Bjortuft O, Eiskj&aelig;r H, et al. Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies. J Heart Lung Transplant 2012; 31:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/87\">",
"      Svendsen CA, Bengtson RB, Park SJ, Shumway SJ. Stage I adenocarcinoma presenting in the pneumonectomy specimen at the time of single lung transplantation. Transplantation 1998; 66:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/88\">",
"      de Perrot M, Fischer S, Waddell TK, et al. Management of lung transplant recipients with bronchogenic carcinoma in the native lung. J Heart Lung Transplant 2003; 22:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/89\">",
"      Ahmad U, Wang Z, Bryant AS, et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg 2012; 94:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/90\">",
"      Pechet TV, de le Morena M, Mendeloff EN, et al. Lung transplantation in children following treatment for malignancy. J Heart Lung Transplant 2003; 22:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/91\">",
"      Hadjiliadis D, Chaparro C, Reinsmoen NL, et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant 2005; 24:S249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/92\">",
"      Shah AS, Nwakanma L, Simpkins C, et al. Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients. Ann Thorac Surg 2008; 85:1919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/93\">",
"      Tyan DB, Li VA, Czer L, et al. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/94\">",
"      Glotz D, Haymann JP, Sansonetti N, et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation 1993; 56:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/95\">",
"      Milman N, Andersen CB, Burton CM, Iversen M. Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J 2005; 26:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/96\">",
"      Rosas V, Conte JV, Yang SC, et al. Lung transplantation and systemic sclerosis. Ann Transplant 2000; 5:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/97\">",
"      Schachna L, Medsger TA Jr, Dauber JH, et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006; 54:3954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/98\">",
"      Massad MG, Powell CR, Kpodonu J, et al. Outcomes of lung transplantation in patients with scleroderma. World J Surg 2005; 29:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/99\">",
"      Yeatman M, McNeil K, Smith JA, et al. Lung Transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant 1996; 15:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26953/abstract/100\">",
"      Allen JG, Weiss ES, Merlo CA, et al. Impact of donor-recipient race matching on survival after lung transplantation: analysis of over 11,000 patients. J Heart Lung Transplant 2009; 28:1063.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4658 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-3399DFF423-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26953=[""].join("\n");
var outline_f26_20_26953=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Recipient age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SPECIAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ventilator dependence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Nutritional status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H127609039\">",
"      Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Previous cardiothoracic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Chronic obstructive pulmonary disease (COPD)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glucocorticoid use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Chronic infection or colonization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prior malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Allosensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OTHER FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4658\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4658|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/25/31135\" title=\"figure 1\">",
"      Indications for lung transplant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/5/41055\" title=\"figure 2\">",
"      Survival by recipient age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12778?source=related_link\">",
"      Bacterial infections following lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=related_link\">",
"      Cystic fibrosis: Antibiotic therapy for lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=related_link\">",
"      Cystic fibrosis: Overview of the treatment of lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11993?source=related_link\">",
"      Estimation of blood glucose control in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26490?source=related_link\">",
"      Evaluation of the potential renal transplant recipient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=related_link\">",
"      Lung transplantation: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31192?source=related_link\">",
"      Lung transplantation: Disease-based choice of procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=related_link\">",
"      Lung volume reduction surgery in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=related_link\">",
"      Management of stable chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26954="Anemia in children due to decreased red blood cell production";
var content_f26_20_26954=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anemia in children due to decreased red blood cell production",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Claudio Sandoval, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/20/26954/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/20/26954/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemias caused by decreased red blood cell production have been grouped under the broad category of bone marrow failure, although their mechanisms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    presentations may be markedly different. They include (",
"    <a class=\"graphic graphic_table graphicRef80295 \" href=\"UTD.htm?18/58/19372\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pure red cell aplasia, either congenital or acquired",
"     </li>",
"     <li>",
"      Bone marrow aplasia involving more than one cell line",
"     </li>",
"     <li>",
"      Anemia caused by decreased erythropoietin availability",
"     </li>",
"     <li>",
"      Anemia related to ineffective erythropoiesis",
"     </li>",
"     <li>",
"      Anemia caused by disordered erythroid maturation",
"     </li>",
"     <li>",
"      Anemia caused by marrow replacement (malignancy, storage disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bone marrow failure, whether congenital or acquired, may result in either a single cytopenia (eg, congenital anemia) or affect multiple cell lines (eg, aplastic anemia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26842?source=see_link\">",
"     \"Inherited aplastic anemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3738?source=see_link\">",
"     \"Acquired aplastic anemia in children and young adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36441?source=see_link\">",
"     \"Causes of congenital and acquired sideroblastic anemias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disorders resulting in isolated anemia with reticulocytopenia may be grouped under the heading of pure red cell aplasia (PRCA). Patients with PRCA generally have a macrocytic, normochromic anemia, and other cell lines are usually not affected. In general, overall bone marrow cellularity is normal, with either decreased or absent erythroid precursors. Pure red blood cell aplasia in children may be congenital (eg, Diamond-Blackfan anemia) or acquired (eg, transient erythroblastopenia of childhood or an erythroblastopenic crisis in a hemolytic anemia, especially one not previously recognized).",
"   </p>",
"   <p>",
"    The most common causes of anemia secondary to decreased red blood cell (RBC) production in the pediatric population are reviewed here. They include congenital and acquired PRCA, impaired erythropoietin production, and erythroid maturation disorders and ineffective erythropoiesis. The general approach to anemia in children is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=see_link\">",
"     \"Approach to the child with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CONGENITAL PURE RED CELL APLASIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diamond-Blackfan anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diamond-Blackfan anemia (DBA,",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim/105650\">",
"     MIM #105650",
"    </a>",
"    ) is a congenital erythroid aplasia that usually presents in infancy. It is characterized by the following features (",
"    <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progressive normochromic, usually macrocytic anemia in infancy or early childhood",
"     </li>",
"     <li>",
"      Reticulocytopenia",
"     </li>",
"     <li>",
"      Normal cellularity of the bone marrow with markedly decreased or absent erythroid precursors",
"     </li>",
"     <li>",
"      White blood cell count is generally normal; platelet counts are generally normal but can be increased or decreased. &nbsp;",
"     </li>",
"     <li>",
"      Congenital malformations (50 percent of patients)",
"     </li>",
"     <li>",
"      Increased risk of malignancies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Associated malignancies include acute myelogenous leukemia, myelodysplastic syndrome, and solid tumors including colon cancer, female genital cancers, and osteogenic sarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In a report from a DBA registry that included 546 patients who had not received hematopoietic cell transplantation and approximately 20 years of follow-up, 15 solid tumors, two acute myeloid leukemias, and two cases of myelodysplastic syndrome were diagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/3\">",
"     3",
"    </a>",
"    ]. The cumulative incidence of solid tumor or leukemia was approximately 20 percent by age 46 years. The risk of solid tumors in nontransplanted patients begins to rise around 30 years of age. The cancer risk is substantially higher than in a healthy population but is lower than that for Fanconi anemia or dyskeratosis congenita. However, the degree of risk for cancer has not been fully established, so it is not yet possible to make recommendations for cancer surveillance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9671287\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 90 percent of patients with DBA are diagnosed within the first year of life, with 35 percent diagnosed within the first month [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4\">",
"     4",
"    </a>",
"    ]. In general, patients are significantly anemic at the time of presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4\">",
"     4",
"    </a>",
"    ]. A report from the UK registry, consisting of 80 patients from a 20 year birth cohort, suggests an annual incidence of five cases of DBA per million live births [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/5\">",
"     5",
"    </a>",
"    ]. Males and females appear to be equally affected. Although most case reports are of Caucasians, the syndrome has been noted in several different ethnic groups [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;DBA is a ribosomopathy, caused by genetic mutations affecting ribosome synthesis. This results in stabilization and activation of the TP53 (tumor protein p53) tumor suppressor pathway, which is thought to be the main cause of the clinical manifestations including impaired erythropoiesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. About 45 percent of cases are familial, usually displaying autosomal dominant inheritance, but with a wide range of severity within a family (reduced penetrance) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/9\">",
"     9",
"    </a>",
"    ]. Therefore, some cases that appear to be sporadic may prove to be familial if genetic testing is performed. Among 219 patients with DBA, 129 distinct mutations were found (82 of which were de novo, and 45 were inherited; in the remaining cases the inheritance was not ascertained) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The gene encoding ribosomal protein 19 (RPS19) is mutated in 25 percent of patients with DBA. Disease-causing mutations in genes encoding the large (RPL35A, RPL5, RPL11) and small (RPS24, RPS17, RPS7, RPS10, RPS26) ribosomal subunits have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/11-15\">",
"     11-15",
"    </a>",
"    ]. These include deletions and copy-number variations, which are not consistently detected by sequencing [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Genotype-phenotype correlations exist, with patients harboring mutations in RPL5 or RPL11 presenting more frequently with somatic malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/18\">",
"     18",
"    </a>",
"    ]. For example, in one series 21 of 24 patients with DBA and cleft palate have a RPL5 mutation, whereas no patient with a cleft palate had an RPS19 mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/10\">",
"     10",
"    </a>",
"    ]. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Erythropoietin production is normal in children with DBA, and antibodies to erythropoietin have not been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4\">",
"     4",
"    </a>",
"    ]. No evidence has been found for an abnormality in other regulators of erythropoiesis, such as interleukin (IL)-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), or c-kit or its ligand Steel factor (also called stem cell factor) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=see_link\">",
"     \"Regulation of erythropoiesis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Physical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thirty to 50 percent of patients with DBA have associated congenital abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. These findings occur mainly in the head and upper limb area and include (",
"    <a class=\"graphic graphic_table graphicRef67544 \" href=\"UTD.htm?1/39/1661\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Craniofacial abnormalities",
"     </li>",
"     <li>",
"      Ophthalmological anomalies",
"     </li>",
"     <li>",
"      Neck anomalies",
"     </li>",
"     <li>",
"      Cardiac anomalies",
"     </li>",
"     <li>",
"      Thumb abnormalities",
"     </li>",
"     <li>",
"      Genitourinary malformations",
"     </li>",
"     <li>",
"      Pre- and postnatal growth failure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with DBA sometimes have characteristic facial features, with tow-colored hair, snub nose, wide set eyes, thick upper lip, and an intelligent expression, although faces with different appearances have been reported in other children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4\">",
"     4",
"    </a>",
"    ]. The presence of physical anomalies does not predict the severity of the hematologic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Because of the association of cardiac and renal anomalies in patients with DBA, renal and cardiac imaging is recommended as a part of the evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. We reported a girl with DBA and multiple malformations (external auditory canal atresia, cleft palate, ventricular septal defects, left-sided cross-fused renal ectopia, and right-sided Morgagni hernia with eventration of the liver into the thorax) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/22\">",
"     22",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Growth retardation occurs in 30 percent of affected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/5,23,24\">",
"     5,23,24",
"    </a>",
"    ]. It is often associated with other congenital abnormalities and the need for ongoing therapy. However, linkage to the RPS 19 gene mutation is not associated with growth retardation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation of a patient with suspected DBA should include a complete blood count (CBC) with RBC indices, reticulocyte count, measurement of hemoglobin F (eg, by hemoglobin electrophoresis), and erythrocyte adenosine deaminase (eADA) activity. The results will establish whether the anemia is due to decreased RBC production, and help to distinguish between DBA and transient erythroblastopenia of childhood (",
"    <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For patients with a high clinical suspicion of DBA we also suggest genetic screening for mutations in the genes associated with DBA. A list of laboratories that can perform this testing is available at",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/disease/dba?db=genetests&amp;search_param=contains\">",
"     GeneTests",
"    </a>",
"    . If the disease-causing mutation in the proband&rsquo;s family is not known, the most efficient strategy is to first do sequence analysis for mutations in RPS19 (since mutations in this gene are the most common cause of DBA), followed by molecular testing for the other eight genes associated with DBA. If a disease-causing mutation is found, the parents and siblings of the proband should be screened for the same mutation even if they are asymptomatic to guide genetic counseling and because of the increased risk for malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormal laboratory findings in DBA consist primarily of anemia, which is generally macrocytic (ie, increased RBC mean corpuscular volume, or MCV). The anemia is usually profound at diagnosis, with a mean Hgb of 6.5 in infants younger than two months of age and 4.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in infants older than two months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. However, some patients with non-classical DBA have only mild anemia, or only subtle erythroid abnormalities.",
"   </p>",
"   <p>",
"    White blood cell (WBC) and platelet counts are generally unaffected. Patients usually have an increased percentage of fetal hemoglobin (Hgb F) for age, and their red cells have increased expression of the i antigen beyond the first year of life. These fetal-like red cell features are indicative of stress erythropoiesis and persist even in patients with spontaneous remissions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bone marrow examination shows normal overall cellularity with decreased or absent erythroid precursors. However, a report of 28 patients with steroid-refractory DBA who were followed for up to 13 years found that 75 percent ultimately developed moderate to severe bone marrow hypoplasia, with bone marrow cellularity ranging between 0 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/26\">",
"     26",
"    </a>",
"    ]. This hypoplasia correlated with the development of neutropenia and thrombocytopenia in 43 and 29 percent of the patients, respectively. None of the patients who were studied had cytogenetic abnormalities noted at the time of hypoplasia.",
"   </p>",
"   <p>",
"    In addition to the above abnormalities, eADA activity is elevated in 47 to 100 percent of patients with DBA who undergo such testing [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. Although the significance of this finding is not clear, it may be useful in differentiating between DBA and transient erythroblastopenia of childhood in ambiguous cases. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Transient erythroblastopenia of childhood (TEC)'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;DBA should be suspected in infants presenting with severe anemia and reticulocytopenia during the first year of life, particularly if congenital malformations are present. Diagnostic criteria for DBA were established by an international clinical consensus group [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of classic DBA is made if all of the following",
"    <strong>",
"     diagnostic criteria",
"    </strong>",
"    are met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age less than one year",
"     </li>",
"     <li>",
"      Macrocytic anemia with no other significant cytopenias",
"     </li>",
"     <li>",
"      Reticulocytopenia",
"     </li>",
"     <li>",
"      Normal marrow cellularity with a paucity of erythroid precursors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients who do not meet all of the above criteria,",
"    <strong>",
"     supportive criteria",
"    </strong>",
"    , which are divided into major and minor findings, can be added to make a \"probable diagnosis.\"",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Major supporting criteria include the presence of a gene mutation associated with DBA and a positive family history.",
"     </li>",
"     <li>",
"      Minor supporting criteria include elevated eADA activity, congenital anomalies associated with DBA, an elevated hemoglobin F, and no evidence of another inherited bone marrow failure syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A probable diagnosis of DBA can be made in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three diagnostic criteria and a positive family history",
"     </li>",
"     <li>",
"      Two diagnostic criteria and three minor criteria",
"     </li>",
"     <li>",
"      A positive family history and three minor criteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, a diagnosis of non-classical DBA can be made if a patient has a DBA-associated gene mutation but does not meet sufficient diagnostic criteria to make the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The differential diagnosis of anemia due to decreased RBC production includes transient erythroblastopenia of childhood (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Transient erythroblastopenia of childhood (TEC)'",
"    </a>",
"    below.), and other genetic conditions characterized by bone marrow failure, including Fanconi anemia, Shwachman-Diamond syndrome, and dyskeratosis, which usually have additional cytopenias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26842?source=see_link\">",
"     \"Inherited aplastic anemia in children\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstays of therapy of DBA are corticosteroids and blood transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. However, spontaneous remissions have been reported in as many as 25 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/31\">",
"     31",
"    </a>",
"    ]. Overall, approximately 40 percent of individuals with DBA are steroid-dependent, 40 percent are transfusion-dependent, and 20 percent go into remission by age 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2,24\">",
"     2,24",
"    </a>",
"    ]. In most cases the remission is stable.",
"   </p>",
"   <p>",
"    The response rate to corticosteroids has ranged from 50 to 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4,23\">",
"     4,23",
"    </a>",
"    ]. Steroid responsiveness is associated with older age at presentation, a family history of DBA, and a normal platelet count at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/23\">",
"     23",
"    </a>",
"    ]. Interestingly, patients harboring mutations in RPS26 have the lowest response to steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/10\">",
"     10",
"    </a>",
"    ]. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Because of the significant adverse effects of steroids in infants, most experts recommend avoiding steroid therapy until 6 to 12 months of age, and instead maintain the infant on transfusion therapy during this time period [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. When",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    therapy is initiated, we usually begin with an oral dose of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, administered as one or two doses. Reticulocytes typically appear within one to two weeks in responders [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/31\">",
"     31",
"    </a>",
"    ]. Following a rise in the hemoglobin (Hgb) to &ge;10",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    a tapering schedule may be instituted, starting with a reduction in the number of daily doses. The steroid dose should be reduced slowly until a minimum effective dose is reached. Such minimally effective doses are highly variable, and many children who respond to steroids cannot be completely weaned [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. The taper should be over an 8 to 12 week time period with a goal of reaching a dose &le;0.5",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    or &le;1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every other day, with a target Hgb between 8 to 10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. Consideration should be given to starting prophylaxis with sulfamethoxazole-trimethoprim for patients who receive prolonged prednisone therapy. Live virus vaccination should be avoided while the patient remains on high or moderate doses of corticosteroid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    A trial of four weeks should be given, and if there is no response, therapy should be discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. There are no data that suggest continuation of therapy beyond this time or an escalation of dosing in non-responders is warranted.",
"   </p>",
"   <p>",
"    Transfusion therapy is the mainstay of treatment for patients in whom steroid therapy is ineffective or in whom corticosteroid toxicity is prohibitive. To avoid red cell sensitization and transfusion reactions, complete red cell typing should be performed, and blood should be leuko-depleted. Patients are transfused to maintain Hgb levels compatible with normal activity (Hgb &ge;8",
"    <span class=\"nowrap\">",
"     g/dL),",
"    </span>",
"    usually every four to six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. Immediate family members should not be used as blood donors, to avoid allosensitization which might jeopardize future hematopoietic cell transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/32\">",
"     32",
"    </a>",
"    ]. The major complication of transfusion therapy is hemosiderosis, which may result in significant morbidity and mortality. Iron chelation therapy should, therefore, be instituted in patients with evidence of significantly increased iron stores. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=see_link&amp;anchor=H11#H11\">",
"     \"Iron overload syndromes other than hereditary hemochromatosis\", section on 'Transfusional iron overload'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Hematopoietic cell transplantation (HCT) has been employed with success in steroid refractory patients. The outcomes and timing of HCT for treatment of this disease are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17030?source=see_link&amp;anchor=H2#H2\">",
"     \"Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children\", section on 'Diamond-Blackfan anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other therapies that have resulted in limited responses include androgens, IL-3,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"     metoclopramide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/33-35\">",
"     33-35",
"    </a>",
"    ], and immunosuppressive agents [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/6,36,37\">",
"     6,36,37",
"    </a>",
"    ]. Experimental studies in mice and zebrafish [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/38,39\">",
"     38,39",
"    </a>",
"    ] and human case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/40\">",
"     40",
"    </a>",
"    ] suggest that treatment with the amino acid L-leucine can ameliorate DBA caused by some mutations. The proposed mechanism is that L-leucine upregulates mRNA translation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Aase syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aase syndrome was first described in 1969 in two brothers with congenital anemia and triphalangeal thumbs [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/41\">",
"     41",
"    </a>",
"    ]. Affected children may also have cardiovascular and craniofacial (cleft lip-palate) anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. This syndrome is probably a variant of DBA rather than a distinct clinical entity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/25,43,44\">",
"     25,43,44",
"    </a>",
"    ]. As with DBA, corticosteroids are effective in a subset of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/42,45\">",
"     42,45",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ACQUIRED PURE RED CELL APLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple etiologies exist for acquired PRCA. They include aplasia associated with infections, drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/46,47\">",
"     46,47",
"    </a>",
"    ], autoimmune disorders (eg, systemic lupus erythematosus, rheumatoid arthritis), thymoma, malignancies, and autoantibodies (",
"    <a class=\"graphic graphic_table graphicRef78795 \" href=\"UTD.htm?19/45/20189\">",
"     table 4",
"    </a>",
"    ). Many of these associated conditions occur primarily in adults. Therefore, this section will concentrate on conditions most commonly seen in children, namely transient erythroblastopenia of childhood (TEC) and infections resulting in aplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Transient erythroblastopenia of childhood (TEC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEC was first described in 1970 as a transient or temporary red cell aplasia, distinguishing it from the chronic condition, DBA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. It is a self-limited anemia occurring in previously healthy children, due to a temporary cessation of erythrocyte production. It is the most common cause of decreased RBC production in children, and it is likely that many cases are subclinical. TEC should be suspected in an otherwise healthy child with anemia and reticulocytopenia. An extensive evaluation usually is not necessary, provided that the MCV is normal and the blood smear does not suggest a RBC disorder or leukemia. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology is unknown. Possible causes of TEC may include viral illness, serum inhibitors against erythroid progenitor cells, and cell-mediated suppression of erythropoiesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/51-54\">",
"     51-54",
"    </a>",
"    ]. A genetic predisposition has been postulated but not established. &nbsp;",
"   </p>",
"   <p>",
"    In approximately one-half of the cases, children have a history of a viral illness in the preceding two to three months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/50,55\">",
"     50,55",
"    </a>",
"    ]. Echovirus 11, human herpesvirus type 6, and parvovirus have all been reported to be associated with the development of TEC [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/51,52,56\">",
"     51,52,56",
"    </a>",
"    ]. In particular, an association with parvovirus serotype 19 has been suggested, but not generally supported by virologic investigations. For example, in one case of TEC, parvovirus B19 genome was detected in blood and bone marrow at diagnosis and no longer detected when TEC resolved clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/57\">",
"     57",
"    </a>",
"    ]. However, in a series of 16 patients ages 3 to 23 months with TEC, amplification for parvovirus B19 from bone marrow was negative, suggesting parvovirus may not be the cause of TEC in young patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/58\">",
"     58",
"    </a>",
"    ]. Seasonal clustering has been noted in small groups of patients. However, when large groups of patients are reviewed, no overall seasonal predominance is appreciated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/59,60\">",
"     59,60",
"    </a>",
"    ], speaking against a specific viral etiology.",
"   </p>",
"   <p>",
"    A report of simultaneous presentation of TEC in identical twins raises the possibility that this anemia results from an inherited abnormal response to a common environmental insult (eg, virus or toxin) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/61\">",
"     61",
"    </a>",
"    ]. Other reports describing TEC occurring simultaneously or separately in siblings also support the possibility of a genetic predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/62\">",
"     62",
"    </a>",
"    ]. Early linkage analysis studies in seven TEC sibling pairs, two with a parent having had a period of transient anemia in childhood, suggest allelism for TEC and DBA at the ribosomal protein S19 gene locus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/63\">",
"     63",
"    </a>",
"    ]. Each case analysis of genomic DNA revealed normal sequence chromatograms corresponding to the RPS19 gene sequence. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Diamond-Blackfan anemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEC is usually seen in patients older than six months of age (generally between the ages of one and four), with a range of one month to six years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Two reviews suggest that presentation at less than six months of age may occur more commonly than has been previously recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Males may be affected more often than females, and TEC has been seen in all ethnic groups [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/50\">",
"     50",
"    </a>",
"    ]. Unlike many patients with DBA, those with TEC are otherwise clinically normal (",
"    <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Hematologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients generally have anemia in the range of 6 to 8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    with reticulocytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/60\">",
"     60",
"    </a>",
"    ]. Mild neutropenia has been noted in &ge;50 percent of patients with TEC in several series, and platelet counts may be normal or elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/60,66,67\">",
"     60,66,67",
"    </a>",
"    ]. In contrast to patients with DBA, patients with TEC do not have an elevated RBC MCV at diagnosis nor do they have an increased percentage of hemoglobin F or i antigen, and eADA activity is almost always normal (",
"    <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"     2",
"    </a>",
"    ]. Hemoglobin concentrations in patients prior to presentation with TEC have been documented to be within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/64\">",
"     64",
"    </a>",
"    ]. Patients with TEC may have a slightly elevated MCV at the time of recovery because of the increased number of reticulocytes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link&amp;anchor=H3#H3\">",
"     \"Macrocytosis\", section on 'Reticulocytosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TEC may be distinguished from DBA based on the above clinical and laboratory data (",
"    <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"     table 2",
"    </a>",
"    ). These data may obviate the need for a bone marrow examination in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/60\">",
"     60",
"    </a>",
"    ]. Distinguishing between DBA and TEC patients who present with hypoplastic anemia in the first year of life may be particularly challenging. Many times these patients do not have previously documented blood counts, and their erythrocytes may have residual fetal characteristics (eg, i antigen and increased Hgb F) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/64\">",
"     64",
"    </a>",
"    ]. Serial measurements of MCV in children presenting with hypoplastic anemia during the first year of life may help to differentiate between these two entities, because patients with DBA are expected to have persistently elevated MCVs for age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical clinical course of TEC consists of anemia of one to two months' duration, followed by complete recovery. At the time of presentation, 5 to 10 percent of patients are already in the recovery phase, with 80 percent recovering within one month [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/50,59\">",
"     50,59",
"    </a>",
"    ] and the remainder within two months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/55\">",
"     55",
"    </a>",
"    ]. Some authors report that the absolute neutrophil count returns to normal prior to the appearance of reticulocytes, while others report that WBC recovery has no relation to the recovery of the anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/60,67\">",
"     60,67",
"    </a>",
"    ]. Corticosteroids have been employed in the treatment of some patients with TEC; however, there is no evidence that steroids affect time to recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/59\">",
"     59",
"    </a>",
"    ]. In the author's experience, children with TEC tolerate the anemia remarkably well, and packed red blood cell transfusions are required only for those with cardiorespiratory symptoms or fatigue that interferes with their quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Infectious agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple infectious agents have been associated with the development of acquired red cell aplasia, including hepatitis A, B, and C, Epstein-Barr virus (EBV), HIV, and parvovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/68-73\">",
"     68-73",
"    </a>",
"    ]. However, the infectious agent most commonly associated with acquired red cell aplasia is parvovirus. Whether parvovirus is responsible for some cases of TEC is not clear, as discussed above. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Transient erythroblastopenia of childhood (TEC)'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p>",
"    Human parvovirus B19 (HPV) is a common infection that results in erythema infectiosum (fifth disease) in childhood and may be associated with polyarthropathy in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/74\">",
"     74",
"    </a>",
"    ]. The virus has been associated with aplastic crisis in patients with hemolytic anemias, prolonged red cell aplasia and chronic anemias in patients with underlying immunodeficiency states, and infrequently, transient aplasia in the normal host [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/75\">",
"     75",
"    </a>",
"    ]. Parvovirus replicates solely in erythroid progenitor cells that have the P antigen receptor. Thus, individuals who are P antigen negative are resistant to the virus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Parvovirus infection results in a temporary cessation of RBC production. In patients who have normal RBC turnover, this cessation may be of insignificant consequence (",
"    <a class=\"graphic graphic_figure graphicRef75004 \" href=\"UTD.htm?29/45/30430\">",
"     figure 1",
"    </a>",
"    ). However, in patients who have a concurrent active hemolytic process and thus a shortened red cell lifespan, the temporary cessation of RBC production may result in severe anemia or \"aplastic (erythroblastopenic) crisis\" [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/74\">",
"     74",
"    </a>",
"    ]. Patients with hemolytic anemias, including sickle cell anemia, thalassemia, pyruvate kinase deficiency, autoimmune hemolytic anemia, spherocytosis, pyropoikilocytosis, and elliptocytosis have all been reported to have erythroblastopenic crisis in conjunction with parvovirus infections [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/77-83\">",
"     77-83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, these crises are self-limiting and resolve in one to two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/84\">",
"     84",
"    </a>",
"    ]. However, the anemia may be severe enough to result in symptoms of heart failure and require transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/74,84\">",
"     74,84",
"    </a>",
"    ]. During the period of aplasia, patients may also have a decrease in their WBC and platelet numbers (",
"    <a class=\"graphic graphic_figure graphicRef75004 \" href=\"UTD.htm?29/45/30430\">",
"     figure 1",
"    </a>",
"    ). Occasionally, patients with well-compensated and previously unsuspected hereditary hemolytic anemias are diagnosed following presentation with parvovirus-induced RBC aplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/82,85\">",
"     82,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with immunocompromised states, including those with HIV and those undergoing immunosuppressive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    myelosuppressive therapy, are at risk for the development of chronic anemia with parvovirus infections, because of their inability to clear the viral infection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. Infants infected in utero may develop hydrops fetalis, with parvovirus being responsible for 10 to 15 percent of all cases of nonimmune hydrops [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/74\">",
"     74",
"    </a>",
"    ]. A case of anemia of the newborn caused by parvovirus infection, lasting until the eleventh day of life, has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/89\">",
"     89",
"    </a>",
"    ]. Both the infant and mother were found to have HPV-specific IgM and IgG in their serum. This case illustrates the possibility that some cases previously thought to be DBA with spontaneous recovery may actually have been cases of TEC secondary to in utero parvovirus infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Diagnostic workup",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic workup for patients suspected of having a parvovirus infection may include serum titers for parvovirus IgM and IgG, detection of viral DNA via polymerase chain reaction (PCR) techniques on bone marrow samples, and routine bone marrow examination [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/84\">",
"     84",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32312?source=see_link\">",
"     \"Epidemiology and laboratory diagnosis of parvovirus B19 infection\"",
"    </a>",
"    .) Affected patients may display giant proerythroblasts in their bone marrow samples (",
"    <a class=\"graphic graphic_picture graphicRef51435 \" href=\"UTD.htm?26/42/27304\">",
"     picture 1",
"    </a>",
"    ), along with decreased to absent erythroid precursors. However, not all patients, especially those children with known underlying hemolytic processes, will require a bone marrow examination for diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic hemolysis who present with aplasia generally have resolution of their anemia in a short period of time and may only require transfusions based upon clinical symptoms caused by the anemia. Immunosuppressed patients may benefit from therapy with intravenous immunoglobulin (IGIV, IVIG), which may result in a brisk reticulocytosis and rise in Hgb levels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]. Patients with continued immunosuppression, especially those with HIV, should be monitored for recurrence of the infection and may benefit from maintenance IGIV infusions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/75,88\">",
"     75,88",
"    </a>",
"    ]. Infants with parvovirus-induced hydrops may benefit from intrauterine simple or exchange transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/84\">",
"     84",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31767?source=see_link\">",
"     \"Treatment and prevention of parvovirus B19 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other bone marrow failure syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other bone marrow failure syndromes, such as aplastic anemia and Fanconi Anemia, which affect granulocytes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    platelets in addition to RBC, may present with hypoplastic anemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3738?source=see_link\">",
"     \"Acquired aplastic anemia in children and young adults\"",
"    </a>",
"    .) Malignancy and myelofibrosis may also result in bone marrow replacement, causing anemia with a poor reticulocyte response.",
"   </p>",
"   <p>",
"    Metabolic causes of myelofibrosis include hypoparathyroidism, chronic renal failure, and vitamin deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/84\">",
"     84",
"    </a>",
"    ]. Marrow failure resulting in red cell aplasia may also occur as result of infiltrating malignancies, bone diseases, and some connective tissue disorders such lupus erythematosus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27303?source=see_link&amp;anchor=H4#H4\">",
"     \"Hematologic problems in children and adolescents with systemic lupus erythematosus\", section on 'Anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     IMPAIRED ERYTHROPOIETIN PRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythropoietin (EPO) is the growth factor responsible for the regulation of RBC production. It is produced initially in the fetal and neonatal liver, and subsequently, primarily in the kidneys. EPO is part of a complex regulatory system, adjusting RBC production based upon tissue oxygen demand [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/90\">",
"     90",
"    </a>",
"    ]. Hypoxic conditions (ie, anemia), as well as a fall in the arterial oxygen pressure (eg, from cardiopulmonary disease or exposure to high altitude), stimulate EPO production and thus RBC production.",
"   </p>",
"   <p>",
"    Metabolic factors may influence EPO production. For example, hypophysectomy, hypothyroidism, and starvation result in reduced EPO levels, and stimulation of thyroid hormone results in increased EPO levels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. Abnormally low EPO production, or failure of EPO levels to rise in the face of hypoxia, may result in anemia with a poor reticulocyte response.",
"   </p>",
"   <p>",
"    Children with chronic renal disease are known to have normocytic anemia that is likely multifactorial but is largely caused by low erythropoietin levels. Therapy with EPO has been proven effective in resolving anemia in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/90,93\">",
"     90,93",
"    </a>",
"    ]. Moreover, these patients can be iron deficient and benefit from intravenous iron therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/94\">",
"     94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Anemia of chronic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia of chronic disease (ACD) is multifactorial, and is usually associated with the presence of infection, inflammation, or malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Associated hematologic abnormalities include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/95\">",
"     95",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shortened RBC survival",
"     </li>",
"     <li>",
"      Abnormal iron physiology with low serum iron concentrations",
"     </li>",
"     <li>",
"      Elevated serum ferritin levels due to iron sequestration by the reticuloendothelial system",
"     </li>",
"     <li>",
"      Impaired bone marrow response caused by either impaired EPO production or impaired ability of erythroid progenitors to respond appropriately to EPO",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with inflammation and anemia have been found to have low erythropoietin levels for their degree of anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/95\">",
"     95",
"    </a>",
"    ]. ACD is usually a mild anemia with either normocytic or microcytic cells and reticulocytopenia. The presence of normal to elevated ferritin concentrations serves to distinguish ACD from iron deficiency anemia, in which ferritin concentrations are low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H7#H7\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'Laboratory findings'",
"    </a>",
"    .) Most patients with ACD will require no specific therapy; correction of the underlying condition will result in an increase in Hgb concentrations. However, some patients may have anemia or symptoms significant enough to warrant intervention. Preliminary data from patients with underlying Crohn's disease and rheumatoid arthritis suggest a role for EPO supplementation in such patients, sometimes with concomitant IV iron [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36616?source=see_link&amp;anchor=H2#H2\">",
"     \"Hematologic manifestations of rheumatoid arthritis\", section on 'Anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     ERYTHROID MATURATION DISORDERS AND INEFFECTIVE ERYTHROPOIESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders of erythroid maturation or ineffective erythropoiesis may also result in anemia with reticulocytopenia. Common acquired causes of anemia that fall into this category include iron deficiency, sideroblastic anemias, anemia secondary to lead poisoning, and megaloblastic anemias. These topics are covered in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36441?source=see_link\">",
"     \"Causes of congenital and acquired sideroblastic anemias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8058?source=see_link\">",
"     \"Pathophysiology of beta thalassemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Congenital dyserythropoietic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The congenital dyserythropoietic anemias (CDA, types I, II, III, and IV) are a rare group of disorders that result in anemia caused by ineffective erythropoiesis and multinuclear erythroblasts, and may present in childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/98-102\">",
"     98-102",
"    </a>",
"    ]. Genes have thus far been identified for types I, II and IV, and a gene locus has been identified for type III. These disorders have pathognomonic cytopathologic findings consisting of nuclear abnormalities in bone marrow erythroid precursors (",
"    <a class=\"graphic graphic_table graphicRef51418 \" href=\"UTD.htm?23/43/24252\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/98-100\">",
"     98-100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CDA type I (",
"      <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim/224120\">",
"       MIM #224120",
"      </a>",
"      ) is caused by a homozygous or compound heterozygous mutation in the gene encoding codanin-I (CDAN1) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/103-105\">",
"       103-105",
"      </a>",
"      ]. It is characterized by megaloblastic changes in erythroblasts, with chromatin bridges between the nuclei. Bone abnormalities, especially of the hands and feet, have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/104\">",
"       104",
"      </a>",
"      ]. &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      CDA type II (",
"      <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim/224100\">",
"       MIM #224100",
"      </a>",
"      ), also called Hereditary Erythroblastic Multinuclearity with a Positive Acidified Serum test (HEMPAS), is the most common form of CDA and is characterized by normocytic binuclear or multinuclear red cells. It is caused by homozygous or compound heterozygous mutations in the SEC23B gene [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/106\">",
"       106",
"      </a>",
"      ]. A founder mutation E109K in the SEC23B gene, estimated to be 2400 years old, was detected in Israeli Moroccan Jewish patients with CDA II [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/107\">",
"       107",
"      </a>",
"      ]. Moreover, a genotype-phenotype association has been established; among 42 patients with CDA II, those with one missense and one nonsense mutation (compound heterozygotes) exhibited a more severe phenotype with lower reticulocyte counts and higher serum ferritin than patients with two missense mutations [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/108\">",
"       108",
"      </a>",
"      ]. Clinically, the compound heterozygous patients exhibited predominantly ineffective erythropoiesis, whereas the patients with two missense mutations had ineffective erythropoiesis and peripheral hemolysis.",
"      <br/>",
"      <br/>",
"      In a series of 98 subjects, the mean age at presentation for CDA type II was five years (range: 1 month to 25 years), although the mean age at the time of correct diagnosis was 16 years (range: 4 months to 65 years) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/109\">",
"       109",
"      </a>",
"      ]. Anemia and jaundice were present in 66 and 53 percent of subjects, respectively. Twenty-three percent of 64 evaluable patients developed anemia during the neonatal period; two-thirds of these required transfusions during this time. Only five subjects remained transfusion-dependent during adulthood.",
"     </li>",
"     <li>",
"      CDA type III (",
"      <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim/105600\">",
"       MIM #105600",
"      </a>",
"      ) has been localized to chromosome 15q21-q25 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/110\">",
"       110",
"      </a>",
"      ], and is characterized by prominent erythroblastic multinuclearity forming 'gigantoblasts' with up to 12 nuclei. An autosomal dominant pattern of inheritance is described. &nbsp;",
"     </li>",
"     <li>",
"      CDA type IV (",
"      <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim/613673\">",
"       MIM #613673",
"      </a>",
"      ) is caused by a heterozygous mutation in the KLF (erythroid kruppel-like factor) gene, which encodes a transcriptional activator [",
"      <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/111\">",
"       111",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hemosiderosis, caused by multiple RBC transfusions as well as increased absorption of intestinal iron, is a problem for patients with all types of CDA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/100,112\">",
"     100,112",
"    </a>",
"    ]. It is, at least in part, related to the presence of severe degrees of ineffective erythropoiesis, along with inappropriate suppression of hepcidin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=see_link&amp;anchor=H2#H2\">",
"     \"Iron overload syndromes other than hereditary hemochromatosis\", section on 'Anemia due to ineffective erythropoiesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study of 48 patients with type II CDA, the majority of patients developed splenomegaly within the first three decades of life [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/114\">",
"     114",
"    </a>",
"    ]. Thus, the absence of splenomegaly in an adolescent should raise doubts regarding the diagnosis. Gallstones were found in 22 of 39 patients before the age of 40 years, appearing during childhood or adolescence a small percentage of the time; cholecystectomy was performed at a median age of 26 years. An inadequate reticulocyte response (ie, a normal or only moderately increased reticulocyte count despite the anemia) in a patient with congenital hemolytic anemia suggested this diagnosis, while the presence of binucleated normoblasts on the peripheral blood smear was felt to be highly specific. &nbsp;",
"   </p>",
"   <p>",
"    Families with variants of CDA that do not fall into the outlined types have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/6,100\">",
"     6,100",
"    </a>",
"    ]. An X-linked form is caused by a mutation in the gene for GATA-1, a transcription factor that contributes to erythroid and megakaryocytic differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/115-117\">",
"     115-117",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=see_link&amp;anchor=H10#H10\">",
"     \"Regulation of erythropoiesis\", section on 'GATA-1'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4458?source=see_link&amp;anchor=H9#H9\">",
"     \"Megakaryocyte biology and the production of platelets\", section on 'GATA-1 transcription factor'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy depends upon the type of CDA and may include splenectomy (effective in type II CDA but not in type I), interferon alfa (effective in most patients with type I), and transfusion in symptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/98,100,101,103,109,112,114,118\">",
"     98,100,101,103,109,112,114,118",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Iron chelation may be used in the treatment of the iron overload state in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/114\">",
"     114",
"    </a>",
"    ]. Iron therapy is almost always contraindicated in these patients because of their predisposition to develop iron overload [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/100\">",
"     100",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/49/25370?source=see_link\">",
"     \"Chelation therapy for iron overload states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hematopoietic cell transplantation (HCT) is a curative therapy for many malignant and non-malignant",
"    <span class=\"nowrap\">",
"     hematologic/immunologic",
"    </span>",
"    disorders. HCT has been described in seven patients with CDA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/20/26954/abstract/119-123\">",
"     119-123",
"    </a>",
"    ]. Four had CDA I, two had CDA II, and in one case the CDA type was unknown. These seven patients received hematopoietic stem cells from matched sibling donors, and all successfully engrafted and became transfusion independent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9672399\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders due to decreased red blood cell production in children are considered &ldquo;pure&rdquo; red cell aplasias, because other cell lines are not affected. They are characterized by reticulocytopenia and anemia, which is generally normocytic and normochromic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H353251\">",
"    <span class=\"h2\">",
"     Diamond-Blackfan anemia",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diamond-Blackfan anemia (DBA) is a congenital erythroid aplasia that usually presents in infancy. It is characterized by a progressive normocytic anemia with reticulocytopenia, with normal marrow cellularity and other cell lines; 50 percent of patients have associated malformations, most commonly craniofacial anomalies. DBA is associated with a predisposition to cancer; the cumulative incidence of solid tumors and leukemia is approximately 20 percent by 46 years of age. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diamond-Blackfan anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genes encoding ribosomal proteins are mutated in many cases. About 45 percent of cases are familial, with autosomal dominant patterns of inheritance. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The laboratory evaluation of a patient with suspected DBA should include a complete blood count (CBC) with RBC indices, reticulocyte count, measurement of hemoglobin F (eg, by hemoglobin electrophoresis), and erythrocyte adenosine deaminase (eADA) activity. The results will establish whether the anemia is due to decreased RBC production and help to distinguish between DBA and transient erythroblastopenia of childhood (",
"      <a class=\"graphic graphic_table graphicRef76264 \" href=\"UTD.htm?12/30/12781\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mainstays of therapy of DBA are corticosteroids and blood transfusion. Infants should be maintained with transfusions until they are 6 to 12 months old, then a trial of corticosteroids should be given. Overall, approximately 40 percent of individuals with DBA are steroid-dependent, 40 percent are transfusion-dependent, and 20 percent go into remission by age 25 years. Hematopoietic cell transplantation (HCT) has been successfully employed in steroid refractory patients. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H353267\">",
"    <span class=\"h2\">",
"     Acquired pure red cell aplasias",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multiple etiologies exist for acquired pure red cell aplasias. They include aplasia associated with infections, drugs, autoimmune disorders (eg, systemic lupus erythematosus, rheumatoid arthritis), thymoma, malignancies, and autoantibodies (",
"      <a class=\"graphic graphic_table graphicRef78795 \" href=\"UTD.htm?19/45/20189\">",
"       table 4",
"      </a>",
"      ). Many of these associated conditions occur primarily in adults. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Acquired pure red cell aplasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transient erythroblastopenia of childhood (TEC) is a self-limited red-cell aplasia of unclear etiology occurring in previously healthy children, due to a temporary cessation of erythrocyte production. It is the most common cause of decreased RBC production in children and should be suspected in an otherwise healthy child with anemia and reticulocytopenia. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Transient erythroblastopenia of childhood (TEC)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infectious causes of acquired red cell aplasia, include parvovirus B19 (HPV, the virus responsible for erythema infectiosum), hepatitis A, B, and C, Epstein-Barr virus and HIV. In patients who have an underlying active hemolytic process, the temporary cessation of RBC production may result in severe anemia. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Infectious agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H353340\">",
"    <span class=\"h2\">",
"     Congenital dyserythropoietic anemia",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The congenital dyserythropoietic anemias (CDA) are a rare group of disorders that result in anemia caused by ineffective erythropoiesis and multinuclear erythroblasts (",
"      <a class=\"graphic graphic_table graphicRef51418 \" href=\"UTD.htm?23/43/24252\">",
"       table 5",
"      </a>",
"      ). Treatment may include splenectomy, interferon alfa, and transfusion in symptomatic patients. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Congenital dyserythropoietic anemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/1\">",
"      Willig TN, Gazda H, Sieff CA. Diamond-Blackfan anemia. Curr Opin Hematol 2000; 7:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/2\">",
"      Vlachos A, Ball S, Dahl N, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008; 142:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/3\">",
"      Vlachos A, Rosenberg PS, Atsidaftos E, et al. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012; 119:3815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/4\">",
"      Halperin DS, Freedman MH. Diamond-blackfan anemia: etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol 1989; 11:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/5\">",
"      Ball SE, McGuckin CP, Jenkins G, Gordon-Smith EC. Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol 1996; 94:645.",
"     </a>",
"    </li>",
"    <li>",
"     Alter B. Inherited bone marrow failure. In: Nathan and Oski's Hematology of Infancy and Childhood, 6th, Nathan DG, Orkin SH, Ginsberg D, Look AT (Eds), WB Saunders, Philadelphia 2003. p.280.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/7\">",
"      Dutt S, Narla A, Lin K, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011; 117:2567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/8\">",
"      Jaako P, Flygare J, Olsson K, et al. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011; 118:6087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/9\">",
"      Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol 2004; 125:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/10\">",
"      Boria I, Garelli E, Gazda HT, et al. The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat 2010; 31:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/11\">",
"      Cmejla R, Cmejlova J, Handrkova H, et al. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 2007; 28:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/12\">",
"      Doherty L, Sheen MR, Vlachos A, et al. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet 2010; 86:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/13\">",
"      Gazda HT, Grabowska A, Merida-Long LB, et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 2006; 79:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/14\">",
"      Gazda HT, Sheen MR, Vlachos A, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 2008; 83:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/15\">",
"      Farrar JE, Nater M, Caywood E, et al. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 2008; 112:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/16\">",
"      Farrar JE, Vlachos A, Atsidaftos E, et al. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 2011; 118:6943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/17\">",
"      Kuramitsu M, Sato-Otsubo A, Morio T, et al. Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. Blood 2012; 119:2376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/18\">",
"      Quarello P, Garelli E, Carando A, et al. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations. Haematologica 2010; 95:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/19\">",
"      Abkowitz JL, Broudy VC, Bennett LG, et al. Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anemia. Blood 1992; 79:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/20\">",
"      Bagnara GP, Zauli G, Vitale L, et al. In vitro growth and regulation of bone marrow enriched CD34+ hematopoietic progenitors in Diamond-Blackfan anemia. Blood 1991; 78:2203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/21\">",
"      Sieff CA, Yokoyama CT, Zsebo KM, et al. The production of steel factor mRNA in Diamond-Blackfan anaemia long-term cultures and interactions of steel factor with erythropoietin and interleukin-3. Br J Haematol 1992; 82:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/22\">",
"      McFarren A, Jayabose S, Fevzi Ozkaynak M, et al. Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with Diamond-Blackfan anemia: case report. J Pediatr Hematol Oncol 2007; 29:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/23\">",
"      Willig TN, Niemeyer CM, Leblanc T, et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Soci&eacute;t&eacute; d'H&eacute;matologie et d'Immunologie P&eacute;diatrique (SHIP), Gesellshaft f&uuml;r P&auml;diatrische Onkologie und H&auml;matologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res 1999; 46:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/24\">",
"      Chen S, Warszawski J, Bader-Meunier B, et al. Diamond-blackfan anemia and growth status: the French registry. J Pediatr 2005; 147:669.",
"     </a>",
"    </li>",
"    <li>",
"     Clinton C, Gazda HT. Diamond-Blackfan anemia. GeneReviews (internet). Available at: file://www.ncbi.nlm.nih.gov/books/NBK7047/.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/26\">",
"      Giri N, Kang E, Tisdale JF, et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol 2000; 108:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/27\">",
"      Glader BE, Backer K, Diamond LK. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med 1983; 309:1486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/28\">",
"      Whitehouse DB, Hopkinson DA, Pilz AJ, Arredondo FX. Adenosine deaminase activity in a series of 19 patients with the Diamond-Blackfan syndrome. Adv Exp Med Biol 1986; 195 Pt A:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/29\">",
"      Glader BE, Backer K. Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases. Br J Haematol 1988; 68:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/30\">",
"      Fargo JH, Kratz CP, Giri N, et al. Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/31\">",
"      Alter BP. Childhood red cell aplasia. Am J Pediatr Hematol Oncol 1980; 2:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/32\">",
"      Vlachos A, Muir E. How I treat Diamond-Blackfan anemia. Blood 2010; 116:3715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/33\">",
"      Abkowitz JL, Schaison G, Boulad F, et al. Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis. Blood 2002; 100:2687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/34\">",
"      Akiyama M, Yanagisawa T, Yuza Y, et al. Successful treatment of Diamond-Blackfan anemia with metoclopramide. Am J Hematol 2005; 78:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/35\">",
"      Leblanc TM, Da Costa L, Marie I, et al. Metoclopramide treatment in DBA patients: no complete response in a French prospective study. Blood 2007; 109:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/36\">",
"      Ball SE, Tchernia G, Wranne L, et al. Is there a role for interleukin-3 in Diamond-Blackfan anaemia? Results of a European multicentre study. Br J Haematol 1995; 91:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/37\">",
"      Leonard EM, Raefsky E, Griffith P, et al. Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989; 72:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/38\">",
"      Payne EM, Virgilio M, Narla A, et al. L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 2012; 120:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/39\">",
"      Jaako P, Debnath S, Olsson K, et al. Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 2012; 120:2225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/40\">",
"      Pospisilova D, Cmejlova J, Hak J, et al. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007; 92:e66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/41\">",
"      Aase JM, Smith DW. Congenital anemia and triphalangeal thumbs: a new syndrome. J Pediatr 1969; 74:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/42\">",
"      Muis N, Beemer FA, van Dijken P, Klep-de Pater JM. The Aase syndrome. Case report and review of the literature. Eur J Pediatr 1986; 145:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/43\">",
"      Alter BP. Thumbs and anemia. Pediatrics 1978; 62:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/44\">",
"      Hurst JA, Baraitser M, Wonke B. Autosomal dominant transmission of congenital erythroid hypoplastic anemia with radial abnormalities. Am J Med Genet 1991; 40:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/45\">",
"      D'Avanzo M, Pistoia V, Santinelli R, et al. Heterogeneity of the erythropoietic defect in two cases of Aase-Smith syndrome. Pediatr Hematol Oncol 1994; 11:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/46\">",
"      Thompson DF, Gales MA. Drug-induced pure red cell aplasia. Pharmacotherapy 1996; 16:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/47\">",
"      Lin YW, Okazaki S, Hamahata K, et al. Acute pure red cell aplasia associated with allopurinol therapy. Am J Hematol 1999; 61:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/48\">",
"      Wranne L. Transient erythroblastopenia in infancy and childhood. Scand J Haematol 1970; 7:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/49\">",
"      Lovric VA. Anaemia and temporary erythroblastopaenia in children. A syndrome. Australas Ann Med 1970; 19:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/50\">",
"      Oski FA. Transient Erythroblastopenia. Pediatr Rev 1982; 4:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/51\">",
"      Penchansky L, Jordan JA. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 1997; 108:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/52\">",
"      Elian JC, Frappaz D, Pozzetto B, Freycon F. Transient erythroblastopenia of childhood presenting with echovirus 11 infection. Acta Paediatr 1993; 82:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/53\">",
"      Dessypris EN, Krantz SB, Roloff JS, Lukens JN. Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood 1982; 59:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/54\">",
"      Tamary H, Kaplinsky C, Shvartzmayer S, et al. Transient erythroblastopenia of childhood. Evidence for cell-mediated suppression of erythropoiesis. Am J Pediatr Hematol Oncol 1993; 15:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/55\">",
"      Mupanomunda OK, Alter BP. Transient erythroblastopenia of childhood (TEC) presenting as leukoerythroblastic anemia. J Pediatr Hematol Oncol 1997; 19:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/56\">",
"      Wodzinski MA, Lilleyman JS. Transient erythroblastopenia of childhood due to human parvovirus B19 infection. Br J Haematol 1989; 73:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/57\">",
"      Prassouli A, Papadakis V, Tsakris A, et al. Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow. J Pediatr Hematol Oncol 2005; 27:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/58\">",
"      Rogers BB, Rogers ZR, Timmons CF. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood. Pediatr Pathol Lab Med 1996; 16:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/59\">",
"      Gerrits GP, van Oostrom CG, de Vaan GA, Bakkeren JA. Transient erythroblastopenia of childhood. A review of 22 cases. Eur J Pediatr 1984; 142:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/60\">",
"      Hays T, Lane PA Jr, Shafer F. Transient erythroblastopenia of childhood. A review of 26 cases and reassessment of indications for bone marrow aspiration. Am J Dis Child 1989; 143:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/61\">",
"      Labotka RJ, Maurer HS, Honig GR. Transient erythroblastopenia of childhood. Review of 17 cases, including a pair of identical twins. Am J Dis Child 1981; 135:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/62\">",
"      Shaw J, Meeder R. Transient erythroblastopenia of childhood in siblings: case report and review of the literature. J Pediatr Hematol Oncol 2007; 29:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/63\">",
"      Gustavsson P, Klar J, Matsson H, et al. Familial transient erythroblastopenia of childhood is associated with the chromosome 19q13.2 region but not caused by mutations in coding sequences of the ribosomal protein S19 (RPS19) gene. Br J Haematol 2002; 119:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/64\">",
"      Ware RE, Kinney TR. Transient erythroblastopenia in the first year of life. Am J Hematol 1991; 37:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/65\">",
"      Miller R, Berman B. Transient erythroblastopenia of childhood in infants &lt; 6 months of age. Am J Pediatr Hematol Oncol 1994; 16:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/66\">",
"      Rogers ZR, Bergstrom SK, Amylon MD, et al. Reduced neutrophil counts in children with transient erythroblastopenia of childhood. J Pediatr 1989; 115:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/67\">",
"      Cherrick I, Karayalcin G, Lanzkowsky P. Transient erythroblastopenia of childhood. Prospective study of fifty patients. Am J Pediatr Hematol Oncol 1994; 16:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/68\">",
"      Ide T, Sata M, Nouno R, et al. Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia. Am J Gastroenterol 1994; 89:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/69\">",
"      al-Awami Y, Sears DA, Carrum G, et al. Pure red cell aplasia associated with hepatitis C infection. Am J Med Sci 1997; 314:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/70\">",
"      Davidovitz Y, Halpern Z, Vardi J, et al. Pure red cell aplasia responsive to interferon-alpha in a patient with hepatitis C virus infection. Acta Haematol 1998; 100:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/71\">",
"      Parmentier L, Boucary D, Salmon D. Pure red cell aplasia in an HIV-infected patient. AIDS 1992; 6:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/72\">",
"      Purtilo DT, Zelkowitz L, Harada S, et al. Delayed onset of infectious mononucleosis associated with acquired agammaglobulinemia and red cell aplasia. Ann Intern Med 1984; 101:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/73\">",
"      Socinski MA, Ershler WB, Tosato G, Blaese RM. Pure red blood cell aplasia associated with chronic Epstein-Barr virus infection: evidence for T cell-mediated suppression of erythroid colony forming units. J Lab Clin Med 1984; 104:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/74\">",
"      Brown KE, Young NS. Human parvovirus B19 infections in infants and children. Adv Pediatr Infect Dis 1997; 13:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/75\">",
"      Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells 1996; 14:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/76\">",
"      Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/77\">",
"      Rechavi G, Vonsover A, Manor Y, et al. Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5'-nucleotidase deficiency. Acta Haematol 1989; 82:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/78\">",
"      Lowenthal EA, Prchal JT. Parvovirus B19 induced red blood cell aplasia in a patient with hereditary pyropoikilocytosis. Blood 1995; 86:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/79\">",
"      Duncan JR, Potter CB, Cappellini MD, et al. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet 1983; 2:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/80\">",
"      Serjeant GR, Serjeant BE, Thomas PW, et al. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993; 341:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/81\">",
"      Mallouh AA, Qudah A. An epidemic of aplastic crisis caused by human parvovirus B19. Pediatr Infect Dis J 1995; 14:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/82\">",
"      Lefrere JJ, Courouce AM, Girot R, et al. Six cases of hereditary spherocytosis revealed by human parvovirus infection. Br J Haematol 1986; 62:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/83\">",
"      Tomiyama J, Adachi Y, Hanada T, Matsunaga Y. Human parvovirus B19-induced aplastic crisis in autoimmune haemolytic anaemia. Br J Haematol 1988; 69:288.",
"     </a>",
"    </li>",
"    <li>",
"     Shimamura A, Guinan G. Acquired aplastic anemia. In: Nathan and Oski's Hematology of Infancy and Childhood, 6th ed, Nathan DG, Orkin SH, Ginsberg D, Look AT (Eds), WB Saunders, Philadelphia 2003. p.256.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/85\">",
"      Skinnider LF, McSheffrey BJ, Sheridan D, Deneer H. Congenital spherocytic hemolytic anemia in a family presenting with transient red cell aplasia from parvovirus B19 infection. Am J Hematol 1998; 58:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/86\">",
"      Rao SP, Miller ST, Cohen BJ. B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy. Med Pediatr Oncol 1994; 22:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/87\">",
"      Wong TY, Chan PK, Leung CB, et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/88\">",
"      Koduri PR, Kumapley R, Valladares J, Teter C. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients. Am J Hematol 1999; 61:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/89\">",
"      Tugal O, Pallant B, Shebarek N, Jayabose S. Transient erythroblastopenia of the newborn caused by human parvovirus. Am J Pediatr Hematol Oncol 1994; 16:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/90\">",
"      Van Damme-Lombaerts R, Herman J. Erythropoietin treatment in children with renal failure. Pediatr Nephrol 1999; 13:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/91\">",
"      Nomiyama J, Shinohara K, Inoue H. Improvement of anemia by recombinant erythropoietin in a patient with postoperative hypopituitarism. Am J Hematol 1994; 47:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/92\">",
"      Das KC, Mukherjee M, Sarkar TK, et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 1975; 40:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/93\">",
"      Belsha CW, Berry PL. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis. Pediatr Nephrol 1998; 12:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/94\">",
"      Kovesdy CP, Kalantar-Zadeh K. Iron therapy in chronic kidney disease: current controversies. J Ren Care 2009; 35 Suppl 2:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/95\">",
"      Means RT Jr. Clinical application of recombinant erythropoietin in the anemia of chronic disease. Hematol Oncol Clin North Am 1994; 8:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/96\">",
"      Nordstr&ouml;m D, Lindroth Y, Marsal L, et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int 1997; 17:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/97\">",
"      Dohil R, Hassall E, Wadsworth LD, Israel DM. Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease. J Pediatr 1998; 132:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/98\">",
"      Wickramasinghe SN. Congenital dyserythropoietic anemias. Curr Opin Hematol 2000; 7:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/99\">",
"      Wickramasinghe SN. Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev 1998; 12:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/100\">",
"      Marks PW, Mitus AJ. Congenital dyserythropoietic anemias. Am J Hematol 1996; 51:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/101\">",
"      Shalev H, Tamary H, Shaft D, et al. Neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr 1997; 131:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/102\">",
"      Benjamin JT, Rosse WF, Daldorf FG, McMillan CW. Congential dyserythropoietic anemia--type IV. J Pediatr 1975; 87:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/103\">",
"      Heimpel H, Schwarz K, Ebn&ouml;ther M, et al. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 2006; 107:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/104\">",
"      Tamary H, Dgany O, Proust A, et al. Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol 2005; 130:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/105\">",
"      Dgany O, Avidan N, Delaunay J, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 2002; 71:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/106\">",
"      Schwarz K, Iolascon A, Verissimo F, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 2009; 41:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/107\">",
"      Amir A, Dgany O, Krasnov T, et al. E109K is a SEC23B founder mutation among Israeli Moroccan Jewish patients with congenital dyserythropoietic anemia type II. Acta Haematol 2011; 125:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/108\">",
"      Iolascon A, Russo R, Esposito MR, et al. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica 2010; 95:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/109\">",
"      Iolascon A, Delaunay J, Wickramasinghe SN, et al. Natural history of congenital dyserythropoietic anemia type II. Blood 2001; 98:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/110\">",
"      Lind L, Sandstr&ouml;m H, Wahlin A, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet 1995; 4:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/111\">",
"      Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet 2010; 87:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/112\">",
"      Lavabre-Bertrand T, Blanc P, Navarro R, et al. alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol 1995; 89:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/113\">",
"      Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood 2008; 112:5241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/114\">",
"      Heimpel H, Anselstetter V, Chrobak L, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003; 102:4576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/115\">",
"      Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/116\">",
"      Hollanda LM, Lima CS, Cunha AF, et al. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet 2006; 38:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/117\">",
"      Kratz CP, Niemeyer CM, Karow A, et al. Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation. Leukemia 2008; 22:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/118\">",
"      Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 2005; 131:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/119\">",
"      Ariffin WA, Karnaneedi S, Choo KE, Normah J. Congenital dyserythropoietic anaemia: report of three cases. J Paediatr Child Health 1996; 32:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/120\">",
"      Iolascon A, Sabato V, de Mattia D, Locatelli F. Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant 2001; 27:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/121\">",
"      Ayas M, al-Jefri A, Baothman A, et al. Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/122\">",
"      Remacha AF, Badell I, Pujol-Moix N, et al. Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 2002; 100:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/20/26954/abstract/123\">",
"      Nair V, Das S, Sharma A. Hematopoietic stem cell transplantation in children with genetic defects. Indian Pediatr 2009; 46:241.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5931 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-211.167.112.15-CF2E8830EA-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26954=[""].join("\n");
var outline_f26_20_26954=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9672399\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CONGENITAL PURE RED CELL APLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diamond-Blackfan anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9671287\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Physical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Aase syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ACQUIRED PURE RED CELL APLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Transient erythroblastopenia of childhood (TEC)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Hematologic findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Infectious agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Diagnostic workup",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other bone marrow failure syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      IMPAIRED ERYTHROPOIETIN PRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Anemia of chronic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      ERYTHROID MATURATION DISORDERS AND INEFFECTIVE ERYTHROPOIESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Congenital dyserythropoietic anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9672399\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H353251\">",
"      Diamond-Blackfan anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H353267\">",
"      Acquired pure red cell aplasias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H353340\">",
"      Congenital dyserythropoietic anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5931\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5931|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/45/30430\" title=\"figure 1\">",
"      Course of acute B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5931|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/42/27304\" title=\"picture 1\">",
"      Giant proerythroblast in PRCA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5931|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/58/19372\" title=\"table 1\">",
"      Causes decr RBC production",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/30/12781\" title=\"table 2\">",
"      DBA versus TEC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/39/1661\" title=\"table 3\">",
"      DBA physical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/45/20189\" title=\"table 4\">",
"      Acquired PRCA diff diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/43/24252\" title=\"table 5\">",
"      Congen dyseryth anemias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3738?source=related_link\">",
"      Acquired aplastic anemia in children and young adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=related_link\">",
"      Approach to the child with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36441?source=related_link\">",
"      Causes of congenital and acquired sideroblastic anemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/49/25370?source=related_link\">",
"      Chelation therapy for iron overload states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32312?source=related_link\">",
"      Epidemiology and laboratory diagnosis of parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36616?source=related_link\">",
"      Hematologic manifestations of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27303?source=related_link\">",
"      Hematologic problems in children and adolescents with systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17030?source=related_link\">",
"      Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26842?source=related_link\">",
"      Inherited aplastic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=related_link\">",
"      Iron overload syndromes other than hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4458?source=related_link\">",
"      Megakaryocyte biology and the production of platelets",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8058?source=related_link\">",
"      Pathophysiology of beta thalassemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=related_link\">",
"      Regulation of erythropoiesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31767?source=related_link\">",
"      Treatment and prevention of parvovirus B19 infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_20_26955="Presenting symptoms MG";
var content_f26_20_26955=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F70475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F70475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Presenting symptoms of myasthenia gravis and the major considerations in the differential diagnosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Presenting symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other disorders to consider",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ocular (50 percent)",
"       </td>",
"       <td>",
"        Brainstem and cranial nerve lesions (including Horner's syndrome), thyroid ophthalmopathy, oculopharyngeal muscular dystrophy, chronic external ophthalmoplegia (mitochondrial disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bulbar (15 percent)",
"       </td>",
"       <td>",
"        Brainstem and multiple cranial nerve lesions, motor neuron disease, obstructive or malignant lesion of the nasal and oropharynx",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limb weakness (&lt;5 percent)",
"       </td>",
"       <td>",
"        Motor neuron disease, chronic inflammatory demyelinating polyneuropathy (CIDP) and other motor neuropathies, multiple radiculopathies, Lambert-Eaton myasthenic syndrome, myopathies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isolated neck (uncommon)",
"       </td>",
"       <td>",
"        Motor neuron disease, inflammatory myopathy, paraspinous myopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isolated respiratory (rare)",
"       </td>",
"       <td>",
"        Motor neuron disease, acid maltase deficiency, polymyositis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distal limb (rare)",
"       </td>",
"       <td>",
"        Motor neuron disease, CIDP and other motor neuropathies, distal myopathies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26955=[""].join("\n");
var outline_f26_20_26955=null;
var title_f26_20_26956="Assessment of thyroid function";
var content_f26_20_26956=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patterns of thyroid function tests during assessment of thyroid function",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Serum TSH",
"      </td>",
"      <td class=\"subtitle1\">",
"       Serum Free T4",
"      </td>",
"      <td class=\"subtitle1\">",
"       Serum T3",
"      </td>",
"      <td class=\"subtitle1\">",
"       Assessment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"       Normal hypothalamic-pituitary function",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Euthyroid",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal",
"      </td>",
"      <td>",
"       Normal or high",
"      </td>",
"      <td>",
"       Normal or high",
"      </td>",
"      <td>",
"       Euthyroid hyperthyroxinemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal",
"      </td>",
"      <td>",
"       Normal or low",
"      </td>",
"      <td>",
"       Normal or low",
"      </td>",
"      <td>",
"       Euthyroid hypothyroxinema",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal",
"      </td>",
"      <td>",
"       Low",
"      </td>",
"      <td>",
"       Normal or high",
"      </td>",
"      <td>",
"       Euthyroid: triiodothyronine therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal",
"      </td>",
"      <td>",
"       Low normal or low",
"      </td>",
"      <td>",
"       Normal or high",
"      </td>",
"      <td>",
"       Euthyroid: thyroid extract therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       High",
"      </td>",
"      <td>",
"       Low",
"      </td>",
"      <td>",
"       Normal or low",
"      </td>",
"      <td>",
"       Primary hypothyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       High",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Subclinical hypothyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Low",
"      </td>",
"      <td>",
"       High or normal",
"      </td>",
"      <td>",
"       High",
"      </td>",
"      <td>",
"       Hyperthyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Low",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Subclinical hyperthyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"       Abnormal hypothalamic-pituitary function",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal or high",
"      </td>",
"      <td>",
"       High",
"      </td>",
"      <td>",
"       High",
"      </td>",
"      <td>",
"       TSH-mediated hyperthyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal or low*",
"      </td>",
"      <td>",
"       Low or low-normal",
"      </td>",
"      <td>",
"       Low or normal",
"      </td>",
"      <td>",
"       Central hypothyroidism",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In central hypothyroidism, serum TSH may be low, normal or slightly high.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26956=[""].join("\n");
var outline_f26_20_26956=null;
var title_f26_20_26957="Contents: Pediatric EMS";
var content_f26_20_26957=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?10/42/10926\">",
"       Adult and Pediatric Emergency Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric EMS",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric EMS",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/28/26057\">",
"           Pediatric considerations in prehospital care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/59/26553\">",
"           Prehospital pediatrics and emergency medical services (EMS)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/8/39047\">",
"           Preparing an office practice for pediatric emergencies",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-5913B02DDA-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f26_20_26957=[""].join("\n");
var outline_f26_20_26957=null;
var title_f26_20_26958="Causes of facial palsy";
var content_f26_20_26958=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of facial palsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Idiopathic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bell's palsy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Melkersson-Rosenthal syndrome (recurrent alternating facial palsy, furrowed tongue, faciolabial edema)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Congenital",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Traumatic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myotonic dystrophy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Moebius syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hereditary congenital facial paresis 1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hereditary congenital facial paresis 2",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hereditary hypertrophic neuropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hemifacial microsomia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Poland syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Teratogenesis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Osteopetrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sclerosing bone dysplasias",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trisomy 13, trisomy 18",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Trauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Basal skull fracture",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Penetrating injury to middle ear",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lightning",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Barotrauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neurologic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Opercular syndrome (cortical lesion in facial motor area)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Millard-Gubler syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloid neuropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            External otitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Otitis media",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mastoiditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chickenpox",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diphtheria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpes zoster cephalicus (Ramsey Hunt syndrome)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Encephalitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Poliomyelitis (type 1)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mumps",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mononucleosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leprosy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Influenza",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Coxsackievirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tetanus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Botulism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute hemorrhagic conjunctivitis (enterovirus 70)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gnathostomiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mucormycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cat scratch",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            HIV",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Metabolic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diabetes mellitus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hyperthyroidism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pregnancy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypertension",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vitamin A deficiency",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neoplastic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benign lesions of parotid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cholesteatoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Seventh nerve tumor",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Glomus jugulare tumor",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meningioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hemangioblastoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carcinoma (invading or metastatic)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hemangioma of tympanum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hydradenoma (external canal)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Schwannoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Teratoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fibrous dysplasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Vascular",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anomalous sigmoid sinus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carotid artery aneurysm",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Toxic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thalidomide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ethylene glycol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Alcoholism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Arsenic intoxication",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carbon monoxide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Iatrogenic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mandibular block anesthesia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Antitetanus serum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vaccine treatment for rabies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Postimmunization",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Parotid surgery",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mastoid surgery",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Posttonsillectomy and adenoidectomy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Iontophoresis (local anesthesia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Embolization",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dental",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Autoimmune syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Temporal arteritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thrombotic thrombocytopenic purpura",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Periarteritis nodosa",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Guillain-Barr&eacute; syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Multiple sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myasthenia gravis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Jackson C, von Doersten P. The facial nerve. Current trends in diagnosis, treatment, and rehabilitation. Med Clin North Am 1999; 83:179.",
"      </li>",
"      <li>",
"       Shapiro N, Cunningham MJ, Parikh S, et al. Congenital unilateral facial paralysis. Pediatrics 1996; 97:261.",
"      </li>",
"      <li>",
"       <a href=\"file://www.ncbi.nlm.nih.gov/omim\" target=\"_blank\">",
"        Online Mendelian Inheritance in Man",
"       </a>",
"       .",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26958=[""].join("\n");
var outline_f26_20_26958=null;
var title_f26_20_26959="Endogenous Candida endophthalmitis";
var content_f26_20_26959=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Endogenous Candida endophthalmitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endogenous Candida endophthalmitis showing fungal chorioretinal (white) lesions, not obscured by overlying vitritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marlene Durand, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_20_26959=[""].join("\n");
var outline_f26_20_26959=null;
